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Abstract 
RNF4 belongs to the family of SUMO-targeted ubiquitin E3 ligases (STUbLs). 
The role of STUbLs in maintaining genomic stability was first discovered in yeast. The 
yeast STUbL mutants displayed genomic instability, elevated mutation rates, sensitivity 
to DNA damaging agents and also demonstrated synthetic lethality with other DNA 
repair genes. Although the role of vertebrate RNF4 in the DNA damage response was 
not yet established, it could rescue the Schizosaccaromyces pombe STUbL mutant 
phenotypes, showing that RNF4 is a functional homologue of the yeast STUbL proteins, 
and that it might be implicated in the vertebrate DNA damage response.  
A homozygous knockout of RNF4 in the DT40 chicken lymphocyte cell line 
was generated to investigate the involvement of vertebrate RNF4 in protecting cells 
against DNA damage. Although the complete loss of RNF4 did not affect cell 
proliferation or cell cycle distribution, the RNF4 -/- cells exhibited a selective 
hypersensitivity to some S-phase specific DNA damaging agents. This hypersensitivity 
could be rescued by introducing an ortholog of RNF4 from another vertebrate species, 
and this was dependent on a functional ubiquitin E3 ligase activity of RNF4.  
To explore the physiological function of RNF4 in the context of a whole 
organism, Danio rerio was chosen as an in vivo model. Danio rerio RNF4 shared 
similar in vitro biochemical characteristics as RNF4 from other vertebrates – it was able 
to autoubiquitylate itself and also ubiquitylate SUMO2 chains. In Danio rerio, RNF4 is 
a maternally provided gene and is highly expressed in the adult gonads. In the ovaries, 
RNF4 expression was restricted to the early stage oocytes, suggesting a possible role in 
oocyte development. Loss-of-function studies in Danio rerio were performed using 
morpholino knockdown and zinc-finger knockout technologies, and the depletion of 
xviii  
RNF4 in zebrafish did not affect early embryonic development or viability of the 
animal.  
The results presented in this thesis suggests that while vertebrate RNF4 is not 
likely to be an essential gene in some vertebrates, it plays a role in the DNA damage 
response and might be implicated in gonad development in Danio rerio. The zinc-finger 
knockout model has just been established and a more in-depth analysis is necessary to 
shed more light on the in vivo functions of RNF4.
1  
Chapter One: Introduction and aims of the study 
1.1 Ubiquitin and the ubiquitin conjugation pathway 
1.1.1 The discovery of ubiquitin 
Ubiquitin is a small 76-amino acid, 8.5-kDa, single domain polypeptide that is 
involved in posttranslational modifications of proteins. It was named ‘ubiquitin’ based 
on the observation that it is present in all eukaryotic cells and is also highly conserved 
across all eukaryotic species. Ubiquitin was initially isolated and identified as part of an 
ATP-dependent proteolytic system in reticulocyte lysates (Ciechanover et al., 1980a; 
Ciechanover et al., 1980b). It was shown to regulate intracellular protein degradation 
independent of the lysosomal degradation pathway. The authors noted that the direct 
covalent conjugation of ubiquitin to its substrate proteins was essential in this protein 
degradation pathway. Another significant early discovery was the isopeptide linkage 
between ubiquitin and histone2A, implicating ubiquitylation in histone modification, 
and suggesting its role in gene regulation and expression (Busch and Goldknopf, 1981; 
Goldknopf and Busch, 1977). 
 
1.1.2 The ubiquitin conjugation pathway 
The concerted enzymatic processes required for the conjugation of ubiquitin to 
target proteins are defined as the ubiquitin conjugation pathway (Figure 1.1). The 
ubiquitin-activating enzyme, E1, mediates the initial step in this pathway. E1 catalyses 
the activation of ubiquitin by forming a ubiquitin-adenylate intermediate via the 
displacement of pyrophosphate (PPi) from ATP (Ciechanover et al., 1981; Haas and 
Rose, 1982; Haas et al., 1982). Subsequently, an energy-rich thioester linkage is formed 
between the carboxyl group of the C-terminal glycine residue of ubiquitin and the thiol 
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group of the active site cysteine residue of E1, releasing AMP. Activated ubiquitin is 
then transferred to the active site cysteine residue of the ubiquitin-conjugating enzyme 
(E2) via a thioester transacylation process (Ciechanover, 1991). In the final step of the 
ubiquitylation process, an E3 ubiquitin ligase catalyses the formation of an isopeptide 
bond between ubiquitin and a lysine residue on the substrate protein. 
 
 
Figure 1.1: Schematic representation of the ubiquitin conjugation pathway 
 
The ubiquitin activating enzyme (E1) initiates the ubiquitylation reaction by forming a 
thioester bond with ubiquitin, hydrolysing ATP in the process. The E2-conjugating 
enzyme receives the activated ubiquitin from E1, forming a thioester linkage with it. 
The E3 ligase brings the E2 and the protein substrate in close proximity and mediates 
the formation of an isopeptide bond between ubiquitin and a lysine residue on the 
susbtrate protein. Deubiquinating enzymes (DUBs) reverse the ubiquitylation reaction 
by hydrolysing the isopeptide bond between ubiquitin and the lysine residue on the 
substrate. This generates free ubiquitin which is then channelled to the conjugation of 
other substrates.  
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The relative affinities of the enzymes are altered upon binding to their respective 
partners, directing the progression of the conjugation pathway to completion. For 
instance, the formation of an E1-ubiquitin thioester (E1~Ub) enhances the affinity of E1 
for free E2 (Hershko et al., 1983; Miura et al., 1999; Pickart, 2001). This facilitates the 
release of the uncharged E1 after ubiquitin is transferred to E2. On the other hand, E3 
ligases have a weaker affinity for free E2s as compared to E2-ubiquitin thioesters 
(E2~Ub) (Kawakami et al., 2001; Kerscher et al., 2006; Plechanovova et al., 2011; 
Siepmann et al., 2003). This propels the binding of E2~Ub to E3, and promotes the 
subsequent release of free E2.  
Due to the lack of sequence homologies in ubiquitylated sites on proteins, there 
is no known primary consensus sequence that can predict which lysine residue on a 
protein is a preferred target for ubiquitylation, although the presence of basic residues 
may enhance the reactivity of a nearby lysine residue (Deshaies and Joazeiro, 2009). 
The embedded code hypothesis suggests that the primary sequence, post-translational 
modifications and protein-folding state of a substrate contribute to its recognition by the 
ubiquitin machinery (Jadhav and Wooten, 2009). Examples of ubiquitin substrate 
recognition signals include the stabilizing or destabilizing N-terminal amino acids in the 
N-end rule (Tasaki et al., 2012); the PEST (proline-glutamate-serine-threonine) 
sequence motif that is associated with ubiquitin-dependent protein degradation and also 
shown to be dependent on the phosphorylation of the serine or threonine residue (Meyer 
et al., 2011; Rogers et al., 1986; Spencer et al., 2004); the TEK box sequence near to the 
site the assembly of Lys11 ubiquitin chains by the APC/C (Jin et al., 2008); and post-
translational modifications such as N-glycosylation and hydroxylation of proline (Ivan 
et al., 2001; Yoshida, 2003; Yoshida et al., 2002). 
Although lysine is the amino acid most commonly targeted for ubiquitylation, 
recent studies have shown that cysteine, serine and threonine residues may also be 
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ubiquitylated (Cadwell and Coscoy, 2005; Ravid and Hochstrasser, 2007; Wang et al., 
2007b). 
The conjugation of ubiquitin onto a target protein is dynamic and reversible via 
the proteolytic activity of deubiquitinating enzymes (DUBs). DUBs were shown to 
associate with the 26S proteosome, cleaving off ubiquitin from modified proteins that 
were targeted for proteasomal degradation, enabling the recycling of free ubiquitin 
(Verma et al., 2002; Yao and Cohen, 2002). In addition to the deubiquitylation of 
modified proteins, DUBs are also required for the proteolytic processing of ubiquitin to 
the mature form, which has an exposed C-terminal di-glycine motif.   
 
1.1.3 Components of the ubiquitin conjugation pathway 
The complexity of the ubiquitin network can be attributed to the hierarchical 
organization of the E1-E2-E3 cascade. In humans, there are only two known E1 
enzymes, Ube1 and Uba6. These E1s charge different groups of E2s with ubiquitin 
(Haas et al., 1982; Jin et al., 2007). There are approximately 30 to 40 E2s, all possessing 
a conserved 150 to 200 amino-acid core catalytic domain (Pickart, 2001), the ubiquitin-
conjugating domain (UBC). Residues in the UBC are needed for interactions with 
ubiquitin, E1 and E3s.  
In contrast to the number of E1s and E2s, there are several hundreds of E3 
ligases that have been identified. There are four main families of ubiquitin E3 ligases 
based on the proteins’ characteristic structural domains – HECT (Homologous to E6-
AP Carboxy Terminal), RING (Really Interesting New Gene), U-box, and RBR (RING 
in between RING). 
Observations from structural studies of known E3 ligases have shown that these 
proteins possess substrate-binding motifs, indicating their contribution to the substrate 
specificity of a ubiquitylation reaction (Hao et al., 2007; Kussie et al., 1996; Liu and 
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Nussinov, 2009). As each E3 ligase may interact with several E2 enzymes, it is the 
combination of a specific E2 and E3 that determines the type of ubiquitin modification 
on the substrate, and therefore, the outcome of the substrate. 
 
1.1.3.1 HECT E3 ligases 
One of the earliest characterized human E3 ligases, E6-AP, belongs to the 
family of HECT E3 ligases. It was discovered as the ubiquitin E3 ligase responsible for 
the polyubiquitylation of p53 that leads to its degradation in human papilloma virus 
(HPV)-infected cells (Scheffner et al., 1993). The HECT E3 ligases differ from the 
other two families of E3 ligases in the molecular mechanism of the final step in the 
ubiquitylation cascade. Unlike the RING and U-box E3 ligases, HECT E3 ligases 
mediate the transfer of ubiquitin from E2 to itself, forming a thioester bond with 
ubiquitin before transferring it to the target lysine on the substrate protein (Huibregtse et 
al., 1995; Scheffner et al., 1995). On the other hand, RING and U-box E3 ligases bind 
to both E2 and the substrate protein, and effect a direct transfer of ubiquitin from E2 to 
the substrate.  
The HECT domain is composed of two lobes joined by a flexible linker. The N-
terminal lobe contains residues are responsible for substrate recognition and E2 binding, 
while the C-terminal lobe contains the conserved cysteine residue essential for the 
formation of a thiol intermediate with ubiquitin (Schwarz et al., 1998). A structural 
analysis on the NEDD4L HECT domain and its corresponding E2 UbcH5B showed that 
the HECT domain and the E2-ubiquitin thioester forms a compact structure mediated by  
non-covalent interactions. E2-Ub first associates with the N-terminal lobe of HECT 
before inducing a conformational rotation between both the N and C lobes of HECT, 
and between E2 and its bound ubiquitin, driving the transfer of ubiquitin from E2 to 
HECT (Kamadurai et al., 2009). 
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1.1.3.2 U-Box E3 ligases 
The U-box E3 ligases are the most recently established family of E3-ligases. 
The conserved U-box domain of these proteins is critical for their E3 ligase activity. 
The yeast orthologs of these ligases were found to play a role in the elongation of 
ubiquitin chains on modified substrates (Koegl et al., 1999). However, since these yeast 
U-box proteins require the activities of an E1, E2 and E3 ligase for successful 
polyubiquitylation, they were classified as E4 enzymes. The mammalian U-box 
proteins, on the other hand, did not require an accompanying ubiquitin E3 ligase, and 
were able to catalyze polyubiquitylation requiring only an E1 and E2 protein 
(Hatakeyama et al., 2001). 
 
1.1.3.3 RING E3 ligases 
Freemont and colleagues were the first to document the characteristics of the 
RING finger motif-containing family of proteins (Borden and Freemont, 1996; 
Freemont et al., 1991). RING finger proteins possess a distinctive series of histidine and 
cysteine residues (Cys3HisCys4 or C3HC4) that coordinate two zinc atoms in a cross-
brace fashion. Unlike most other protein families, there is little protein sequence 
homology within the RING finger motifs in the family. Instead, it is the zinc ligand 
spacing that is highly conserved. The RING finger motif forms a tight, globular 
structure that is believed to be essential for many important protein-protein interactions. 
Despite a growing number of ubiquitin E3 ligases that have been shown to 
possess and require an intact RING finger for functional E3 ligase activity, it is not 
known if all RING finger proteins are E3 ligases. However, while some RING finger 
proteins demonstrate a lack of any intrinsic ubiquitin E3 ligase activity, they are able to 
form heterodimers with catalytically active RING E3 ligases. A well-studied example of 
this is MdmX, which interacts with Mdm2 via their RING domains. MdmX is inactive 
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on its own, but its interaction with Mdm2 can synergistically enhance ubiquitylation. 
The binding of MdmX to Mdm2 is said to impede the autoubiquitylation and 
proteasomal degradation of Mdm2, enhancing its stability in cells and increasing the 
ubiquitylation of its substrate, p53 (Jackson and Berberich, 2000; Sharp et al., 1999; 
Stad et al., 2001; Stad et al., 2000).  
The RING finger motif in RING E3 ligases is critical and sufficient for their 
ability to catalyze the transfer of ubiquitin from E2 to the acceptor lysine residue on the 
substrate protein. Unlike HECT E3 ligases, RING E3 ligases do not form thioester 
intermediates with ubiquitin. It was hypothesized that RING E3 ligases induce a 
conformational change in the E2~Ub in a way that facilitates the transfer of ubiquitin to 
the substrate (Ozkan et al., 2005). This conformational change involves the 
rearrangement of the E2 active site such that an essential asparagine side chain, which 
usually faces away, is rotated towards the active site cysteine residue. This allows the 
asparagine side chain to stabilize the oxyanion transition state intermediate when 
ubiquitin is transferred to the substrate.  
Dimeric RING E3 ligases show an enhanced affinity to charged E2s over free 
E2s. E2~Ub binds to dimeric RING E3 ligases in an extended conformation such that 
E2 associates with the residues on one RING domain while the Ile44 hydrophobic patch 
of ubiquitin interacts with the hydrophobic side chain of a conserved tyrosine residue in 
the dimerization motif of the other RING monomer. This binding of the E2-ubiquitin 
thioester across the RING E3 dimer activates the thioester bond for catalysis for the 
release of ubiquitin for binding to the substrate (Plechanovova et al., 2011). 
The residues near the RING motif are usually required for E2 binding.  These 
E2-binding residues often lie within the loop regions connecting the RING central helix 
to the zinc coordination sites (Freemont, 2000). In contrast, the residues involved in 
substrate recognition do not usually lie within the RING motif. In some cases, where 
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RING E3 ligases function as a multi-protein complex, a separate subunit may bind the 
substrate. Cullin-RING ubiquitin ligases are an extensive group of RING E3 complexes 
that are made up of a cullin scaffold protein, a RING finger protein, a variable 
substrate-recognition subunit (SRS) and one or more adaptor proteins. Eukaryotes have 
multiple cullins and each cullin associates with a specific set of RING and SRS proteins 
(Bosu and Kipreos, 2008). The SCF (Skp1-Cullin-FBox protein) E3 ligase is an 
example of a well characterized RING E3 ligase complex, in which Rbx1 (RING-Box1) 
bears the RING finger motif while the Fbox protein contains the substrate-specific 
binding site (Deshaies, 1999; Skowyra et al., 1997). Table 1.1 shows examples of some 
known RING E3 complexes and their biological functions. 
Table 1.1: RING E3 ligase complexes and their functions 
RING E3 
complex 
RING 
finger 
protein 
Substrate 
recognition  
Examples of substrates and roles 
SCF 
(Skp1-
Cullin-
FBox) 
Rbx1 
(Ohta et 
al., 1999) 
FBox 
proteins 
(Lyapina et 
al., 1998) 
Cell cycle regulation – targets Cyclins D and E 
for degradation (Nakayama et al., 2000; Russell 
et al., 1999; Yeh et al., 2001; Yu et al., 1998); 
signal transduction and transcription – regulates 
degradation of I"B#, the inhibitor of the NF"B 
transcription factor (Fuchs et al., 1999; 
Hatakeyama et al., 1999; Spencer et al., 1999; 
Wu and Ghosh, 1999; Yaron et al., 1998) 
APC/C 
(Anaphase-
promoting 
complex/ 
cyclosome) 
Apc11 Dbox 
Mediates metaphase to anaphase transition by 
inducing the degradation of securin and cyclin 
B, and mitotic exit by degradation of Aurora A 
and Plk (Peters, 1998; Rape et al., 2006) 
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RING E3 
complex 
RING 
finger 
protein 
Substrate 
recognition  
Examples of substrates and roles 
VCB 
(VHL-
Elongin C/ 
Elongin B) 
Rbx1 
VHL (von 
Hippel-
Lindau) 
Loss or mutations in the VHL gene causes 
inherited predisposition to some cancers 
(Melmon and Rosen, 1964). Regulates hypoxia-
mediated transcription by ubiquitylating the 
HIF1# and HIF2# (Iwai et al., 1999; Kamura et 
al., 1999; Lisztwan et al., 1999; Maxwell et al., 
1999). 
CRL4 
(Cullin 
RING 
ligase 4) 
Rbx1 
DDB1 
(DNA-
damage 
binding 
protein 1) 
Induces ubiquitylation of Cdt1 replication 
licensing factor, thus regulating DNA 
replication (Higa et al., 2003; Hu et al., 2004; 
Jackson and Xiong, 2009; Jin et al., 2006; 
Zhong et al., 2003). 
Mdm2-
MdmX 
Mdm2 Mdm2 
Ubiquitylation and degradation of p53 (Gu et 
al., 2002; Linares et al., 2003; Shadfan et al., 
2012; Wang et al., 2011)  
 
 
1.1.3.4 RBR E3 ligases 
Members of the RBR family possess two RING domains with an intervening in 
between RING (IBR) domain. The N-terminal RING (or RING1) has a canonical 
C3HC4 structure that coordinates 2 zinc ions while the C-terminal RING (or RING2) 
binds only one zinc ion (Eisenhaber et al., 2007). Together, these three motifs make up 
the RBR domain, which is implicated in mediating interactions between proteins. A 
subset of members in this family was shown to possess ubiquitin E3 ligase activity. 
Most of the known RBR ubiquitin E3 ligases, such as Parkin (Marin et al., 2004), 
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recruit the corresponding E2s and substrate via the RING1 domain, but it may not 
always be the case as some non-RBR regions have shown to mediate interactions with 
substrates (Huang et al., 2006; Ito et al., 2003; Niwa et al., 2002). Although the Parkin 
and the parkin-like cytoplasmic (PARC) RBR E3 ligases have shown to function 
independently in vitro, they have shown to associate with the components of the SCF 
E3 ligase complex, suggesting that they might carry out their ubiquitin ligase function 
in a multimeric complex (Staropoli et al., 2003). The ubiquitylation mechanism of the 
RBR E3 ligases are also described to be a RING-HECT hybrid because of the N-
terminal RING1 which associates with E2s, and a conserved active site cysteine residue 
in the C-terminal RING2 domain (Wenzel and Klevit, 2012). This was shown for the 
RBR-containing catalytic subunit of the linear ubiquitin chain assembly complex 
(LUBAC), which transfers ubiquitin to its substrate via a thioester intermediate through 
its RING2 conserved cysteine (Stieglitz et al., 2012).  
 
1.1.4 Types of ubiquitin chain linkages 
A single ubiquitin peptide has 7 lysine residues (Lys6, 11, 27, 29, 33, 48 and 63) 
and each of these is a potential acceptor for the covalent conjugation of another 
ubiquitin peptide. This enables the assembly of ubiquitin polymers that may vary in 
length and linkage. Polymeric ubiquitin chains can be assembled in two ways: in a 
sequential manner such that the ubiquitin chain is created on the substrate progressively, 
or, in an en bloc manner, where the ubiquitin chain is built on the E2~Ub then 
transferred to the substrate (Deshaies and Joazeiro, 2009).   
The type of ubiquitin modification can be classified into four general groups 
(Figure 1.2)(Ikeda and Dikic, 2008). The first group is monoubiquitylation – where a 
single ubiquitin peptide is conjugated to a lysine residue on the substrate protein. 
Multiple monoubiquitylation may also occur on a substrate that possesses multiple 
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lysine residues available for ubiquitylation. 
 
 
Figure 1.2: Types of ubiquitin linkages that may be formed on substrates 
 
There are four main groups of ubiquitin conjugations: monoubiquitylation (which may 
occur singly or on more than one lysine residue in a substrate); homotypic ubiquitin 
chains which are made up of the same lysine linkages between the ubiquitin monomers; 
mixed ubiquitin chains which are composed of different lysine linkages; and 
heterologous chains which incorporate other ubiquitin-like proteins. Ub: ubiquitin, S2: 
SUMO2 
 
The second group is the homotypic ubiquitin chains. Homotypic ubiquitin 
chains are formed by the sequential conjugation of ubiquitin peptides onto the same 
lysine residue of the preceding ubiquitin peptide. The sequential assembly of ubiquitin 
peptides onto several different lysines results in the third group - mixed ubiquitin 
chains. Finally, heterologous ubiquitin chains consist of polymers of ubiquitin and other 
ubiquitin-like (Ubl) proteins, such as small ubiquitin-like modifier (SUMO) and 
developmentally downregulated 8 (NEDD8).  
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Aside from these, linear ubiquitin chains are synthesized when ubiquitin 
molecules share a peptide linkage with the amino-terminal methionine residue of the 
preceding ubiquitin. They are linked in a head-to-tail fashion and are imperative in 
immune and inflammatory signalling pathways. 
There is no known fixed rule governing what determines the chain linkage 
formed in ubiquitin polymers. For a number of E2 conjugating enzymes, chain linkage 
specificity appears to be an intrinsic property. This is usually due to the presence of a 
non-covalent ubiquitin interaction site on the E2 that positions a particular lysine of the 
acceptor ubiquitin to attack the thioester bond. For example, Ubc13-MMS2 mediates 
the assembly of Lys63-linked chains (Hofmann and Pickart, 1999); Cdc34, Ubc1 and 
Ubc7 form Lys48-linked chains (Banerjee et al., 1993; Rodrigo-Brenni and Morgan, 
2007; Van Nocker and Vierstra, 1991); and UbcH10 assembles Lys11-linked chains on 
APC/C substrates (Jin et al., 2008).  
In cases where the E2 enzyme is less discriminating and is able to assemble 
chains of a variety of linkages, the E3 ligase may determine chain linkage specificity 
via its ubiquitin-binding domains that orient the acceptor lysine residues. In addition, 
some HECT E3 ligases have been described to form only specific ubiquitin chains. For 
instance, E6AP forms Lys48-linked chains on its active site cysteine residue while 
KIAA10 makes either Lys29 or Lys48-linked chains (Kim et al., 2007; You and Pickart, 
2001). The linear ubiquitin chain assembly complex (LUBAC) is a unique example of 
an E3 determining the type of ubiquitin chains form. This RBR E3 ligase-containing 
complex forms only linear ubiquitin chains on its substrates, even when it associates 
with an E2 that has intrinsic linkage specificity (Kirisako et al., 2006).  
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1.1.5 Determining the cellular function of ubiquitin 
The extensive number of E2 and E3 enzymes, and the permutations of their 
combinations contribute to the plasticity of the ubiquitin conjugation system. The types 
of ubiquitin modifications further enhance this. Different ubiquitin modifications may 
effect a variety of biological responses depending on which ubiquitin-binding domain 
(UBD) proteins are recruited. UBDs form non-covalent interactions with ubiquitin via 
its hydrophobic patch that is centered around the residue Ile44 (Hicke et al., 2005). To 
date there are more than 20 families of ubiquitin-binding domains described. Table 1.2 
below summarizes some of the well-studied UBDs.  
 
Table 1.2: Known Ubiquitin Binding Domains (UBD) and their functions (Dikic et 
al., 2009) 
Ubiquitin Binding Domain (UBD) Structure Known Functions 
Ubiquitin-associated domain 
(UBA) 
Proteasomal targeting, kinase 
signaling, autophagy 
Ubiquitin-interacting motif 
(UIM) 
Proteasomal targeting, endocytosis, 
multivesicular body (MVB) 
biogenesis, DNA repair 
Ubiquitin-binding in ABIN and 
NEMO (UBAN) 
Nuclear factor "B (NF"B) signaling  
Ubiquitin-binding motif (UBM) 
#-helix  
 
DNA damage tolerance 
Ubiquitin-binding zinc finger 
(UBZ) 
DNA damage tolerance and NF"B 
signaling 
Polyubiquitin-associated zinc 
finger (PAZ) 
Proteasome function, aggresome 
function, autophagy 
Nuclear protein localization Zinc 
Finger (NZF) 
Zinc 
Finger 
 
Endoplasmic reticulum associated 
degradation (ERAD), MVB biogenesis 
Ubiquitin-conjugating enzyme E2 
variant (UEV) 
DNA repair, MVB biogenesis, kinase 
signaling 
Ubiquitin-conjugating (UBC) 
Ubc-like 
Ubiquitin transfer  
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Some UBDs, like UBAN, which binds specifically to Lys63-linked chains or 
linear ubiquitin chains, have shown to bind preferentially to ubiquitin chains of a 
specific linkage, while other UBDs are more promiscuous. Although much is still 
unknown about the biological significance of every type of ubiquitin modification on a 
particular substrate, it is well-established that monoubiquitylation is pivotal in cellular 
events such as receptor transport, viral budding, DNA repair and chromatin 
modification (Haglund et al., 2003; Huang and D'Andrea, 2006; Shilatifard, 2006); 
Lys48-linked chains target proteins to the proteasome (Thrower et al., 2000), thus 
playing an important role in protein turnover and quality control; Lys63-linked chains 
are of particular importance in regulating the NF"B pathway and DNA-damage 
signaling. In both instances, Lys63-linked chains are a platform for the recruitment of 
key signaling proteins in each pathway.  
Detailed studies in this field are uncovering more information about the roles of 
different ubiquitin modifications. Lys6-linked chains are implicated in DNA repair 
(Nishikawa et al., 2004); Lys11-linked chains formed by the APC/C E3 complex targets 
cell cycle proteins for proteasomal degradation (Jin et al., 2008; Matsumoto et al., 
2010), and Lys29/Lys33 mixed chains modulate the AMPK signaling cascade by 
blocking phosphorylation at residues in the activation loops of kinases (Al-Hakim et al., 
2008). Chastagner and colleagues also showed how the E3 ligase ITCH/AIP4 forms 
Lys29-linked chains that associate with the lysosomal degradation pathway (Chastagner 
et al., 2006). 
1.2 Ubiquitin-like proteins and SUMO 
1.2.1 Ubiquitin-like proteins  
A group of small proteins was found to possess the similar three-dimensional !-
grasp fold as ubiquitin. These are termed the ubiquitin-like (Ubl) proteins and they are 
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able to undergo processing and conjugation in pathways analogous to ubiquitylation, 
except that their conjugation pathways involve their own unique sets of E1, E2, E3 and 
proteolytic enzymes. Table 1.3 summarizes a list of Ubls that have been characterized.  
 
Table 1.3: Ubiquitin-like proteins, their E1 and E2 enzymes, and their functions 
Ubiquitin-like 
protein (Ubl) 
E1 
activating 
enzyme 
E2 conjugating 
enzyme 
Known functions 
Ubiquitin Ube1, Uba6  
30- 40 different 
E2s 
Proteasomal targeting, 
signal transduction, etc 
(Aguilar and Wendland, 
2003; Amerik and 
Hochstrasser, 2004; 
Kerscher et al., 2006).  
SUMO1, 2, 3 
Aos1-Uba2 
(in yeast)/ 
SAE1-
SAE2 (in 
verterbrates) 
Ubc9 
Regulating substrate 
localization and protein 
interactions (Johnson, 
2004). 
Interferon-stimulated 
15 kDa (ISG15) 
UBEL1 UbcH8 
Induced by type I 
interferons; antiviral 
response (Giannakopoulos 
et al., 2005; Zhao et al., 
2005). 
NEDD8 Uba3-Ula1  Ubc12 +Ube2F 
Known substrates are 
cullins for the activation 
and destablization of SCF 
complexes, and p53 for 
mediating transcriptional 
regulation (Xirodimas et 
al., 2004). 
FAT10 UBA6 unknown 
Non-ubiquitin signal for 
proteasomal degradation; 
induced by TNF# and 
IFN$ (Hipp et al., 2005). 
Atg8 (autophagy-
related protein 8) 
Atg7 Atg3 
Atg12  (autophagy-
related protein 12) 
Atg7 Atg10 
Autophagy (Ohsumi, 
2001; Thompson et al., 
2005) 
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1.2.2 SUMO and the SUMO conjugation pathway 
Of all the Ubls, the SUMO family has the largest number of known substrates 
and diverse range of functions such as chromatin remodeling, nuclear transport, DNA 
repair, transcription, signal transduction and cell cycle regulation. The SUMO protein is 
an 11-kDa peptide that has only about 18% of sequence identity with ubiquitin. It is 
found in all eukaryotes and is essential for viability (Fraser et al., 2000; Hayashi et al., 
2002; Nacerddine et al., 2005).  While yeast and invertebrates have been shown to 
possess only one SUMO gene, three SUMO genes were found in vertebrates – SUMO1, 
SUMO2 and SUMO3. The SUMO2 and SUMO3 isoforms differ only in 3 amino acid 
residues at their N-terminus and share a 95% sequence identity, and are thus commonly 
referred to as SUMO2/3.  SUMO1, on the other hand, shares only 50% sequence 
identity with SUMO2/3.  
 
 
Figure 1.3: Multiple sequence alignment of the three human SUMO homologues 
 
SUMO1 shares only 50% identity with SUMO2 and SUMO3, which are highly 
identical and differ only in 3 amino acid residues. 
 
 
As with the other Ubls, the SUMO conjugation pathway is mechanistically 
similar to that of the ubiquitin conjugation pathway. Table 1.4 summarizes the 
components of the vertebrate SUMO conjugation pathway. Only one SUMO E1 and E2 
have been identified to date. In contrast, there are 3 groups of SUMO E3 ligases: the 
protein inhibitors of activated STAT (PIAS) family, the nuclear pore protein, Ran 
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binding protein 2 (RanBP2), and the polycomb group protein, Pc2. Like the RING 
ubiquitin E3 ligases, the SUMO E3s do not form thioester intermediates. These 
different SUMO E3s target different substrates and also display differential activity in 
the conjugation of the different SUMO isoforms. 
 
Table 1.4: Components of the vertebrate SUMO conjugation pathway 
 
One distinct feature of SUMOylation is the highly conserved sequence of amino 
acid residues that are adjacent to the targeted lysine. This SUMO consensus motif is %-
K-X-D/E, where % is a large hydrophobic residue such as isoleucine, valine or leucine, 
and X is any amino acid. The SUMO E2 conjugating enzyme, Ubc9, determines 
substrate specificity by binding to this consensus site (Bernier-Villamor et al., 2002) 
while the SUMO E3 ligase further complements substrate specificity by its interaction 
with another site on the substrate. 
SUMO2/3 isoforms are able to form polymeric chains via sequential 
SUMOylation on lysine 11 on preceding SUMO peptides. In cells, most of the 
SUMO2/3 protein is unconjugated while there is hardly any free, unconjugated 
SUMO1. The pool of free SUMO2/3 is said to be primed for conjugation to critical 
SUMO 
genes  
E1 activating 
enzyme 
E2 
conjugating 
enzyme 
E3 ligase 
SUMO 
proteases 
PIAS  
PIAS1, 
PIAS3, 
PIASx#, 
PIASx!, 
PIASy 
RanBP2  
SUMO1 
SUMO2 
SUMO3 
SAE1/SAE2  
heterodimer 
Ubc9 
Pc2   
SENP1 
SENP2 
SENP3 
SENP5 
SENP6 
SENP7 
(Sentrin-
specific 
proteases) 
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substrates in response to physiological stresses such as heat-shock, while SUMO1 is not 
involved in such cellular responses (Saitoh and Hinchey, 2000). 
SUMO-specific proteases, as with the DUBs, are critical in the proteolytic 
processing of precursor SUMO peptides into their mature form. They are also key 
regulators of global SUMOylation levels in cells via their deconjugation activity. In 
vertebrates, there are six identified Sentrin-specific proteases (SENPs). These six 
SENPs contain a C48 cysteine protease catalytic domain at their C-termini while the 
sequences at their N-termini determine their subcellular localization (Li and 
Hochstrasser, 2003). These six proteases also show different preferences for the various 
SUMO isoforms, as summarized in Table 1.5. 
 
Table 1.5: SUMO-specific proteases, their substrates and their localization (Di 
Bacco et al., 2006; Gong and Yeh, 2006; Reverter and Lima, 2004; Shen et al., 2006a; 
Xu and Au, 2005)  
SENP 
SUMO 
processing 
SUMO 
deconjugation 
Subcellular 
localization 
Tissue expression 
SENP1 
Yes; 
SUMO1 > 
SUMO2 > 
SUMO3 
SUMO1, 
SUMO2/3 
Nuclear pore 
and 
nucleoplasmic 
speckles 
Testes (high), spleen, 
pancreas, liver, ovaries, 
small intestine, thymus 
(low) 
SENP2 
Yes; 
SUMO2 > 
SUMO1 > 
SUMO3 
SUMO2/3 > 
SUMO1 
Nuclear pore Unknown 
SENP3 Unknown 
SUMO2/3 >> 
SUMO1 
Nucleolus Unknown 
SENP5 Unknown 
SUMO2/3 >> 
SUMO1 
Nucleolus Unknown 
SENP6 No 
SUMO2/3 >> 
SUMO1 
Nucleoplasm 
Testes (high), pancreas, 
ovaries, colon, peripheral 
blood leukocytes 
SENP7 Unknown Unknown Nucleoplasm Unknown 
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1.2.2.1 SUMO interacting motifs 
The covalent conjugation of SUMO to a substrate may affect its function by 
altering properties such as its localization, activation, interactions with other proteins 
and half-life. Akin to ubiquitin, the addition of SUMO onto a protein may create or 
block a potential protein interaction site. There have been proteins that are described to 
bind to SUMO non-covalently (Hecker et al., 2006). Detailed analyses of these proteins 
isolated a consensus sequence of amino acids: %-X-%-% or %-%-X-% (where % 
represents valine, isoleucine or leucine; and X is any amino acid). This consensus 
sequence, the SUMO-interacting motif (SIM), forms a hydrophobic ß-sheet that can be 
sandwiched between the groove formed between the ß2 sheet and #1 helix of the 
SUMO protein. Adjacent to the SIM are usually acidic residues and/ or serine, which 
enhance the SUMO-SIM interactions and dictate the orientation in which the SIM binds 
to SUMO (Song et al., 2004).  
SIMs can regulate the function of sumoylated proteins by recruiting downstream 
effectors or directing the disassembly of protein complexes. For instance, the 
recruitment of the Srs2 DNA helicase via its C-terminal SIM, to sumoylated PCNA, a 
DNA processivity factor involved in DNA replication, prevents the assembly of Rad51 
nucleofilaments which are part of the homologous recombination machinery. This 
ensures that DNA replication proceeds smoothly and prevents replication fork stalling 
(Pfander et al., 2005).  
Thymine DNA glycosylase (TDG) is a DNA repair enzyme that removes 
mismatched thymine and uracil bases in double-stranded DNA. The dissociation of 
TDG following the hydrolysis of a mismatched base is dependent on it being 
sumoylated and the binding of its SIM to SUMO, which brings about a protein 
conformational change that weakens its strong binding to the mismatch site (Baba et al., 
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2005). This is an example of the SUMO modification and SIM being on a single protein 
moiety.  
SIMs also play a pivotal role in the localization of cellular proteins. A 
quintessential example of this is the assembly of promyelocytic leukemia (PML) 
nuclear bodies. PML bodies are a dynamic, sub-nuclear domain that is associated with 
active transcription and DNA repair processes effectuated by the different proteins 
located at these bodies. The transcriptional repressor, Death associated protein 6 
(DAXX), TDG and the SUMO E2-conjugating enzyme, Ubc9, are some of the proteins 
present in PML bodies . A large number of these proteins are sumoylated and a 
considerable number interact with SUMO via their SIMs. It was proposed that the 
interactions between SUMO-conjugates and SIMs mediate the nucleation of proteins in 
the PML bodies (Shen et al., 2006b).  
In addition to these roles, SIMs are also able to influence SUMO-conjugation on 
proteins. Several components of the SUMO conjugation pathway - Uba2, PIAS E3 
ligases and RanBP2, possess SIMs and may be recruited by other sumoylated proteins. 
The hydrophobic interaction between the SIMs on these proteins and SUMO may also 
modulate their enzymatic activity. For DAXX,  the non-covalent binding of SUMO to 
its SIM is prerequisite for its covalent modification with SUMO (Lin et al., 2006).  
Finally, SIMs are also an imperative factor in the bridging of the ubiquitin and 
SUMO signaling pathways. Members of the SUMO-targeting ubiquitin E3 ligases 
(STUbLs) protein family are known to possess multiple SIMs which are critical for the 
binding of substrates to be ubiquitylated. STUbLs are discussed in further detail in 
Section 1.3.3. 
 
21  
1.3 Ubiquitin and SUMO in the DNA damage pathway 
1.3.1 DNA damage response and cancer therapy 
Cellular DNA, which carries heritable genetic information vital for a cell to 
function normally, is constantly exposed to environmental factors and stresses that 
create lesions, threatening cell viability and genomic stability. The ability of a cell to 
repair these lesions swiftly and efficiently is essential for its survival, and this is also 
implicated in aging and cancer in an organism. The DNA damage response is an 
extensive conglomerate of protein activity and signalling cascades that extends from the 
initial sensing of the DNA damage signals, to signal transduction and amplification, and 
finally to the activation of protein effectors which bring about cellular changes such as 
cell cycle arrest, DNA repair, and in the event of unsuccessful repair, apoptosis. Figure 
1.4 gives an overview of the sources and types of DNA lesions, and some of the 
corresponding DNA repair mechanisms. DNA repair pathways are extensively studied 
because of the vast number potential drug targets for cancer therapy. Many clinical 
treatments against cancer available today target the unregulated proliferation of cells by 
inducing DNA damage, which leads to cell cycle arrest and eventually, apoptosis. The 
effectiveness of this therapy depends heavily on the efficiency of DNA repair. 
Competent DNA repair responses would remove these damage lesions before the cells 
are killed, opposing the effects of the cancer treatment. As such, inhibitors of DNA 
repair pathways are highly sought after (Helleday et al., 2008; Kelley and Fishel, 2008).  
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Figure 1.4: Overview of DNA damage 
 
The sources of DNA damage may be endogenous or exogenous. Exogenous sources 
include UV radiation, gamma-irradiation, chemicals and viruses. Endogenous sources 
originate from metabolic byproducts (such as reactive oxygen species) and DNA 
replication errors. These result in different DNA lesions such as base damage (due to 
oxidation, hydrolysis or alkylation), DNA crosslinking, the formation of bulky adducts, 
single and double DNA strand breaks, pyrimidine dimers and mismatched bases. Some 
of the well-studied DNA repair mechanisms include base and nucleotide excision 
repair, homologous recombination, microhomology-mediated and non-homologous end 
joining, translesion synthesis,  and mismatch repair.  
 
1.3.2 Ubiquitin and SUMO are important mediators in the DNA damage response 
While it has long been established that phosphorylation is a cornerstone in DNA 
damage signal transduction, an increasing number of studies are showing the 
involvement of other post-translational modifications in the DNA damage response. 
Ubiquitylation and SUMOylation are pivotal in the recruitment, activation and 
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regulation of several key players in various DNA damage responses and repair 
mechanisms. Here, a few significant pathways in which the roles of ubiquitylation and 
SUMOylation have been expounded, will be described.  
 
1.3.2.1 Homologous recombination  
DNA double strand breaks  (DSBs) are the most cytotoxic DNA lesions and are 
repaired by non-homologous end joining (NHEJ), microhomology-mediated end joining 
(MHEJ) and homologous recombination (HR). While NHEJ and MHEJ are error-prone 
and are active throughout the cell cycle, DNA repair by HR takes place during and 
shortly after DNA replication, in the S and G2 phase, where the intact sister chromatid 
acts as a template for repair. HR is also important in meiosis and class-switch 
recombination of T and B-lymphocytes. A model of the key ubiquitylation events in HR 
is depicted in Figure 1.5. Briefly, DNA damage sensors such as the MRN complex 
(Mre11/Rad50/NBS1) (Lee and Paull, 2005; Paull and Lee, 2005) initiate the 
recruitment of DNA damage responsive kinases like ataxia telangiectasia mutated 
(ATM) and DNA-dependent protein kinase (DNA-Pk). This precedes the development 
of a DNA repair micro-environment or DNA damage foci, where critical proteins 
accumulate and are activated to rectify the DNA lesion. These kinases bring about the 
key phosphorylation event on Ser139 of the histone variant H2AX, which is referred to 
as $H2AX. $H2AX is commonly used as a cellular marker for DNA damage foci, and is 
also a docking site for the MDC1 scaffold protein (Stucki et al., 2005). MDC1 is a 
target of phosphorylation by DNA damage responsive kinases and its ATM-
phosphorylated TQXF motif (Mailand et al., 2007) is recognized by the forkhead-
associated domain of RNF8 ubiquitin E3 ligase. RNF8 cooperates with UBC13 E2 
conjugating enzyme to ubiquitylate the histones H2A and H2AX (Mailand et al., 2007), 
and this is required for the subsequent recruitment of RNF168 ubiquitin E3 ligase. The 
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motif-interacting with ubiquitin (MIU) sites on RNF168 bind specifically to the 
ubiquitylated histones, and together with UBC13, it catalyses the accumulation of 
Lys63-linked polyubiquitin chains at the DNA DSB foci (Doil et al., 2009; Stewart et 
al., 2009). The initiation and amplification of the ubiquitin signal by RNF8 and RNF168 
E3 ligases are essential for the downstream recruitment of DNA repair effectors such as 
Rad18, 53BP1 and BRCA1.  
The accumulation of HERC2 ubiquitin E3 ligase at DNA DSBs is dependent on 
its interaction with the FHA domain of RNF8. HERC2 stabilizes the interaction 
between RNF8 and UBC13, resulting in a preferential generation of Lys63-linked 
polyubiquitin chains over other types of ubiquitin conjugates. HERC2 stabilizes the 
localization of RNF168 at the DNA damage foci (Bekker-Jensen et al., 2010), and 
contributes to the recruitment of 53BP1. However, the mechanism by which 53BP1 is 
recruited via ubiquitination has yet to be defined as it lacks ubiquitin binding motifs and 
is not known to bind to any of the ubiquitin-binding proteins at DNA DSBs.  
BRCA1 (breast cancer type 1 susceptibility protein), a tumour suppressor 
protein which is implicated in genetic predisposition to breast and ovarian cancers, is 
essential for functional HR repair. BRCA1-deficient cells display radiation sensitivity 
and have impaired HR (Moynahan et al., 2001). BRCA1 recruitment to the DNA 
damage foci is dependent on ubiquitylation. Phosphorylated BRCA1 interacts with the 
receptor associated protein 80 (RAP80) adaptor protein via Abraxas (Wang et al., 
2007a; Yan et al., 2007). RAP80 possesses two ubiquitin-interating motifs (UIM) which 
bind specifically to the Lys63-linked polyubiquitin chains synthesized by RNF8 and 
RNF168, bringing BRCA1 to the damage foci.  
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Figure 1.5: The key 
involvement of ubiquitylation in 
homologous  
recombination. 
 
The star represents the site of a 
DSB and green cylinders depict 
ubiquitin E3 ligases. Sensing of 
DNA damage induces the 
phosphorylation of histones H2A 
and H2AX by DNA damage 
responsive kinases. MDC1 binds 
to $H2AX and is phosphorylated. 
MDC1 acts as a scaffold for the 
docking of RNF8 via its FHA 
domain. RNF8 associates with 
UBC13 E2 and directs the 
ubiquitylation of the H2A histone 
variants.   
RNF168 binds to the 
ubiquitylated histones via its 
MIU. It also associates with 
UBC13, leading to the generation 
of Lysine63 polyubiquitin chains.  
 
These polyubiquitin chains are a 
binding site for repair proteins 
such as Rad18, which is recruited 
via its UBZ domain. The RAP80 
adapter protein binds via its UIM, 
tethering the Abraxas-BRCA1 
complex with it. Abraxas forms a 
complex with phosphorylated 
BRCA1. 53BP1 is recruited via a 
pathway downstream of HERC2, 
which is recruited via RNF8’s 
FHA domain.  
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Like ubiquitylation, the SUMO conjugation pathway is also integral to a 
functional HR process.  An early event in HR is the 5’ to 3’ resection of the broken ends 
of DNA, generating single-stranded DNA which is bound by replication protein A 
trimeric complex (RPA) and Rad52. Rad52 mediates the removal of RPA in exchange 
for Rad51 recombinase at the DSB. Rad51 nucleofilaments are assembled and stimulate 
strand exchange and recombination (Jackson, 2002). Sacher, M. and colleagues 
demonstrated that the SUMOylation of Rad52 stabilizes it at DSBs and prevents its 
ubiquitin-dependent degradation (Sacher et al., 2006). In addition, the successful 
assembly of Rad51 nucleofilaments is also dependent on the SUMOylation of the 
RPA70 subunit of RPA (Dou et al., 2010). SENP6 binds to RPA70 and keeps it in a 
hypo-sumoylated state, preventing the formation of Rad51 nucleofilaments in normal S-
phase cells, but in the event of replication stress or DSBs, SENP6 dissociates from 
RPA70.  
The accumulation of SUMO1 and SUMO2/3 at DNA DSBs is mediated by the 
SUMO E3 ligases PIAS1 and PIAS4 (Galanty et al., 2009). The loss of PIAS4 resulted 
in a failure to recruit both BRCA1 and 53BP1 while the loss of PIAS1 prevents BRCA1 
recruitment. BRCA1 is a target for SUMO2/3 conjugation, and its SUMOylation 
contributes to its ubiquitin E3 ligase activity, which induces the production of Lys-6 
polyubiquitin chains at DSB foci (Morris et al., 2009). On the other hand, 53BP1 or one 
of its interacting partner is the major SUMO1 substrate at DNA DSBs. This is mediated 
by PIAS4 SUMO E3 ligase, which was also shown to be required for histone H2A 
ubiquitylation. Although the depletion of PIAS4 does not affect the localization of 
RNF8 to the DNA DSBs, it prevents the ubiquitylation of the H2A histone variants, 
suggesting that the mere recruitment of RNF8 to the damage foci is insufficient and 
SUMOylation is required to activate its ubiquitin E3 ligase.  
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1.3.2.2 Translesion synthesis 
Translesion synthesis (TLS) is defined as the process whereby lesions in DNA 
are bypassed during DNA replication by means of switching the type of DNA 
polymerases from a high fidelity replicative polymerases to a low fidelity translesion 
polymerases. This mechanism is crucial in the prevention of replication fork stalling 
which may eventually lead to replication fork collapse, generating cytotoxic DNA 
DSBs. The DNA sliding clamp, proliferating cell nuclear antigen (PCNA), plays a 
central role in instigating TLS in S phase. Depending on the ubiquitin or SUMO 
conjugation on its Lys164 residue, PCNA might engage different DNA polymerases.  
In normal replicating cells, PCNA is sumoylated, enabling the recruitment of the 
DNA helicase Srs2, which has SIMs that bind to the SUMO conjugate. Srs2 inhibits the 
assembly of Rad51 nucleofilaments, preventing unnecessary DNA recombination 
(Krejci et al., 2003; Veaute et al., 2003). In the event of replication stress due to the 
presence of lesions in the replicating DNA, stalling of the replication fork generates 
single stranded DNA which is quickly bound by RPA (Davies et al., 2008). RPA 
recruits Rad18 RING E3 ligase, and together with Rad6 ubiquitin E2 conjugating 
enzyme, results in the monoubiquitylation of PCNA on Lys164. This is the signal for 
TLS polymerases such as Pol! and Pol" which possess a PCNA binding motif, PIP box, 
as well as ubiquitin binding domains like UBM and UBZ, to be recruited for TLS 
(Kannouche et al., 2004).   
If TLS allows DNA replication to proceed successfully, the DUB USP1 removes 
the ubiquitin conjugate on PCNA. In some cases, depending on the type of DNA lesion 
or if TLS fails, PCNA may become polyubiquitylated with Lys-63 linked chains, 
mediated by UBC13-MMS2 E2 complex and Rad5 RING E3 ligase. This initiates error-
free bypass, of which the exact mechanism and molecular targets are still unclear.  
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1.3.2.3 The Fanconi Anaemia pathway 
The Fanconi Anaemia (FA) pathway is responsible for the DNA damage 
response to interstrand crosslinks (ICL) by integrating the HR and TLS signalling 
pathways. This DNA damage pathway is associated with an autosomal recessive or X-
linked disease of the same name, which is hallmarked by chromosomal instability, 
hypersensitivity to DNA crosslinkers and a predisposition to cancers like leukemia and 
squamous cell carcinoma (Niedernhofer et al., 2005). There are a total of 13 FA genes, 
of which 8 (FANCA, B, C, E, F, G, L and M) assemble to form a core, active ubiquitin 
E3 ligase complex, with FANCL being the main catalytic component. FANCD2 is the 
key substrate for the core E3 ligase complex (together with the E2, UBE2T) and its 
monoubiquitylation on Lys561 is fundamental in this pathway (Alpi et al., 2007; Alpi et 
al., 2008; Garcia-Higuera et al., 2001).  
The monoubiquitylation of FANCD2 directs its localization to the sites of ICL, 
where it interacts with components of the HR or TLS pathway. FANCD2 associates 
with BRCA2, leading to the recruitment of Rad51 to drive HR (Hussain et al., 2004; 
Wang et al., 2004). Ubiquitylated FANCD2 is also able to engage the TLS polymerases 
Rev1 and Rev3, possibly through their ubiqutin binding domains (Niedzwiedz et al., 
2004). It was recently shown that the DNA nuclease, FAN1, which has a UBZ-like 
domain, is recruited to ICLs via monoubiquitylated FANCD2, and is critical for the 
successful repair of ICLs (Liu et al., 2010; MacKay et al., 2010). These studies 
demonstrate that a nuclease-dependent mechanism is also involved the FA pathway.  
The ubiquitylation of FANCD2 is regulated in several ways. Other than the 
proper assembly of the core E3 ligase complex, the monoubiquitylation of FANCD2 is 
also dependent on phosphorylation by ATR (Andreassen et al., 2004). FANCD2 
interacts with FANCI in a heterodimeric complex and studies in DT40 knockout cells 
showed that ATR phosphorylates FANCI, and this is a prerequisite for the 
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monoubiquitylation of FANCD2 (Ishiai et al., 2008; Wang, 2008). While it is expected 
that the deubiquitylation of FANCD2 would negatively regulate the FA pathway, the 
loss of USP1 deubiquitylation enzyme in DT40 cells resulted in a hypersensitivity 
rather than resistance to the DNA crosslinking agents, suggesting the importance of 
USP1 in recycling FANCD2 from repaired ICLs (Oestergaard et al., 2007),.  
 
1.3.3 SUMO-targeting ubiquitin E3 ligases (STUbLs) – a link between ubiquitin and 
SUMO  
1.3.3.1 Yeast STUbLs reveal their importance in genome stability 
It was previously hypothesized that the ubiquitin and SUMO pathways were 
antagonistic because most of the lysine residues targeted by ubiquitin ligases could also 
be modified with SUMO. It was believed that while ubiquitin conjugation would target 
a protein for proteasomal degradation, SUMOylation stabilizes it. The discovery of the 
SUMO-targeting ubiquitin E3 ligases (STUbLs) family of proteins demonstrated that 
that these two pathways may be unified for a specific biological function, and showed 
how SUMOylation of a protein can also result in proteasomal degradation. Members of 
the STUbL family are characterized by having two or more SUMO-interacting motifs 
for substrate recognition, as well as a C3HC4 RING domain. Thus, this group of 
ubiquitin E3 ligases specifically target sumoylated proteins.  
The earliest members of the STUbL family, Synthetic Lethal X gene 5 (Slx5) 
and Synthetic Lethal X gene 8 (Slx8) were discovered in budding yeast (Saccharomyces 
cerevisiae) in a synthetic lethal screen with the Sgs1 helicase (a human BLM and WRN 
homologue) of the RecQ family of genes (Mullen et al., 2001). Yeast mutants of Slx5 
and Slx8 showed impaired growth in media containing hydroxyurea (HU), an inhibitor 
of the enzyme ribonucleotide reductase, which depletes deoxyribonucleotides and 
interferes with DNA replication. On the contrary, these mutants were not hypersensitive 
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to transient exposures to HU. In addition, they showed enhanced rates of gross 
chromosomal rearrangements, mutation rates and an increased appearance of DNA 
damage foci (Zhang et al., 2006), suggesting that Slx5 and Slx8 do not function directly 
to restore stalled replication forks but instead prevent the accumulation of DNA lesions 
due to replication stress. Further genetic analyses of Slx8 mutants also showed epistatic 
interactions with HR repair genes such as RAD51 and RAD52 (Burgess et al., 2007; 
Zhang et al., 2006).  
It was later demonstrated that Slx5 and Slx8 functioned as a heterodimeric 
complex that localized to sites of DNA DSBs, via the SIMs on Slx5 (Cook et al., 2009). 
The functional homologues of Slx5 in fission yeast (Schizosaccharomyces pombe) are 
the RING finger proteins Rfp1 and Rfp2. While these two proteins are functionally 
redundant, the deletion of both genes resulted in a DNA damage sensitive phenotype 
similar to that for Slx8. The Rfp1-Rfp2 mutants displayed impaired growth rates, a 
delay in cell cycle progression, and sensitivity to UV-C irradiation and chronic 
exposure to methyl methanesulfonate (MMS), a DNA alkylating agent that stalls 
replication forks (Kosoy et al., 2007).  
Rfp1 and 2 possess SIMs that interact noncovalently with SUMO (Sun et al., 
2007) and each protein forms mutually exclusive heterodimers with Slx8, which 
demonstrated functional ubiquitin E3 ligase activity in vitro. The loss of Slx8 resulted in 
an accumulation of SUMO conjugates, which is likely to be associated with the DNA 
damage phenotype observed (Bylebyl et al., 2003; Prudden et al., 2007). An important 
discovery was that the human ortholog of the Rfp1-Slx8/ Rfp2-Slx8 heterodimers, 
RNF4, could revert the levels of SUMO conjugates in cells and rescue the genome 
instability defects (Kosoy et al., 2007; Prudden et al., 2007). This suggests that the 
function of STUbLs in regulating SUMO homeostasis and maintaining genomic 
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stability is evolutionary conserved. However, STUbLs in higher eukaryotes appear to be 
involved in a heterogeneous mix of pathways and processes, as discussed below. 
 
1.3.3.2 STUbLs in higher eukaryotes have more diversified functions  
Unlike the heterodimers in yeast, the STUbLs in chordates are present as a 
single protein, Ring finger protein 4 (RNF4). The human RNF4 gene was mapped to 
p16.3 on Chromosome 4, a gene-rich region that is highly associated with several 
genetic diseases such as Huntington disease and multiple myeloma (Chiariotti et al., 
1998). The RNF4 protein has four SIMs at its N-terminus, a C3HC4 RING domain and 
a dimerization motif at the C-terminus. The SIMs, zinc-coordinating residues of the 
RING motif, and the dimerization sequence are well conserved across several chordates 
(Figure 4.3).  
In vitro binding assays confirmed that having four SIMs in tandem means that 
RNF4 preferentially binds to polySUMO chains over SUMO monomers, and the 
successful ubiquitylation of polymeric SUMO requires an intact RING domain (Tatham 
et al., 2008). In addition, RNF4 ubiquitylates polySUMO2 in vivo and in vitro, and 
corresponding mass spectrometry analyses indicate that a variety of ubiquitin chains 
(Lys-11, Lys-48, Lys-63 and to a smaller extent, Lys-6) were made (Tatham et al., 
2008). This suggests RNF4-directed ubiquitylation of sumoylated proteins may have 
varying outcomes. Like many other RING E3 ligases, dimerization of RNF4 is also 
essential for its ubiquitin ligase activity (Plechanovova et al., 2011).  
 
1.3.3.2.1 RNF4 in the arsenic treatment of acute promyelocytic leukemia (APL) 
More than 95 % of acute promyelocytic leukemia cases are characterized by the 
expression of a fusion PML-RAR# protein (de The et al., 1991; Rowley et al., 1977). 
RAR# is a hormone-dependent nuclear receptor, which regulates transcription that is 
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required for the differentiation of myeloid cells. PML is a protein that is highly 
abundant in subnuclear compartments, PML bodies. PML-RAR# is a dominant-
negative protein that, in the absence of its ligand, retinoic acid, displays an enhanced 
affinity for transcriptional corepressors, blocking the expression of genes that drive 
myeloid differentiation (Melnick and Licht, 1999).  
The administration of pharmacological doses of retinoic acid results in a 
conformational change in PML-RAR# that favours the binding of transcription 
coactivators over the corepressors, lifting the inhibition on gene transcription for 
myeloid differentiation. However, this form of treatment only results in transient 
remission of the disease (Warrell et al., 1993). On the other hand, treatment with arsenic 
trioxide appeared to be more robust (Soignet et al., 1998). The mechanism of how 
arsenic trioxide results in the remission of the disease was not well understood until it 
was discovered that it induced the proteasomal degradation of the PML-RAR# fusion 
protein (Lallemand-Breitenbach et al., 2001).  
The link between RNF4 and PML was uncovered when the depletion of RNF4 
resulted in an accumulation of SUMO and PML in subnuclear speckles, as well as an 
increased level of SUMOylated PML was observed (Tatham et al., 2008). It was 
previously established that the SUMOylation of PML preceded its proteasomal 
degradation in response to arsenic treatment (Lallemand-Breitenbach et al., 2001), and 
this indicated that polysumoylated PML and PML-RAR# might be targeted by RNF4 
for ubiquitylation. Indeed, in vitro experiments showed that only polysumoylated PML 
and not unmodified PML could be ubiquitylated by RNF4, and the depletion of RNF4 
prevented the arsenic-mediated degradation of PML (Lallemand-Breitenbach et al., 
2008; Tatham et al., 2008). Further analysis demonstrated that arsenic drives the 
localization of PML to PML nuclear bodies where it becomes SUMO-modified. 
Thereafter, RNF4 undergoes a SUMO-dependent relocalization from the nucleoplasm 
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into the PML nuclear bodies where it ubiquitylates PML and ultimately directs it to the 
20S proteasome to be degraded (Geoffroy et al., 2010). 
 These studies not only present PML as the first in vivo substrate of RNF4 
ubiquitin E3 ligase, it accounts for the mechanism by which arsenic can induce 
differentiation in the primary haematopoietic cells upon degradation of PML-RAR# 
(Lallemand-Breitenbach et al., 2008). 
 
1.3.3.2.2 RNF4 and epigenetic regulation  
The methylation of DNA regulates transcription, genomic imprinting and 
development (Reik, 2007). During gametogenesis and postfertilization, genomic DNA 
undergoes a complete demethylation and failure to do so would lead to drastic 
developmental defects (Weiss and Cedar, 1997).  
In a study to identify genes that are instrumental in active DNA demethylation, a 
cell-based gain-of-function screen was performed. In this screen, RNF4 was one of the 
most active hits that enhanced the expression of a reporter driven by a methylation-
silenced promoter (Hu et al., 2010). The reactivation of the methylation-silenced 
reporter by RNF4 required its SIMs and an intact RING domain. However, the 
sumoylated substrate of RNF4 in this pathway has yet to be identified. RNF4 also 
interacts with enzymes of the base excision repair (BER) pathway, thymine DNA 
glycosylase (TDG) and apurinic/apyrimidinic endonuclease (APE1), in a SIMs and 
RING-independent manner. These enzymes are normally involved in the repair of DNA 
mismatch lesions, but have now been shown to be required for RNF4-mediated 
demethylation. The importance of RNF4 and its role in regulating active DNA 
demethylation was further established when the homozygous loss of RNF4 in mice led 
to embryonic lethality. The RNF4 knockout mice suffered from defects in cardiac 
development and this is possibly attributed to the increased genomic DNA methylation 
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observed. Thus, it is likely that RNF4 engages the BER pathway to drive DNA 
demethylation and failure to do so would result in deregulation of developmental genes. 
 
1.3.3.2.3 RNF4 and transcriptional regulation 
Before it was discovered that RNF4 was an ubiquitin E3 ligase, it was shown to 
function as transcription co-regulator. Also referred to as the small nuclear RING finger 
(SNURF), RNF4 localized mainly in the nuclei of cells. It was found to be abundant in 
human foetal tissues but low in most adult human tissues except in the testes (Chiariotti 
et al., 1998). Its functions in transcriptional regulation were unravelled when it 
interacted with the steroid receptors: androgen receptor (AR), progesterone receptor 
(PR) and glucocorticoid receptor (GR), and enhanced their transactivation potential in a 
steroid-dependent manner. While the interaction with these steroid receptors were 
mapped to the N-terminus of RNF4, which overlaps with the SIMs, an intact RING 
domain is dispensable for their activation (Moilanen et al., 1998). Conversely, the 
RING domain of RNF4 is essential for it to stimulate basal transcription from response 
elements of the transcription factors Specificity protein 1 (Sp1) and Activator protein 1 
(AP1) (Moilanen et al., 1998; Poukka et al., 2000). Sp1 modulates genes involved in 
early development while AP1 plays a role in differentiation, proliferation and apoptosis.  
Different regions of RNF4 have been shown to be critical for the interaction 
with various transcription factors (Figure 1.6). In addition, RNF4 also modulates 
transcription differently for different transcription factors. For instance, RNF4 is shown 
to potentiate the transcriptional activity of the murine activator protein of stromelysin 
gene (SPBP) (Lyngso et al., 2000); alleviate the repression by trichorhinophalangeal 
syndrome 1 (TRPS1) on GATA-mediated transcription (Kaiser et al., 2003); and acts as 
a transcriptional co-repressor when in a complex with a novel POZ-AT-hook-zinc 
finger protein (PATZ) (Fedele et al., 2000; Pero et al., 2002). In addition, RNF4 was 
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also shown to bind to DNA and mononucleosomes in a RING-independent manner, 
possibly promoting the assembly of nucleoprotein structures which may influence 
transcriptional activities (Hakli et al., 2001).  
Since all these functions of RNF4 were identified before it was reported that it is a 
STUbL, it is uncertain if its involvement in these transcription pathways are dependent 
on the transcription factors being sumoylated. However, since many of these 
transcription factors are subjected to post-translational modifications (Faus and 
Haendler, 2006), it is likely that RNF4 binds to the sumoylated transcription factors and 
either enhance their activities by promoting dynamic cycling via the proteasome, or 
restrict their activities by decreasing the protein levels by proteasomal degradation 
(Heideker et al., 2009). 
 
Figure 1.6: Enzymes and transcription factors interact with different regions of 
RNF4.  
The extreme N-terminus of RNF4 is responsible for binding to DNA and nucleosomes 
(in a non-sequence specific manner). The region containing SIMs has been reported to 
interact with the steroid receptors: androgen receptor (AR) progesterone receptor (PR), 
glucocorticoid receptor (GC); Goosecoid-like protein (Gscl), a transcription factor 
expressed in early brain and gonad development; trichorhinophalangeal syndrome 1 
(TRPS1), a transcriptional repressor; and the base-excision repair enzymes thymine 
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DNA glycosylase (TDG) and apurinic/apyrimidinic endonuclease (APE1), which can 
bind to RNF4, independent of the SIM sequence. The C-terminal RING domain is 
critical for the interactions with the transcription factors Specificity protein 1 (Sp1), 
POZ-AT-hook-zinc finger protein (PATZ) and activator protein of stromelysin gene 
(SPBP). Some of the E2s that RNF4 engages for ubiquitylation in vitro are also shown. 
(Fedele et al., 2000, Galili et al., 2000, Hakli et al., 2001, Hakli et al., 2004, Hu et al., 
2010 Kaiser et al., 2003, Lyngso et al., 2000, Moilanen et al., 1998). 
 
RNF4 is also implicated in hypoxia-related transcription. The hypoxia-inducible 
factors (HIF) are transcription factors that are present at low levels during normoxia due 
to proteasomal degradation. However, at decreased oxygen levels, they are stabilized 
and accumulate to activate the transcription of genes that enable cells to tolerate the 
hypoxic conditions. The HIF-2# subunit has specific roles in vascular remodelling and 
lung development (Compernolle et al., 2002; Peng et al., 2000) and is modulated by 
several post-translational modifications. RNF4 was shown to specifically target 
SUMO2 conjugated HIF-2# for proteasomal degradation during hypoxia without 
affecting the overall protein level of HIF-2#. Mutating a consensus SUMOylation site 
on HIF-2# resulted in an increase in transcriptional activity, suggesting that 
SUMOylation negatively regulates HIF-2# (van Hagen et al., 2010). Thus, RNF4 might 
be involved in removing this repressed form of HIF-2# during hypoxia.  
The heat shock response in cells is a well-studied example of how an 
environmental stress triggers changes in transcriptional activity to cope with the 
deleterious effects of the stress. Heat shock proteins (HSP) are rapidly induced to act as 
molecular chaperones for aggregated and misfolded proteins.  
In cells, heat shock induces a global increase in SUMO2/3 conjugation 
(Golebiowski et al., 2009), of which one of the substrates is poly-(ADP-ribose) 
polymerase 1 (PARP-1). Other than its involvement in DNA single-stranded break 
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repair, PARP-1 is able to modify proteins by poly ADP-ribosylation and this is 
implicated in stress-responsive modulation of chromatin structure and thus influencing 
transcriptional activity (Kraus, 2008). Martin and colleagues demonstrated that 
polysumoylated PARP-1 is essential for the full activation of the HSP70.1 gene in 
response to heat shock. In addition, RNF4 was shown to bind to polysumoylated PARP-
1 and ubiquitylate it for proteasomal degradation, and this was necessary for the activity 
of the heat-shock-inducible HSP70.1 promoter (Martin et al., 2009). This study 
demonstrates how sumoylation-coupled ubiquitination and degradation may aid the 
rapid recycling of a transcriptional regulator, such as PARP-1, to ensure a continuous 
activation of a promoter by the fresh binding of the transcriptional regulator.  
 
1.3.3.2.4 Drosophila STUbL protein is also involved in transcriptional regulation in 
development 
Degringolade (Dgrn), the STUbL identified in Drosophila melanogaster, has a 
more divergent protein sequence compared to RNF4 in chordates, but still possesses 
four N-terminal SIMs and a C-terminal C3HC4 RING domain. It was shown to be 
implicated in the transcriptional regulation of genes during segmentation and 
neurogenesis in Drosophila (Abed et al., 2011).  
Hairy is a transcriptional repressor and Groucho (Gro) is one of several co-
repressors that can interact with Hairy and modulate its function. Abed and colleagues 
demonstrated that Dgrn relieves the transcriptional repression by the Hairy/Gro 
complex by interacting with both proteins and bringing about the dissociation of the 
complex. The RING domain of Dgrn is responsible for binding to Hairy while the N-
terminal SIMs recognize sumoylated Gro. Dgrn then catalyses the formation of mixed 
ubiquitin chains on Hairy which interferes with its binding to Gro. Dgrn also appeared 
mediate the selective intracellular sequestration of sumoylated Gro by a yet to be 
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uncovered mechanism. The hypothesis that Dgrn opposes Gro-mediated gene repression 
was further substantiated in vivo when the overexpression of Dgrn rescued the mutant 
phenotype (small eyes, loss of sensory bristles) of ectopic Gro. This was dependent on 
Dgrn having intact SIMs and RING domain.  
Hairy belongs to the HES family of transcriptional repressors that have the 
canonical basic-helix-loop-helix (bHLH) protein structure. Similar to Hairy, Dgrn 
negatively regulates these proteins by interacting with the basic domain of this family of 
proteins via its RING domain and assembling polyubiquitin chains on them (Barry et 
al., 2011). As this family of proteins are instrumental in many key developmental 
processes (Kageyama et al., 2007), it is reasonable to suggest that Drgn also has its 
functions in these processes.  
Barry and colleagues generated dgrn null mutants and discovered that like 
STUbLs in yeast, Dgrn also contributed to genomic stability in Drosophila. Most of the 
dgrn null embryos arrested early in development and failed to progress beyond two or 
three nuclear divisions. In addition, they had fragmented and decondensed nuclei which 
are similar to those observed in Drosophila RecQ and SUMO mutant phenotypes. 
Following the work done by Abed et al., Barry et al. also described the role of Dgrn in 
the de-repression of genes controlling sex determination and Notch signalling in 
Drosophila.  
Sex lethal (Sxl) protein is required for female development and misexpression in 
males leads to lethality. Dgrn binds and ubiquitylates the repressor of the Sxl gene, 
Dpn, in a way analogous to its regulation of Hairy.  This is consistent with the 
observation that dgrn null mutants fail to express Sxl, showing that Dgrn is pivotal in 
Sxl transcription. Notch signaling is one of the major developmental signaling pathways 
that regulates progenitor cell fate and differentiation. It is also negatively regulated by 
the activity of Sxl. Dgrn was shown to antagonize Notch signalling via its de-repression 
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on Sxl transcription, or by inhibiting another repressor of the HES family, Enhancer of 
Split complex (E(spl)-C) (Abed et al., 2011). 
 
In summary, RNF4 in higher eukaryotes is shown to be involved in a variety of 
biological processes ranging from arsenic-mediated PML degradation; responses to 
stress such as heat-shock and hypoxia; and key developmental processes like DNA 
demethylation, segmentation and neurogenesis. The involvement of RNF4 in such 
diverse pathways may stem from the fact that it regulates a fundamental process such as 
protein stability and turnover, which in turn affects the transcription genes in these 
diverse pathways. 
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1.4 Aims of this study 
When this research project was initiated, it was not yet clear that RNF4 had a 
part to play in the vertebrate DNA damage response. The striking phenotypes observed 
in yeast STUbL mutants and the ability of human RNF4 to rescue them gave a 
compelling indication that the genome stability role of STUbLs might be conserved 
across eukaryotes (Kosoy et al., 2007; Prudden et al., 2007). At this time, my colleague, 
Dr. Yili Yin, had begun investigating the involvement of RNF4 specifically in DNA 
DSBs, using the siRNA knockdown technology.  
As my PhD programme is divided into two parts (half of it is undertaken at the 
University of Dundee while the other half is at the A*STAR-p53Lab in Singapore), it 
was decided that the objective of my research in Dundee would be to generate a RNF4 
DT40 knockout cell line and determine if RNF4 is required for the protection against 
other types of DNA insults by performing colony formation assays. Generating a clean 
genomic knockout of RNF4 would also minimize the non-specific off-target effects 
sometimes observed with the use of siRNA-mediated knockdowns. The advantages of 
utilising DT40 cells include the ability to determine the effects of the loss of RNF4 on 
cell cycle progression and proliferation, and more reliable rescue experiments can be 
performed with the stable integration of the rescue expression construct.  
The second half of my PhD aims to work towards answering the question of 
what the physiological role of RNF4 is in a whole organism, with the zebrafish as the 
vertebrate model organism of choice. Although a RNF4 mouse knockout has been 
established, its early embryonic lethality leaves little room for a more detailed analysis 
of the in vivo functions of RNF4. On the other hand, zebrafish embryos with lethal 
mutations have been shown to survive longer, mainly because of the late onset of 
zygotic transcription (Dooley and Zon, 2000; North and Zon, 2003). The objectives of 
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this study includes the identification and in vitro biochemical analysis of the novel 
zebrafish RNF4 gene; the generation of polyclonal antibodies against zebrafish RNF4 
so as to faciliate the in vivo studies; and creating and characterizing a zinc-finger 
nuclease knockout of RNF4 in zebrafish.  
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Chapter Two: Materials and Methods 
2.1 General methods  
2.1.1 Cell culture and maintenance 
2.1.1.1 DT40 cell culture 
DT40 cells were grown in RPMI-1640 (Gibco, Invitrogen, CA, USA) 
supplemented with 10 % (v/v) fetal bovine serum (FBS), 1 % (v/v) heat-inactivated 
chicken serum (CS), 2 mM L-Glutamine (Gibco, Invitrogen, CA, USA), 10 !M ß-
mercaptoethanol, 100 U/ml penicillin and 100 !g/ml streptomycin. The cells were 
incubated at 37 °C and 5 % CO2. For antibiotic selection, the concentrations of the 
drugs used were as follows: 0.5 !g/ml of puromycin, 50 !g/ml of Blasticidin and 0.5 
mg/ml of Zeocin. When necessary, DT40 cells were frozen and stored in 70 % (v/v) 
FBS, 20 % (v/v) CS and 10 % (v/v) DMSO. 
 
2.1.1.2 H1299 cell culture and transfection 
H1299 cells were grown in DMEM (Hyclone, ThermoScientific, UT, USA) 
supplemented with 10 % (v/v) FBS, 100 U/ml penicillin and 100 !g/ml streptomycin. 
The cells were incubated at 37 °C and 5 % CO2. One day before transfection, 1.5 x 10
5
 
cells were seeded in each well of a 6-well plate. For immunofluorescence staining, the 
base of each well was lined with five 10 mm-diameter sterile, glass coverslips before 
adding the cell suspension.  
The next day, transfection of the plasmids was carried out using Lipofectamine 
2000 (Invitrogen, CA, USA) according to the manufacturer’s instructions. In summary, 
1.36 !g of each plasmid was incubated for 5 minutes in a total volume of 100 !l 
(topped up with serum-free DMEM). Simultaneously, 3.4 !l of Lipofectamine 2000 
(Invitrogen, CA, USA) was incubated with 96.6 !l of serum-free DMEM. After 5 
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minutes, the DNA-DMEM solution was added to the Lipofectamine-DMEM solution 
and mixed thoroughly. The mixture was allowed to stand at room temperature for 20 
minutes it was added to 500 !l of serum-free media in each of the wells. At 6 hours 
after transfection, the media in the wells was changed to fully supplemented DMEM 
media.  
 
2.1.2 Zebrafish husbandry  
Wild-type AB strain zebrafish were raised and maintained at 28.5 °C, with a 14-
hour light and 10-hour dark cycle. The zebrafish are staged as previously described 
(Kimmel et al., 1995) - the age of embryos is indicated as hours post fertilization (hpf), 
and the age of larvae as days post fertilization (dpf). Embryos are obtained by natural 
spawning, are collected in egg water and kept in a 28.5 °C incubator until 7 dpf, after 
which they are transferred to tanks in the Zebrafish Facility at the Institute of Cell and 
Molecular Biology of the Agency of Science, Technology and Research (IMCB, 
A*STAR), Singapore.  
All the experimental procedures involving treatment or killing of live zebrafish 
were reviewed and approved by the Institutional Animal Care and Use Committee of 
A*STAR, Singapore. They were performed according to the guidelines set by 
Responsible Use and Care of Laboratory Animals course. Homozygous vas::EGFP 
transgenic fish (Krovel and Olsen, 2002) were obtained as a gift from Professor Laszlo 
Orban from Temasek Life Sciences Laboratory, Singapore.    
 
Egg water   
• 0.3 % Sea Salt in 20 L dH2O 
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2.1.3 DNA manipulation and cloning 
2.1.3.1 Polymerase Chain Reaction (PCR) with Vent DNA polymerase 
PCR reactions were prepared as follows: 
• 50 ng of template DNA     
• 5 !l of 10X ThermoPol Reaction Buffer (New England Biolabs, MA, USA)   
• 40 !M MgSO4  
• 200 !M dNTPs   
• 0.5 !M each for forward and reverse primers 
• 0.5 !l of Vent DNA Polymerase (2 U/!l; New England Biolabs, MA, USA) 
• Distilled water to 50 !l 
 
Table 2.1: PCR cycling conditions using Vent DNA polymerase 
Steps Cycling temperature Duration  
1 95 °C   5 minutes 
2 95 °C  30 seconds 
3 56 °C  30 seconds 
4 72 °C  1 minute 
5 Repeat Steps 2 to 4 for 30 cycles 
 
For subsequent applications such as restriction digestion and ligation, the PCR products 
were first column purified using the QIAquick PCR purification kit (Qiagen, CA, 
USA). 
 
2.1.3.2 DNA restriction digestion  
Restriction digestion was performed with the desired restriction enzymes at 37 
°C for 2 hours, after which the reactions were run on a 1 % (w/v) agarose gel in Tris-
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acetate-EDTA (TAE) buffer. The desired DNA bands were then excised and gel-
purified using the Gel Extraction Kit (Qiagen, CA, USA). 
 
2.1.3.3 DNA Ligation  
Ligation was carried out at an insert:vector ratio of 10:1. In essence, 50 ng of 
vector was incubated with the insert in the presence of T4 ligase (New England Biolabs, 
MA, USA) for 2 hours at room temperature. The ligation reaction was terminated by 
heating at 65 °C for 10 minutes. 2 !l of the ligation mix was transformed into DH5# 
competent E. coli cells.  
 
2.1.3.4 Transformation of DH5# E. coli 
Transformation was performed as follows: DNA was incubated with 30 !l of 
competent cells on ice for 30 minutes before a 45 second heat shock in a 42 °C water 
bath. Cells were again incubated on ice for 2 minutes and allowed to recover in 500 !l 
of LB media by shaking at 220 rpm in a 37 °C incubator for 1 hour. The cells were then 
spread on an LB-Ampicillin agar plate. Ampicillin was used to a final concentration of 
100 !g/ ml. The plate was incubated overnight at 37 °C.  
 
2.1.3.5 Preparation of plasmid DNA 
A small-scale preparation of DNA was performed by inoculating a single colony 
from the agar plate in 5 ml of LB-Ampicillin medium and left to shake at 220 rpm 
overnight at 37 °C. The bacteria cells were collected by centrifugation at 2800 g for 20 
minutes at 4 °C. Plasmid DNA was purified from the cell pellet according to the 
instructions in the QIAprep Spin Miniprep Kit (Qiagen, CA, USA). Sequences of the 
cloned constructs were verified by DNA sequencing (The Sequencing Service, 
University of Dundee, UK).  
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2.1.3.6 Site-directed mutagenesis 
The reaction mix for site-directed mutagenesis was prepared as follows: 
• 100 ng of template DNA     
• 5 !l of 10X Cloned Pfu Buffer (Stratagene, CA, USA)   
• 200 !M dNTPs   
• 0.5 !M each for forward and reverse primers 
• 1 !l of Pfu Turbo DNA Polymerase (2.5 U/!l; Stratagene, CA, USA) 
• Distilled water to 50 !l 
 
Table 2.2: Cycling conditions for site-directed mutagenesis PCR with Pfu Turbo 
Steps Cycling temperature Duration  
1 95 °C   30 seconds 
2 95 °C  30 seconds 
3 55 °C  30 seconds 
4 68 °C  1 minute (per kb) 
5 68 °C  7 minutes 
6 Repeat Steps 2 to 4 for 18 cycles 
 
After PCR amplification, 1 !l of DpnI was added (20 U/!l; New England Biolabs, MA, 
USA) and the reaction was incubated at 37 °C for 1 - 2 hours. Subsequently, DNA was 
transformed into E. coli DH5# cells and plasmid DNA was prepared.  
 
2.1.4 Genomic DNA extraction  
2.1.4.1 DT40 cells 
DT40 cells were collected by centrifugation in a bench-top centrifuge at 16 000 
g for 5 seconds. The supernatant was removed and the cells were resuspended in the 
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remaining volume of media. 300 !l of Cell Lysis Solution (Qiagen #158908, CA, USA) 
was added to the resuspended cells and the mixture was pipetted up and down to lyse 
the cells. 100 !l of Protein Precipitation Solution (Qiagen #1045697, CA, USA) was 
then added before vigorously vortexing for 20 seconds. Subsequently, the lysate was 
incubated on ice for 2 minutes before centrifugation at 16 000 g for 7 minutes at 4 °C. 
The supernatant was decanted into a clean 1.5 ml microfuge tube containing 500 !l of 
100 % isopropanol. The sample was mixed by inverting gently 50 times before 
centrifugation at 16 000 g for 20 minutes at 4 °C. The supernatant was discarded and 
500 !l of 70 % (v/v) ethanol was added to wash the DNA precipitate. The DNA 
precipitate was collected by centrifugation at 16 000 g for 20 minutes at 4 °C, the 
ethanol was decanted and the DNA precipitate dried in air. To dissolve the DNA pellet, 
50 !l of DNA Hydration Solution (Qiagen #1045698, CA, USA) was added to the DNA 
precipitate and mixed well before incubating in a 65 °C heat block for 1 hour. The DNA 
in solution was then stored at -20 °C.  
 
2.1.4.2 Zebrafish embryos 
Zebrafish embryos were dechorionated manually with two pairs of forceps and 
washed once with dH2O. 10 !l of embryo DNA extraction buffer was added per embryo 
in a 1.5 ml microfuge tube and the embryos were digested overnight at 50 °C. The next 
day, double the volume of ethanol was added and the samples were kept on ice for 30 
minutes. Next, the samples were centrifuged at 14 000 g for 10 minutes at 4 °C to 
collect the precipitated genomic DNA. The supernatant was removed and the precipitate 
was washed with 70 % (v/v) ethanol in dH2O. The genomic DNA was collected by 
centrifugation again, and allowed to air-dry after the removal of ethanol. The genomic 
DNA was subsequently dissolved in 200 !l of TE buffer and stored at -20 °C.  
 
48  
Embryo DNA extraction buffer 
• 10 mM Tris-HCl, pH 8.0 
• 10 mM EDTA 
• 200 mM NaCl 
• 0.5 % (w/v) SDS 
• 200 !g/ml Proteinase K (Roche #03115836001, IN, USA) 
TE buffer 
• 10 mM Tris-HCl, pH 8.0 
• 1 mM EDTA 
 
2.1.4.3 Juvenile zebrafish 
Scales from juvenile zebrafish (~ 3 to 4 months post-fertilization) were picked 
and digested in fish scale DNA extraction buffer overnight at 50 °C. The next day, the 
samples were heated at 95 °C for 5 minutes to inactivate proteinase K. The genomic 
DNA samples were either used for PCR or stored at -20 °C.  
 
Fish scale DNA extraction buffer 
• 10 mM Tris-HCl, pH 8.0 
• 50 mM KCl 
• 200 mM NaCl 
• 0.5 % (w/v) Tween-20 
• 0.3 % (w/v) NP40 
• 200 !g/ml Proteinase K (Roche #03115836001, IN, USA) 
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2.1.5 PCR screening and sequencing for genotyping 
2.1.5.1 DT40 knockout clones 
Polymerase chain reaction (PCR)-mediated amplification of a region in Exon 5 
of the Gallus gallus RNF4 gene was carried out with the primers listed in Table 2.10. 
100 ng of DT40 genomic DNA was used as the template. PCR was performed utilising 
the ReddyMix PCR Mastermix (ThermoScientific #AB-0608/DC/LD, MA, USA) 
according to the manufacturer’s instructions. 2 !l of the PCR reaction was run on a 1 % 
(w/v) agarose gel containing ethidium bromide and the gel visualised under UV light. 
 
2.1.5.2 F2 juvenile zebrafish 
F2 juvenile zebrafish were genotyped with the genomic DNA extracted from 
their scales using the primers listed in Table 2.24. The PCR reaction mix was prepared 
as follows: 
• Genomic DNA                                                                               2 !l 
• Forward primer                                                                           0.5 !l 
• Reverse primer                                                                            0.5 !l 
• 2X DreamTaq Mastermix (K107220, Fermantas, Canada)           5 !l 
• dH2O                                                                                               2 !l 
Table 2.3: PCR cycling conditions using DreamTaq polymerase  
Steps Cycling temperature Duration  
1 95 °C   5 minutes 
2 95 °C  30 seconds 
3 Annealing temperature as indicated 
in Table 2.24 
50 seconds 
4 72 °C 45 seconds 
5 Repeat Steps 2 to 4 for 28 cycles 
6 72 °C 7 minutes 
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The PCR products were subsequently separated by electrophoresis and visualized on a 
DNA gel. 
For the determination of the frequency of somatic mutations in zinc-finger 
nuclease injected embryos and the germ-line mutations in juvenile zebrafish, 20 !l PCR 
reactions using the primers in Table 2.23, were set up as follows: 
• 10 !l of genomic DNA 
• 2 !l of 10X NH4 Buffer 
• 2.5 mM MgCl2 
• 500 !M dNTPs 
• 0.5 !l of BioTaq (5 U/!l, Bioline, UK) 
• Nuclease-free H2O to 20 !l 
Table 2.4: PCR cycling conditions using BioTaq polymerase 
Steps Cycling temperature Duration  
1 95 °C   5 minutes 
2 95 °C  30 seconds 
3 62°C 50 seconds 
4 72 °C 45 seconds 
5 Repeat Steps 2 to 4 for 28 cycles 
6 72 °C 7 minutes 
 
2.1.5.2.1 EXOSAP clean up and cycle sequencing 
PCR products amplified from zebrafish genomic DNA to be sequenced were first 
cleaned up by treatment with Exonuclease I and Shrimp Antartic Phosphatase 
(EXOSAP; M0293L and M0289L, New England Biolabs, MA, USA), before 
proceeding with cycle sequencing. For 20 reactions, 40 !l of ExoSAP mix was prepared 
as follows: 
• Exonuclease I                                           1 !l 
51  
• Exonuclease I buffer                              19 !l 
• Shrimp Antartic Phosphatase (SAP)        5 !l 
• SAP buffer                                              15 !l 
2 !l of ExoSAP was added to 5 !l of PCR product, mixed and incubated at 37 °C for 30 
minutes, followed by a 15 minute incubation at 80 °C. 0.5 !l of the reaction mix was 
then subjected to cycle sequencing. The sequencing reads were performed by the DNA 
Sequencing Facility at IMCB, A*STAR, Singapore.  
BIG Dye sequencing reaction 
• Cleaned up PCR product           0.5 !l 
• Sequencing primer                       1 !l 
• BIG Dye                                       4 !l 
• dH2O                                          4.5 !l 
 
Table 2.5: BIG dye cycle sequencing conditions  
Steps Cycling temperature Duration  
1 95 °C   3 minutes 
2 95 °C  30 seconds 
3 52.5 °C 10 seconds 
4 60 °C 3 minutes 
5 Repeat Steps 2 to 4 for 28 cycles 
 
2.1.6 Quantitative Real-Time PCR  
2.1.6.1 DT40 cells 
To show that the production of RNF4 transcript is abolished in the knockout 
clones, quantitative real-time PCR (qPCR) was carried out. Approximately 5 x 10
6
 
DT40 cells of each genotype were centrifuged at 120 g for 5 minutes at room 
temperature. The cell pellets were then washed twice in ice-cold PBS. RNA was 
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harvested from the cells using the RNeasy Kit (Qiagen, CA, USA), according to the 
provided instructions. The first strand cDNA was obtained from the RNA samples using 
the Superscript III Platinum Two-Step qRT-PCR Kit with SYBR green (Invitrogen 
#11735-032, CA, USA) by following the included protocol. The qPCR were then set up 
in 15 !l reactions as follows: 
• 7.5 !l  Platinum SYBR Green qPCR Supermix-UDG 
• 0.03 !l ROX reference dye 
• 1.5 !l primer mix (each primer to a final concentration of 200 nM; Table 2.11) 
• 6 !l cDNA  
The samples were prepared in triplicates on a 96-well plate and were set to run on the 
Applied Biosystems 7500 Real Time PCR System. 
Table 2.6: Cycling conditions for quantitative real-time PCR on AB7500 RT PCR 
system 
Steps Cycling temperature Duration  
1 50 °C   2 minutes 
2 95 °C  2 minutes 
3 95 °C  15 seconds 
4 60 °C  1 minute 
5 Repeat Steps 3 and 4 for 40 cycles 
6 Run a melt curve after each run 
 
Before the actual qPCR run on the cDNA from DT40 cells of different RNF4 
genotypes, a standard dilution curve was first performed on material obtained from 
wild-type DT40 cells, with the RNF4 and the internal control, ß-actin, primers. Primers 
were designed using the online programme, Primer3 (http://frodo.wi.mit.edu/). The 
standard dilution curve is used to determine the efficiency of the primers and the 
suitable amount of cDNA to use for each primer pair. In an ideal situation, the amount 
of cDNA template will show a linear relationship with the corresponding C(t) values - 
53  
that is, the R
2 
value obtained from the standard curve is close to 1 (>0.98). The ideal 
amount of cDNA to be used in the actual analysis would also give a C(t) value between 
20 – 25 and this can be estimated from the standard dilution graphs (Appendix D, 
Figure D1).  
 
2.1.6.2 Zebrafish 
1 !g of RNA extracted from embryos, adult fish or excised adults organs were 
reverse transcribed to cDNA using the RevertAid H Minus Revere Transcriptase Kit 
(Fermantas, Canada), following the included protocol. Random hexamers were used to 
prime the reverse transcription reactions.  
To determine the optimal amount of cDNA template to be used for each qPCR 
primer, standard dilution curves were plotted based on reactions with varying amount of 
cDNA. Briefly, cDNA obtained from 1 hpf embryos was diluted 4, 8, 16, 32 and 64 
times. 20 !l qPCR reactions for each primer pair (Table 2.17) were set up as follows: 
• 1 !l cDNA 
• 2 !l forward and reverse qPCR primers 
• 10 !l iQ SYBR Supermix (Bio Rad #170-8884, CA, USA) 
• 7 !l nuclease-free H2O 
The samples were set to run on the CFX 96 Real Time System C1000 Thermal Cycler 
(Bio Rad, CA, USA).  
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Table 2.7: Cycling conditions for quantitative real-time PCR on Bio Rad CFX 96 
C1000 
Steps Cycling temperature Duration  
1 95 °C   3 minutes 
2 95 °C  20 seconds 
3 59.7 °C  30 seconds 
4 Repeat Steps 2 and 3 for 39 cycles 
6 Run a melt curve from 55 to 95 °C after each run 
 
The standard dilution curves (Appendix D, Figure D2) were used to determine 
the efficiency of the primers and the suitable amount of cDNA to use for each primer 
pair. The cDNA was diluted 2x for the zRNF4 primer pair and 32x for all the other 
primers pairs. In addition, a graph of deltaCt (the difference between the Ct values of 
zRNF4 and each reference gene) against log of the dilution factor (log input) was 
plotted to verify that the amplification efficiencies of the primers are equal. This is 
shown when the absolute values of the gradients of the graphs are less than 0.1 
(Appendix D, Figure D3).  
qPCR was performed on the zebrafish cDNA in triplicates on a 96-well plate. 
Each experiment was repeated once for a biological replicate.  
 
2.1.7 Protein extraction  
2.1.7.1 DT40 cells 
For Western blot analysis, 5 x 10
6
 DT40 cells were collected by centrifugation at 
120 g for 5 minutes. The cell pellet was washed twice in ice-cold PBS before the 
addition of 2X SDS sample buffer with 10 mM iodoacetamide. The cell lysate was 
sonicated at 35 % output (Branson Digital Sonifier) in the 4 °C cold room for 1 minute 
before boiling for 5 minutes at 95 °C and determination of protein concentration. The 
total protein concentration was determined using the DC Protein Assay Kit (Bio Rad 
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#500 0113/4/5, CA, USA). ß-mercaptoethanol was added to a final concentration of 5 % 
(v/v) before boiling the samples again for 5 minutes at 95 °C.  
 
2X SDS Sample Buffer  
• 150mM Tris-Cl, pH 6.8                               
• 5 % (w/v) SDS                                                    
• 25 % (v/v) Glycerol                                             
• 0.01 % (w/v) Bromophenol blue 
 
2.1.7.2 H1299 cells 
H1299 cell lysates were harvested for protein 24 hours after transfection. The 
cell monolayer was washed twice with ice-cold PBS, after which 150 !l of 2X SDS 
sample buffer with 10 mM iodoacetamide was added to each well. The lysate was 
obtained using a cell scraper and subsequently transferred into 1.5 ml microfuge tubes. 
The lysates were sonicated for 1 minute (Q-Sonica S-4000) before boiling for 5 minutes 
at 95 °C. The total protein concentration was determined using the DC Protein Assay 
Kit (Biorad #500 0113/4/5). ß-mercaptoethanol was added to a final concentration of 5 
% (v/v) before boiling the samples again for 5 minutes at 95 °C. 
  
2.1.7.3 Zebrafish embryos 
50 to 100 embryos at the same developmental stage were selected and collected 
in a 1.5 ml microfuge tube. The egg water was removed from the tubes completely and 
1 ml of Ginzburg Fish Ringer’s Solution was added to the embryos. The embryos were 
dechorionated and deyolked with a 23G needle and a syringe. The embryos were then 
collected by centrifugation at 200 g for 5 minutes at 4 ºC. The yolk protein is removed 
in the supernatant. The embryos were washed once with Ginzburg Fish Ringer’s 
Solution and collected as before. The supernatant is removed completely before the 
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addition of 50 to 100 !l of zebrafish embryo lysis buffer to the embryos. The samples 
were kept on ice and sonicated for 40 seconds (pulse on for 5 seconds and off for 5 
seconds), before leaving to incubate on ice for 10 minutes, allowing thorough cell lysis. 
Next, the samples were centrifuged at 16 000 g for 12 minutes at 4 ºC. The extracted 
protein is collected in the supernatant and transferred into clean microfuge tubes. The 
protein concentration of each sample was determined using the DC Protein Assay Kit 
(Bio Rad, CA, USA) before the addition of 4X XT sample buffer (Bio Rad #161-0791, 
CA, USA) and ß-mercaptoethanol to a final concentration of 5 %.  The samples were 
then boiled for 5 minutes at 95 °C. For western blot analyses, approximately 40 !g of 
protein was loaded per well.  
 
Ginzburg Fish Ringer’s Solution 
• 100 mM NaCl 
• 3.35 mM KCl 
• 2.7 mM CaCl2 
• 2.4 mM NaHCO3 
• Top up with dH2O  
 
Zebrafish embryo lysis buffer 
• 10 mM Tris-HCl, pH 7.5 
• 10 mM NaCl 
• 0.5 % NP-40 
Freshly added: 
• 1X protease inhibitor cocktail (Roche, IN, USA) 
• 20 mM iodoacetamide 
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2.1.8 SDS-PAGE and western blot  
Approximately 30 !g of protein lysate was loaded on a NuPAGE Novex Bis-
Tris gel (4-12 % or 10 %; Invitrogen, CA, USA). The samples were either separated in 
MOPS or MES buffer at 180 V for 60 minutes prior to wet transfer onto a PVDF 
membrane (Immobilon-P Transfer Membrane, Millipore, MA, USA), or dry transfer 
onto a nitrocellulose membrane using the Invitrogen iBlot system. 
For the wet transfer, the PVDF membrane was activated by soaking in methanol 
for a few seconds before incubating in Transfer buffer for 5 minutes. The gel, sponges 
and Whatman paper were also equilibrated in Transfer buffer for 5 minutes. The 
western blot sandwich was assembled according to manufacturer’s instructions (Mini 
Trans-Blot Cell, Bio Rad, CA, USA) and a wet transfer proceeded at 100 V for 60 
minutes. For the transfer of high molecular weight proteins, the wet transfer was carried 
out at a constant current of 25 mA overnight. 
After western transfer, the membrane was blocked with 5 % (w/v) milk (Marvel 
Dried Skimmed Milk, Premier Foods, UK) in PBST (PBS + 0.1 % (v/v) Tween-20) for 
at least 30 minutes before incubation with a primary antibody diluted in 5 % (w/v) milk 
in PBST overnight at 4 °C. Following this, the membrane was washed 4 to 5 times with 
PBST on a shaker prior to incubation with the appropriate secondary antibody diluted in 
5 % (w/v) milk in PBST for 1 hour at room temperature. The membrane was then 
washed 5 times with PBST on a shaker before a 5-minute incubation with a 
chemiluminiscent substrate (either ECL Solutions I and II, combined at a 1:1 ratio, or 
Immun-Star WesternC Chemiluminescence reagent (Bio Rad #170-5070, CA, USA)) 
and exposure to an X-ray film (Konica Minolta, Japan). 
 
Transfer Buffer 
• 24 mM Tris  
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• 93 mM glycine  
• 20 % (v/v) methanol  
ECL Solution I 
• 100 mM Tris-HCl, pH 8.5  
• 2.5 mM luminol  
• 0.4 mM p-coumaric acid  
ECL Solution II 
• 100 mM Tris-HCl, pH 8.5  
• 0.0192 % (v/v) H2O2 
 
2.2 DNA constructs used in the study 
2.2.1 Targeting construct for Gallus gallus RNF4 
The RNF4 targeting construct was constructed previously by Dr. M.C. Geoffroy. 
The chicken RNF4 sequence was obtained from the NCBI database (Gene ID: 
NC_006091.2). Essentially, a 2.4 kb SalI/BamHI fragment (nucleotides 5751 to 8200) 
and a 2.3 kb BamHI/NotI fragment (nucleotides 16502 to 18773) of the RNF4 gene in 
the Gallus gallus genome were cloned into the SalI and NotI sites of the pBluescript 
vector. Puromycin or Blasticidin antibiotic resistance cassettes were then inserted into 
the BamHI site between the two genomic fragments.  
 
 
Figure 2.1: RNF4 targeting construct for DT40 cells 
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2.2.2 RNF4 rescue constructs for DT40 RNF4 -/- cells 
The list of RNF4 rescue constructs is shown here. Their corresponding vector 
maps are in Appendix C (Figures C1- C2). 
Table 2.8: Plasmid constructs used in the generation of RNF4 DT40 rescue clones 
Name Mutations Species Protein tag Vector Backbone 
Flag-WT rat 
RNF4 
None; wild type 
Flag-DM-rat 
RNF4 
E2-binding 
mutant; M140A-
R181A 
Rattus 
norvegicus 
N-terminal 
Flag 
zRNF4 None; wild type Danio rerio None 
pcDNA3.1/Zeo 
 
 
N-terminal Flag-tagged RNF4 from Rattus norvegicus (rRNF4) in a pcDNA3 
vector was received as a gift from J.J. Palvimo (University of Eastern Finland, Kuopio, 
Finland). The Flag-tagged rRNF4 gene was subcloned into the pcDNA3.1/Zeo vector 
(Invitrogen, CA, USA) using the NheI and XhoI restriction sites. The E2-binding mutant 
of rRNF4 was generated by site-directed mutagenesis using the primers listed in Table 
2.12.  
 
2.2.3 Full-length Danio rerio RNF4 
2.2.3.1 For protein expression in bacteria 
The full-length coding sequence of Danio rerio RNF4 (zRNF4) was cloned into 
the NcoI and BamHI sites of the pLou3 vector (Appendix C, Figure C3) using the 
primers in Table 2.14. Plasmid DNA was isolated from successful transformants 
(Qiagen Miniprep Kit, CA, USA) and were sent for DNA sequencing (The Sequencing 
Service, University of Dundee, UK). The E2-binding and dimerization mutants were 
generated by site-directed mutagenesis using primers in Table 2.15.  
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2.2.3.2 For overexpression in H1299 cells 
The wild type and double mutant zRNF4 genes were PCR amplified with 
primers containing BamHI and XhoI restriction sites (Table 2.16) and inserted into the 
pcDNA3 mammalian expression vector. 
 
2.2.4 DNA template for in situ hybridization probes 
The DNA templates for the two in situ hybridization probes were amplified 
from WT zebrafish cDNA by PCR using the primers listed in Table 2.18. These PCR 
primers were designed with a 15 base pair overhang at the 3’ end that is complementary 
to specific restriction sites (BamHI for the forward primer and XhoI for the reverse 
primer) on the pCS2+ vector (Appendix C, Figure C4). This enables the PCR products 
to be cloned into the expression vector easily via In-Fusion cloning (Clontech, CA, 
USA). 
 
2.2.5 5’ UTR morpholino GFP reporter  
The 5’ UTR sequence and part of the coding sequence of zRNF4 was initially 
cloned from zebrafish cDNA into the XhoI and BamHI restriction sites of the EGFP-N1 
vector (Invitrogen, CA, USA) using the primers in Table 2.19. However, when it was 
established that the pCS2+ vector was an ideal choice for overexpression studies in 
zebrafish, the 5’ UTR-EGFP sequence was subcloned into the EcoRI and XhoI 
restriction sites in pCS2+ (Table 2.20). Site-directed mutagenesis was also performed to 
correct the frame-shift mutation of the eGFP gene (Table 2.21). A vector map of the 
reporter construct is shown in Appendix C (Figure C5).  
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2.2.6 Zinc-finger nuclease for RNF4  
The zinc finger nuclease expression cassettes were cut from the pZFN vector 
and cloned into the EcoRI and XhoI restriction sites of pCS2+. 
 
2.3 Specific methods 
 
2.3.1 Transfection of DT40 cells by electroporation 
2.3.1.1 Stable targeted integration of exogenous DNA 
Prior to electroporation, 30 !g of the targeting construct was linearized with 
NotI (New England Biolabs, MA, USA) overnight, precipitated with ethanol and 
resuspended in 50 !l distilled water. 2 x 10
7
 DT40 cells were collected by 
centrifugation at 120 g for 5 minutes, washed with 25 ml of ice-cold phosphate buffered 
saline (PBS), and resuspended in 600 !l of cold PBS.  The DNA solution was added to 
the cells and the mix was transferred to a 0.4 cm electroporation cuvette (Bio Rad #165-
2088, CA, USA). The vial was placed on ice for 20 minutes before gentle vortexing and 
pulsing at  550 V and 25 !F with the Gene Pulser Xcell Electroporation System (Bio 
Rad, CA, USA). The vial was placed on ice for 5 minutes before resuspension into 50 
ml of DT40 medium and incubating at 37 °C, 5 % CO2 overnight. The next day, 50 ml 
of DT40 media containing 2X concentration of selective antibiotic was added to the 50 
ml cell suspension and mixed before plating 200 !l of the suspension into each well of 
clear, flat-bottom 96-well plates. The plates were returned to the incubator for 7 to 10 
days before individual clones were picked and grown in duplicate in 24-well plates. One 
plate was used for the extraction of genomic DNA while the cells in the other plate were 
frozen in 70 % (v/v) FBS, 20 % (v/v) CS and 10 % (v/v) dimethylsulfoxide (DMSO).  
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2.3.1.2 Stable non-targeted integration of exogenous DNA 
Stable non-targeted integration of DT40 cells was performed as the stable 
targeted integration (Section 2.3.1.1) except the targeting constructs need not be 
linearised, and the cells were pulsed at 250 V and 950 !F. 
 
2.3.2 Southern blot  
Approximately 20 !g of genomic DNA was digested with HpaI restriction 
enzyme by incubation at 37 °C overnight before separation on a 0.7 % (w/v) agarose gel 
containing 0.5 !g/ml ethidium bromide in TBE (Tris/Borate/EDTA) buffer at 110 V for 
4 hours. A picture of the UV-illuminated DNA gel was taken alongside a ruler before it 
was processed according to the GE Healthcare HyBond N+ (RPN203B, PA, USA) 
protocol. In essence, the DNA was partially depurinated, denatured and neutralized. The 
DNA on the gel was transferred to the HyBond N+ membrane with 10X saline-sodium 
citrate (SSC) buffer according to the manufacturer’s protocol.  
To synthesize the DNA oligo probe, a PCR reaction using the RNF4 targeting 
construct as the template DNA was carried out to yield a 518 bp DNA oligo that is 
complementary to the sequence on the L arm of the targeting construct (Table 2.9).   
The PCR product was gel-purified using the Gel Extraction kit (Qiagen, CA, USA) 
before radiolabeling. 25 ng of the DNA oligo probe was radiolabeled according to the 
protocol in the NEBlot kit (New England Biolabs #N1500S, MA, USA) and purified 
with illustra G25 microspin columns (GE Healthcare #27-5325-01, PA, USA). 
After the overnight transfer, the membrane was carefully removed and a pencil 
was used to mark the wells of the gel on the membrane. The membrane was kept moist 
by placing it on 2 pieces of Whatman paper soaked with 2X SSC buffer, with the DNA-
bound side facing up. The DNA was crosslinked to the membrane by placing it in a UV 
crosslinker and exposing it to 120 000 J/m
2
 of UV light. After this, the membrane was 
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rinsed in 2X SSC buffer. The membrane was then prehybridized in a roller tube with 
prewarmed Rapid Hyb buffer (GE Healthcare #RPN1635, PA, USA) at 65 °C for at 
least an hour.  
The purified DNA oligo probe was denatured according to instructions in the 
NEBlot kit before dilution in 1-2 ml of prewarmed Rapid Hyb buffer. The diluted probe 
was then added directly to the membrane in the roller tube. The probe was allowed to 
hybridize with the DNA for at least 2 hours at 65 °C. Following this, the membrane was 
washed twice in 2X SSC buffer containing 0.1 % (w/v) SDS for 15 minutes at room 
temperature, once in 1X SSC buffer containing 0.1 (w/v) % SDS for 20 minutes at 65 
°C, and finally in 0.1X SSC buffer containing 0.1% (w/v) SDS at 65 °C, with buffer 
changes until the background count of the membrane detected by a Geiger counter is 
less than 20 cpm. The membrane was then kept moist by wrapping in Saran wrap and 
exposed to a blanked phosphoimager screen overnight before scanning using a Fujifilm 
FLA 5100 PhosphoImager and analysed with the Aida software (Raytest, Germany). 
 
 1X TBE Buffer, pH 8.0 
• 89 mM Tris  
• 89 mM Boric acid 
• 2 mM EDTA 
 
2X SSC Buffer, pH 7.0 
• 1.5 M NaCl 
• 150 mM Sodium Citrate 
 
2.3.3 Nuclear and cytoplasmic fractionation of DT40 cells 
 2 x 10
7
 cells were collected by centrifugation at 120 g for 5 minutes and washed 
with 10 ml of ice-cold PBS (with 200 mM iodoacetamide freshly added) twice. 150 !l 
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of Lysis Buffer was added to the cell pellet and the cells were incubated on ice for 15 
minutes before Nonidet P-40 (NP40) was added to a final concentration of 0.3 % (v/v). 
This lyses the cell membranes and the intact nuclei were then collected by a short spin 
at 300 g for 30 seconds at 4 °C. The cytoplasmic supernatant was removed and an equal 
volume of 2X SDS sample buffer was added before sonicating at an output of 20 % for 
1 minute, followed by boiling for 5 minutes at 95 °C. The nuclear fraction was pelleted, 
washed with 1 ml of Lysis Buffer and pelleted again. The supernatant was removed and 
the nuclear fraction was lysed in 2X SDS sample buffer, sonicated and boiled like the 
cytoplasmic fraction. The protein concentrations of the fractionated lysates were 
determined using the DC Protein Assay Kit (Bio Rad #500 0113/4/5, CA, USA). ß-
mercaptoethanol was added to a final concentration of 5 % (v/v) before boiling the 
samples again for 5 minutes at 95 °C. 1 !l of 10 N NaOH was added to samples that 
turned yellow. 
 
Lysis Buffer  
• 10 mM Tris, pH 7.5                              
• 2 mM MgCl2                                                
• 3 mM CaCl2                                           
• 0.32 M Sucrose 
• 1X Protease Inhibitor Cocktail (Roche, IN, USA) 
• 1 mM Dithiothreitol (DTT)  
• 200 mM IAA 
 
2.3.4 Growth curve determination of DT40 cells 
2 ml of 0.1 x 10
6 
cells/ml cell suspension was seeded in 6-well plates, in 
duplicate. At the indicated time points, 0.4 % Trypan blue solution was mixed with an 
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equal volume of cell suspension and 20 !l of this mixture was loaded onto the chambers 
of the Cellometer Disposable Counting Chambers (Nexcelom, MA, USA). The viable 
cell density of each well was determined using the Cellometer Auto T4 cell counter 
(Nexcelom, MA, USA). The viable cell density was calculated every 24 hours until the 
120
th
 hour after seeding. In addition, to prevent senescence and overcrowding, an equal 
volume of DT40 media was added every 48 hours.  
 
2.3.5 Flow cytometry for DT40 cells 
2.3.5.1 Cell cycle analysis 
0.5 x 10
6
 cells were collected by centrifugation at 120 g for 5 minutes. The 
media was aspirated and the cell pellet was resuspended in the small volume of media 
remaining in the tube. The cells were resuspended in 1 ml of PBS to wash away any 
remaining media before transferring to 5 ml polystyrene round bottom tubes (BD 
Biosciences, NJ, USA). The cells were collected by centrifugation and the supernatant 
was aspirated. The cell pellet was dissociated in the remaining volume of supernatant 
before 1 ml of ice-cold 70 % (v/v) ethanol in distilled water was added to the cells while 
vortexing vigorously. This is to prevent the cells from clumping while being fixed in 
ethanol. The fixed cells were then kept at -20 °C for up to 4 weeks.  
On the day of analysis, the fixed cells were washed twice with 1 % (w/v) bovine 
serum albumin (BSA) in PBS, pelleted and resuspended in 500 !l of DNA staining 
buffer and allowed to incubate for 20 minutes at room temperature, protected from 
light. The cell suspension was run through the FACS Calibur (Becton Dickinson, NJ, 
USA) while the forward and side scatter information, as well as data from the FL2 
detector (which detects the fluorescence emission from propidium iodide) was acquired 
using CellQuest Pro (BD Biosciences, NJ, USA). The acquired data was further 
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analyzed on FlowJo (Tree Star, Inc., OR, USA) and the cell cycle profiles were 
obtained by fitting to the Watson-Pragmatic model.  
 
DNA Staining buffer  
• 50 !g/ml propidium iodide (Invitrogen, CA, USA #P3566) 
• 50 !g/ml ribonuclease A (Sigma #R4642, MO, USA) 
• 0.1 % v/v Triton X-100 in PBS 
 
2.3.5.2 Mitotic index determination 
1 x 10
6
 DT40 cells were plated in 35 mm dishes and treated with 0.5 !g/ ml 
nocodazole for 8 hours, with or without prior exposure to gamma irradiation (IR). The 
dose for IR was 10 Gy and was done using the IBL437C irradiator (Cis 
Biointernational, France). Following nocodazole treatment, the cells were washed with 
PBS before being fixed in ice-cold 70 % (v/v) ethanol and stored at -20 °C for up to 4 
weeks.  
Cells were washed with 1 % (w/v) BSA in PBS before permeabilizing with 0.25 
% (v/v) Triton X-100 in PBS and incubated on ice for 15 minutes. The cells were 
collected by centrifugation and resuspended in 100 !l of diluted primary antibody. The 
primary antibody used for determining the mitotic index of the cells recognizes histone 
H3 that is phosphorylated on Serine 10 (pH3; Millipore #06-570, MA, USA ). It was 
used at a 1:100 dilution in 1 % (w/v) BSA/PBS. The cells were incubated with the 
primary antibody for 1 hour at room temperature before washing with 1 % (w/v) 
BSA/PBS. 100 !l anti-rabbit AlexaFluor488 secondary antibody (Invitrogen, CA, USA) 
diluted 1:500 in 1 % (w/v) BSA/PBS was added to the cells and incubated for 30 
minutes at room temperature, protected from light. The cells were given a final wash 
with 1 % (w/v) BSA/PBS before resuspending in DNA staining buffer to counterstain 
the cells. The cells were left at room temperature in the dark for 30 minutes before 
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running through the FACS Calibur (Becton Dickinson, NJ, USA). Data was acquired 
and analyzed using CellQuest Pro (BD Biosciences, NJ, USA) and FlowJo (TreeStar, 
Inc., OR, USA) respectively. 
 
2.3.6 Colony formation assays for DT40 cells 
2.3.6.1 Preparation of methylcellulose media 
11.9 g of DMEM:F-12 (1:1) + L-glutamine (Gibco #32500, Invitrogen, CA, 
USA) and 2.44 g of sodium  bicarbonate was dissolved in 500 ml MilliQ water and 
sterile-filtered with a 0.2!m filter. 10 g of autoclaved methylcellulose (Sigma M0512, 
MO, USA) was dissolved in 400 ml of MilliQ water that was preheated to 65 °C. The 
methylcellulose suspension was allowed to cool down to 50 °C before adding the 
DMEM: F12 media to it. The mixture was left to stir in the 4 °C cold room overnight. 
When the methylcellulose has completely dissolved, 10 % (v/v) FBS, 1 % (v/v) heat-
inactivated CS, 10 !M ß-mercaptoethanol, 100 U/ml penicillin and 100 !g/ml 
streptomycin was added and allowed to stir further for a few hours. This media is then 
kept at 4 °C and used within 7 days. 
 
2.3.6.2 Hydroxyurea treament  
2 x 10
6 
cells of each genotype were collected by centrifugation at 120g and 
resuspended in 5 ml of media. The cell suspension was subsequently serial diluted 10 
and 100 times. In all the colony formation assays, 100 !l of each dilution of each 
genotype was plated in duplicates in 6-well plates containing 5 ml of pre-warmed 
methylcellulose media. Due to the decreased growth rate of the positive control UBE2T 
-/- DT40 cells, twice the number of cells was seeded in the wells. Hydroxyurea was 
then added to the media to final concentrations of 100, 150 and 200 !M. As with all the 
other treatments, the plates were incubated at 37 °C and 5 % CO2 for 10 days, after 
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which the plates were scanned against a dark background and the colonies were counted 
using Adobe Photoshop CS4. 
 
2.3.6.3 Cisplatin and methyl methanesulfonate (MMS) treatment  
1 x 10
6 
cells of each genotype were collected by centrifugation at 120g and 
resuspended in 5 ml of media. 1 ml of cisplatin or MMS-containing media was added to 
1 ml of cell suspension so that the final cisplatin concentrations were 0, 5 and 10 !M; 
and   the final MMS concentrations were 0, 100 and 200 !M. The cells were returned to 
the incubator for 2 hours, after which they were serial diluted 10 and 100 times before 
plating into wells of 6-well plates containing 5 ml of pre-warmed methylcellulose 
media. 
 
2.3.6.4 Gamma-irradiation  
1 x 10
5 
cells of each genotype were collected by centrifugation at 120g and 
resuspended in 1 ml of media in 3.5 mm dishes and subjected to gamma-irradiation at 2, 
4, and 6 Gy in the IBL437C caesium-137 irradiator (Cis Biointernational, France). The 
irradiated cells were subsequently serial diluted 10 and 100 times before plating into 
wells of 6-well plates containing 5 ml of pre-warmed methylcellulose media.  
 
2.3.6.5 UV irradiation  
5 x 10
5 
cells of each genotype were collected by centrifugation at 120 g and 
resuspended in 1 ml of sterile PBS in each well of a 6-well plate and subjected to UV-C 
irradiation in a crosslinker oven at 0, 2 and 5 J/m
2
, after removing the lid of the plate. 4 
ml of media was added to each well and the cell suspension was serial diluted 10 and 
100 times before plating into wells of 6-well plates containing 5 ml of pre-warmed 
methylcellulose media.  
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2.3.7 Rapid Amplification of cDNA ends PCR (RACE-PCR)  
The 5’ and 3’ ends of the Danio rerio RNF4 (zRNF4) gene were amplified 
from total RNA extracted from 2-day-old AB strain Danio rerio embryos with the 5’/ 3’ 
second generation RACE kit (Roche # 06 353 621 001, IN, USA), according to 
manufacturer’s instructions. PfuTurbo (Stratagene, CA, USA) was used in all PCR 
reactions. The final PCR step in the protocol was repeated with GoTaq polymerase 
(Promega M5001, WI, USA) and the PCR products were further ligated into the pGEM-
T Easy vector (Promega A1360, WI, USA) with a 1:3 insert to vector ratio.  
The ligation mix was transformed into DH5# cells and plated onto Luria-Broth 
Ampicillin (LB-Amp) plates, as described in Section 2.1.3.3. Successful ligation was 
validated by colony PCR. In brief, single bacteria colonies were picked, resuspended in 
40 !l of LB-Ampicillin, and incubated at 37 °C for 1 hour. 1 !l of this suspension was 
used as the template for a PCR reaction with T7 and SP6 primers. Plasmid DNA was 
isolated from successful clones (Qiagen Miniprep Kit, CA, USA) and were sent for 
DNA sequencing (The Sequencing Service, University of Dundee, UK).  
 
2.3.8 Expression and purification of recombinant zRNF4 
Recombinant Maltose Binding Protein (MBP)-6x-Histidine (His)-tagged 
zRNF4 was expressed in E. coli (Rosetta DE3 strain) cells. First, pLou3-zRNF4 
plasmid DNA (WT and mutants) was transformed in the E. coli (Rosetta DE3 strain) 
cells. Next, a single colony was inoculated in 10 ml LB containing 100 !g/ml ampicillin 
and 40 !g/ml chloroamphenicol (LB-Amp-Cam), and incubated overnight at 37 °C with 
shaking at 200 rpm. The 10 ml starter culture was further diluted into a 2-litre culture 
volume and incubated at 37 °C, shaking at 200 rpm, until the OD600 of the culture 
reached 0.6 to 0.8. The culture was then cooled on ice for 10 minutes before induction 
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with 0.1 mM of isopropyl !-D-thiogalactopyranoside (IPTG) at 20 °C for 16 hours. The 
bacteria cells were collected at 6200 g for 20 minutes at 4 °C before sonication in 100 
ml of ice-cold lysis buffer. Sonication was performed on ice for 3 minutes at 50 % 
amplitude, with 20 s pulses and 20 s pauses (Branson Digital Sonifier). Triton X-100 
was then added to the lysate to a final concentration of 0.5 % (v/v). The lysate was 
centrifuged at 27 000 g for 45 minutes at 4 °C and the supernatant was passed through a 
0.2 !m filter.  
An amylose column was prepared with amylose resin (New England Biolabs 
E8021L, MA, USA) and washed with 3 to 5 column volumes of wash buffer before 
passing the filtered lysate supernatant through it. The flow-through was collected for 
subsequent SDS-PAGE analysis by Coomassie Blue staining. Following this, the 
column was washed with 5 column volumes of wash buffer or until 5 !l of the wash 
flow-through did not turn 100 !l of Bradford reagent (Bio Rad Protein Assay #500-
0006, CA, USA) blue. To elute the MBP-tagged recombinant protein, half the column 
volume of elution buffer was added to the column. The column eluate was analysed for 
the presence of protein (5 !l of eluate in 100 !l of Bradford reagent) and protein-
containing fractions were pooled together. The eluate was then dialysed overnight at 4 
°C in dialysis buffer.  
Following dialysis, the concentration of the MBP-tagged zRNF4 protein prep 
was measured using the Bradford reagent and concentrated to approximately 1 mg/ml 
using centrifugal protein concentrators (Vivaspin, Sartorius Stedim Biotech, NY, USA) 
before snap-freezing in liquid nitrogen and storing at -80 °C. 
To obtain untagged zRNF4 protein, 1 mg of TEV protease was added to every 
100 mg of MBP fusion protein and dialysed overnight at room temperature against the 
dialysis buffer. The efficiency of TEV cleavage was verified by SDS-PAGE and 
Coomassie Blue staining. Ni-NTA column purification was subsequently performed to 
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remove the cleaved MBP tag, uncleaved MBP-fusion protein, as well as the TEV 
protease. These proteins carry a 6x-His tag and are able to bind to the Ni-NTA column. 
Prior to Ni-NTA column purification, imidazole was added to the protein prep to a final 
concentration of 50 mM. The Ni-NTA beads were equilibrated with imidazole-
containing dialysis buffer before mixing with the TEV-cleaved protein and rolling at 4 
°C for at least 2 hours. The Ni-NTA beads were then packed onto a column and the 
flow-through was collected. The column was subsequently washed with 30 mM 
imidazole-wash buffer until 5 !l of the wash flow-through did not turn 100 !l of 
Bradford reagent blue. The column flow-through from the washes were also collected 
and pooled together with the first flow-through.  
For a final purification step, amylose beads were washed with 10 mM 
imidazole-wash buffer three times before incubation with the pooled flow-through 
fractions on a roller at 4 °C for 1 hour. The amylose beads were then packed onto a 
column and the flow-through was collected. The column was washed with 10 mM 
imidazole-wash buffer until 5 !l of the wash flow-through did not turn 100 !l of 
Bradford reagent blue. The collected flow-through fractions were then pooled and the 
total protein concentration was measured with Bradford reagent. The final protein prep 
was then dialysed overnight for a final time in dialysis buffer before adjusting the final 
protein concentration to approximately 1 mg/ml with centrifugal protein concentrators 
(Vivaspin, Sartorius Stedim Biotech, NY, USA) prior to snap-freezing in liquid nitrogen 
and storing at -80 °C. 
Bacteria cell lysis buffer 
• 50 mM Tris, pH 7.5 
• 500 mM NaCl 
• 2 mM benzamidine  
• Complete protease inhibitor tablet (Roche, IN, USA) 
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Amylose column wash buffer 
• 50 mM Tris, pH 7.5 
• 500 mM NaCl 
Amylose column elution buffer 
• 50 mM Tris, pH 7.5 
• 500 mM NaCl 
•  15 mM maltose 
•  0.5 mM TCEP 
Dialysis buffer 
• 50 mM Tris, pH 7.5  
• 500 mM NaCl  
• 0.5 mM TCEP 
 
Dialysis buffer (with imidazole) 
• 50 mM Tris, pH 7.5 
• 500 mM NaCl 
• 0.5 mM TCEP 
• 30 mM imidazole 
30 mM imidazole wash buffer 
• 50 mM Tris, pH 7.5 
• 500 mM NaCl 
• 30 mM imidazole 
10 mM imidazole wash buffer 
• 50 mM Tris, pH 7.5 
• 500 mM NaCl 
• 10 mM imidazole 
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2.3.9 In vitro autoubiquitylation assay 
The ubiquitin E3 ligase activity of zRNF4 was tested using MBP-tagged zRNF4 
in an in vitro autoubiquitylation assay. A 10 !l reaction was set up in 50 mM Tris-Cl, 
pH 7.5 buffer as follows:  
• 35 nM UBE1 
• 0.8 !M UbcH5a 
• 2 !M MBP-zRNF4 
• 35 !M Ubiquitin 
• 3 mM ATP 
• 5 mM MgCl2,  
• 1 mM DTT 
• 1X Complete Protease inhibitor cocktail (Roche, IN, USA) 
The reaction was incubated at 37 °C for 3 hours before it was stopped by the 
addition of 10 !l of 2X SDS sample buffer and boiled at 100 °C for 3 minutes. The 
samples were then analysed on an SDS-PAGE gel, stained with Coomassie blue 
staining solution for 1 hour and subsequently destained in the Coomassie destain 
solution overnight. 
The zRNF4 E2-binding mutants: M131A, R172A and DM (M131A-R172A), 
were also tested in the assay. The positive control: wild-type RNF4 from Rattus 
norvegicus (rRNF4); and negative control: RING mutant CS1 rRNF4, were a gift from 
Dr. L. Shen from our laboratory.  
 
2X SDS Sample Buffer  
• 150mM Tris-Cl, pH 6.8                               
• 5 % (w/v) SDS                                                    
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• 25 % (v/v) Glycerol                                             
• 0.01 % (w/v) Bromophenol blue 
Coomassie blue staining solution  
• 0.1 % (w/v) Coomassie brilliant blue R-250  
• 40 % (v/v) methanol 
• 7 % (v/v) acetic acid 
The solution was filtered through a filter paper.  
 Coomassie destain solution 
• 5 % (v/v) methanol 
• 7 % (v/v) acetic acid 
 
2.3.10 In vitro single-turnover polySUMO2 ubiquitylation assay 
The ability of zRNF4 to ubiquitylate polySUMO2 was tested in vitro. In this 
assay, the E2-ubiquitin thioester was generated first. A 10 !l reaction set up was 
prepared as follows:  
• 50 mM Tris, pH 7.5 
• 150 mM NaCl 
• 0.2 !M UBE1 
• 100 !M UbcH5a  
• 60 !M Ubiquitin 
• 3 mM ATP 
• 5 mM MgCl2 
• 0.5 mM TCEP 
The reaction was incubated at 37 °C for 12 minutes before the addition of 1 !l 
apyrase (New England Biolabs, MA, USA) in each 10 !l reaction to deplete ATP. The 
reaction was further incubated at room temperature for 10 minutes. Next, zRNF4 and 
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the 4XSUMO2 substrate (a gift from Dr. A. Plechanovová from our laboratory) were 
mixed with the thioester such that the final concentrations were 0.275 !M and 5.5 !M 
for MBP-zRNF4 and 4XSUMO2 respectively. 
The reaction was allowed to proceed at room temperature and was stopped at 1 
and 10 minutes by the addition of 2X SDS sample buffer and boiling at 100 °C for 3 
minutes. The samples were then separated on an SDS-PAGE gel and subject to Western 
blotting with the antibodies in Table 2.26. 
The zRNF4 E2-binding mutants and rRNF4 controls were also tested in this 
assay. 
 
2.3.11 Production and purification of sheep and chicken polyclonal zRNF4 antibody 
2.3.11.1 Preparation of crude chicken antibody extracts from chicken egg yolks 
1 mg of purified zRNF4 protein was sent for immunization in chicken and sheep at the 
Scottish National Blood Transfusion Service (Castlelaw Building, Pentlands Science 
Park, Penicuik, Midlothian, EH26 0PZ, UK).  
After approximately three months from the immunization, the sheep were bled 
and sera was collected. The frozen sera was sent back to us. For the chickens, the 
antibodies were returned to us in the form of frozen egg yolks.  
The chicken yolks were thawed and an equivolume of phosphate-buffered saline 
(PBS) was added before transferring the mixture into a 50 ml Falcon tube. The tube was 
vortexed for 30 minutes before allowing to stand overnight at 4 °C. The suspension was 
then mixed before dividing equally into two 50 ml Falcon tubes. Chloroform was added 
into both tubes until the 50 ml mark and the tubes were vortexed for 20 minutes before 
leaving to stand for 5 minutes. They were then centrifuged for 30 minutes at 2000 g. 
The crude chicken serum was obtained by removing the upper aqueous top from each 
tube.  
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2.3.11.2 Dot blot 
The crude chicken and sheep serum (from the third bleed) were tested on dot 
blots of recombinant, purified untagged zRNF4 protein. The purified zRNF4 was 
serially diluted and dotted directly onto a nitrocellulose membrane and allowed to air 
dry for 2 minutes before proceeding with blocking in 5 % (w/v) milk in PBST. Western 
blotting of recombinant protein separated on an SDS-PAGE gel was then carried out as 
previously described in Section 2.1.8, with the crude antibody extracts used at a 1:2000 
and 1:10 000 dilution, for the chicken and sheep extracts respectively.  
 
2.3.11.3 Affinity purification of anti-zRNF4 polyclonal antibodies  
20-40 mg of recombinant zRNF4 protein was dialysed overnight at 4 °C in 
Coupling buffer. To prepare the antigen column, 5 ml of N-Hydroxysuccinimidyl-
activated agarose (NHS) beads (Sigma H8280, MO, USA) were washed with 50 ml of 1 
mM HCl in a sintered glass funnel. The beads were then washed with 100 ml of 
Coupling buffer before centrifugation at 3000 rpm for 10 minutes. The dialyzed protein 
was added to the NHS beads and incubated on a roller for 2 hours at 4 °C. The binding 
of the protein to the beads was assessed by measuring the protein concentration of the 
supernatant with the Bradford reagent. When most of the protein have bound to the 
beads, the beads were then packed onto 2 columns before washing with 25 ml of 
Coupling buffer, 50 ml of Buffer A and 50 ml of Buffer B. 50 ml of Buffer A was 
added to the column and left to stand for 30 minutes at room temperature before 
allowing flow through. The column was then washed with 50 ml of Buffer B, 50 ml of 
Buffer A, 50 ml of Buffer B, 50 ml of Column Storage buffer. The antigen columns 
were washed with 50 – 100 ml of Coupling buffer. 10 ml of chicken egg yolk extract 
and sheep serum were each diluted 5 – 10 times with PBS and passed over individual 
antigen columns twice. The columns were then washed with 100 ml of Tris Wash buffer 
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before eluting the antibody with the Elution buffer, collecting 500 !l fractions in tubes 
containing 50 !l of 1 M Tris-Cl, pH 8.0. The concentrations of the fractions were 
determined with the Bradford reagent and those that contained protein were pooled 
together. Bovine serum albumin (BSA) and glycerol were added to the antibody preps 
to final concentrations of 5 mg/ml and 10 % (v/v) respectively before freezing at -80 °C.  
 
Coupling buffer, pH 8.3 
• 0.2 M NaHCO3 
• 0.5 M NaCl 
Buffer A, pH 8.3 
• 0.5 M NaCl 
• 0.5 M Ethanolamine 
Buffer B, pH 4 
• 0.5 M NaCl 
• 0.1 M Sodium acetate 
Column Storage buffer 
• 0.5 M NaCl 
• 0.1 % (w/v) Sodium Azide, in PBS  
Tris Wash buffer, pH 7.5 
• 10 mM Tris-Cl 
• 0.5 M NaCl 
Elution buffer, pH 2.25 
• 0.1 M Glycine 
 
2.3.12 Immunofluorescence for H1299 cells 
The cell monolayer was washed twice with prewarmed (37 ºC) PBS twice, 
giving extra care not to perturb the coverslips or make them float up. The last PBS wash 
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was aspirated and freshly prepared, 37 °C pre-warmed 4 % (w/v) paraformaldehyde was 
added to the top of each coverslip at room temperature for 10 min to fix the cells. The 
coverslips were then rinsed with PBS three times before transferring them onto a flat 
tray lined with parafilm. The cells were then permeabilized with 0.2 % (v/v) Triton X-
100 in PBS for 10 minutes at room temperature. In all subsequent steps, liquids were 
added to the coverslips so that they formed a droplet on the surface without spilling 
over. Aspiration was done by tilting the tray of coverslips at a slight angle. After 
permeabilization, the coverslips were rinsed in PBS three times.  
The blocking buffer was added to the cells for 30 minutes at room temperature. 
During this time, the primary antibody was diluted in blocking buffer. After blocking, 
the blocking buffer was aspirated and the diluted primary antibody was added to the 
coverslips. The tray of coverslips was covered and kept humidified by placing pieces of 
wet tissue around the tray. The primary antibody incubation was done for 2 hours at 
room temperature.  
After aspirating the primary antibody, the coverslips were washed four times 
with wash buffer. The secondary antibody was diluted in blocking buffer and added to 
the coverslips for 45 minutes at room temperature, in the dark. The coverslips were 
washed five times before 0.1 !g/ ml of DAPI was added for 3 minutes, also in the dark. 
The coverslips were washed another five times before mounting on glass slides with 
Hydromount (National Diagnostics, NC, USA).  
The cells were imaged using the Zeiss LSM 510 confocal microscope 
(Germany). 
Paraformaldehyde (to prepare 10 ml of fresh fix) 
• Weigh out 0.4 g of paraformaldehyde in a 15 ml Falcon tube in the fume hood 
• Add 8.6 ml of deionized water  
• Add 5 !l of 1 M NaOH 
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• Allow the PFA to dissolve by incubating in a 60 to 70 °C water bath for 30 
minutes 
• Add 1 ml of 10X PBS and allow to cool to room temperature 
• Sterile filter  
Blocking buffer (sterile filtered) 
• 5 % (w/v) BSA 
• 0.1 % (v/v) Tween-20 in PBS 
Wash buffer (sterile filtered) 
• 1 % (w/v) BSA 
• 0.1 % (v/v) Tween-20 in PBS 
 
2.3.13 Anaesthetizing of adult zebrafish 
Adult zebrafish that were collected for RNA extraction, whole mount 
immunohistochemistry or in situ hybridization, and for paraffin embedding were first 
anaesthetized in 0.016 % tricaine in egg water (diluted from 0.4 % tricaine stock 
solution). When the gills of the fish stop moving, they were euthanized by incubating in 
ice water for 15 minutes. 
  
0.4 % (w/v) Tricaine stock solution, pH 7.0 
• 400 mg Tricaine (Ethyl-3-aminobenzoate methanesulfonate salt; Sigma A5040, 
MO, USA) 
• 20 mM Tris-HCl, pH 9 
• Top up to 100 ml with dH2O 
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2.3.14 Dissection of organs from adult zebrafish  
Dissection of organs from euthanized adult zebrafish for quantitative real-time 
PCR analysis was done as previously described (Gupta and Mullins, 2010).  
Organs that were subjected to whole mount in situ hybridization or whole mount 
immunohistochemistry have to be fixed prior to dissection. In essence, the head and tail 
of the euthanized adult zebrafish were removed with a number 10 scalpel, leaving the 
trunk, within which the organ of interest lies. An incision on the ventral midline of the 
trunk is made with a small scissors before immersing the tissue in freshly prepared 4 % 
(w/v) paraformaldehyde with 120 mM CaCl2 (PFA). Fixing with PFA was done 
overnight at 4 °C, following which the organ of interest is carefully removed as 
mentioned above. 
 
2.3.15 RNA methods in zebrafish 
2.3.15.1 RNA extraction 
Zebrafish embryos were staged by visualization on the Leica MZ16 
stereomicroscope (Germany). 50 embryos at each developmental stage (0.5 hpf, 2 hpf, 4 
hpf, 6 hpf, 12 hpf, 1 dpf, 2 dpf, 3 dpf, 4 dpf, 5 dpf) were collected in 1.5 ml microfuge 
tubes and washed once with deionized water. The water was removed completely and 1 
ml of TRIzol (Invitrogen, CA, USA) was added to each tube. The embryos were 
homogenized completely using a 23 G needle and a 1 ml syringe before allowing to 
stand at room temperature for 5 minutes. 400 !l of chloroform was added to each tube 
and vortexed vigorously, after which they were incubated at room temperature for 10 
minutes. The samples were centrifuged at 16 000 g for 10 minutes at 4 °C to separate 
the aqueous and organic liquids. The upper, aqueous layer (that contains the RNA) was 
transferred into clean 1.5 ml microfuge tubes and 400 !l of chloroform was added to the 
tubes again. The samples were vortexed before centrifugation at 16 000 g for 10 
81  
minutes at 4 °C. The upper, aqueous layer was again transferred to clean 1.5 ml 
centrifuge tubes and 500 !l of isopropanol was added before inverting the tubes several 
times. The samples were incubated at room temperature for 10 minutes to precipitate 
the RNA. The RNA was collected by centrifugation at 16 000 g for 10 minutes at 4 °C. 
The RNA precipitate was washed with 75 % (v/v) ethanol in dH2O and air-dried for 5 
minutes before proceeding to DNA digestion and column purification. 
For the extraction of RNA from adult fish or excised organs, 1 ml of TRIzol was 
added to each 100 g of tissue and homogenized with a tissue homogenizer (Omni TH 
International TH220, GA, USA) fixed with a 7 x 110 mm Omni Tips (Omni TH 
International 34750TH, GA, USA). Chloroform extraction proceeded as for the early 
stage embryos. 
 
2.3.15.2 DNA digestion and column purification of RNA  
100 !l of nuclease-free water was added to each sample to dissolve the RNA 
precipitate. 350 !l of Buffer RLT, followed by 250 !l of ethanol, were added to the 
samples. The samples were transferred to the RNeasy spin columns (RNeasy Mini Kit, 
Qiagen, CA, USA) and centrifuged at 8000 g for 30 seconds. The flow through was 
discarded before 350 !l of RW1 was added to the columns. The samples were 
centrifuged again and the flow through was discarded. 80 !l of DNase I working stock 
(10 !l of DNase I in 70 !l of RDD buffer, Qiagen #79254, CA, USA) was added to 
each column and incubated at room temperature for 15 minutes. Following this, 350 !l 
of RW1 was added and the samples were centrifuged. The flow through was again 
removed and 500 !l of RPE buffer was added to wash the column. The samples were 
centrifuged and the flow through was removed. The column wash with RPE buffer was 
repeated before spinning the columns for 1 minute at 8000 g. The collection tubes were 
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replaced with clean, 1.5 ml microfuge tubes and 50 !l of nuclease-free water was added 
to the columns to elute the RNA by spinning at 8000 g for 1 minute.  
The RNA concentration was determined by spectrophotometry 
(ThermoScientific ND8000, OH, USA) and the samples were kept at -80 °C. 
 
2.3.15.3 In vitro transcription to generate mRNA 
mRNA that was microinjected into zebrafish embryos were transcribed from the 
pCS2+ vector (Appendix B, Figure B4) using the mMESSAGE mMACHINE SP6 kit 
(Ambion, CA, USA). The gene of interest was first cloned into the BamHI and XhoI 
restriction sites in the mutiple cloning site on pCS2+. Next, the DNA template was 
linearised with NotI restriction enzyme (New England Biolabs, MA, USA) and purified 
by gel electrophoresis on a 1 % (w/v) agarose gel, using the Gel Extraction kit (Qiagen, 
CA, USA).  
The transcription reaction was assembled according to the manufacturer’s 
protocol. The concentration of the synthesized mRNA was determined by 
spectophotometry (ThermoScientific ND8000, OH, USA) and the integrity of the 
mRNA was checked by gel electrophoresis. The transcribed RNA was diluted to 400 
ng/ !l and stored in 5 !l aliquots at -80 ºC. 
 
2.3.15.4 RNA gel electrophoresis 
2 % (w/v) agarose was melted in 60 ml of 0.5X TBE buffer and cooled to 
approximately 60 ºC before adding 10 !l of GelStar Nucleic Acid Gel Stain (Lonza, 
ME, USA) and casting the gel in a suitable mould. RNA formaldehyde loading 
dye(Ambion #8552, CA, USA) was added to the RNA samples in a 3:1 volume ratio 
and denatured at 70 ºC for 15 minutes, followed by a 2 minute incubation on ice. The 
RNA ladder (Fermantas Riboruler High Range RNA ladder SM1823, Canada) was 
denatured in the same way. The RNA samples were then separated on the agarose gel 
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by running at a constant voltage of 100V for 45 minutes. A picture of the gel was taken 
by UV illumination on the ChemiDoc XRS machine (Bio Rad, CA, USA) and analysed 
with the Quantity One programme. 
 
2.3.16 Microinjection of zebrafish embryos 
Glass capillaries with filament (Sutter Instrument #BF100-58-10, CA, USA) 
were pulled into microinjection needles using a micropipette puller (Sutter Instrument 
P-97, CA, USA) and the following settings: Heat 605, Pull 100, Vel 80, Time 80. The 
tips of the needles were then clipped to approximately 0.02 mm wide and the injection 
volume is adjusted to 1 nl by calibrating the injection pressure and measuring the 
diameter of an injected droplet suspended in mineral oil. Morpholinos, RNA or DNA 
were diluted to the desired concentration with nuclease-free H2O and contain 0.1% of 
phenol red (Sigma, MO, USA). Embryos were collected before they reach the two-cell 
stage, aligned on a dry petri-dish, and injected with 1 nl of morpholino, RNA or DNA. 
Injection is done through the chorion, to the middle of the yolk.  
 
2.3.16.1 GFP reporter mRNA and morpholinos 
Zebrafish embryos collected before the 2-cell stage were injected with 200 pg of 
GFP reporter mRNA. These treated embryos were then further injected with 0.2 mM of 
the 5’ UTR translation-blocking morpholinos, UTR2 and UTR3. Following this, the 
embryos were kept in egg water and were returned to the 28.5 °C incubator until 
approximately 6 hours later, when they were imaged using the Leica M165FC 
fluorescence stereomicroscope fitted with the DFC310 camera (Germany). Protein 
lysates were harvested from the morpholino-injected embryos at 24 hpf. 
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2.3.16.2 Zinc-finger nuclease pairs 
25, 50 and 100 pg of zinc-finger nuclease mRNA pairs were microinjected into 
200 zebrafish embryos embryos each. The protein lysates from 50 embryos were 
extracted for Western blot analysis while 150 embryos were observed for the 
development of the ‘monster’ phenotype or death.  
 
2.3.17 Whole mount in situ hybridization 
2.3.17.1 Preparation of RNA probes 
Two RNA probes for zRNF4 were prepared. The first probe anneals to the 5’ 
UTR and the first half of the zRNF4 coding sequence while the second probe anneals to 
the second half of the zRNF4 coding sequence and the 3’ UTR. The DNA plasmids 
were linearised by digestion with BamHI or NotI (New England Biolabs, MA, US) for 
the preparation of the anti-sense and sense RNA probes respectively. The linearised 
plasmids were purified by agarose gel electrophoresis and gel extraction (Qiagen Gel 
Purification Kit, CA, USA). 6 !l in vitro transcription reactions were set up as follows: 
• 1 !g linearised DNA 
• 1 !l DIG RNA labelling mix (Roche #11277073910, IN, USA) 
• 1 !l 10X Transcription buffer  
• 1 !l RNase Inhibitor (Roche # 03335399001, IN, USA) 
• 1 !l SP6 or T7 polymerase (Roche #10810274001/ #10881767001, IN, USA) 
SP6 polymerase was used for the generation of the sense probes while T7 polymerase 
was used for the generation of the anti-sense probes.  
The reaction was incubated at 37 °C for at least 2 hours, following which 1 !l of 
DNase I (Roche #04716728001, IN, USA) was added and further incubated at 37 °C for 
15 minutes, to digest the DNA template. The reaction was stopped by the addition of 15 
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!l 7.5M LiCl with 50 mM EDTA solution, and chilled at -20 °C for 30 minutes. The 
synthesized RNA probes were precipitated and collected by centrifugation at 14 0000 g 
for 15 minutes at 4 °C. The supernatant was removed and the RNA precipitate was 
washed with 1 ml of 70 % (v/v) ethanol in dH2O. The ethanol was removed completely 
after centrifugation, and the RNA precipitate was resuspended in 10 !l of nuclease-free 
H2O.  
The concentrations of the RNA probes were determined by spectrophotometry 
(ThermoScientific ND8000, OH, USA) and the quality of the probes were checked by 
electrophoresis on an RNA gel. The probes were diluted to a concentration of 100 ng/ !l 
and stored in 5 !l aliquots at -80 °C. 
 
2.3.17.2 Fixing and dehydration of samples 
Zebrafish embryos were collected, dechorionated with a pair of forceps and 
fixed overnight at 4 °C in 4 % (w/v) paraformaldehyde with 120 mM CaCl2 (PFA). The 
fixation of adult organs was performed as described in Section 2.3.14. The next day, the 
samples were washed with PBS 3 times for 10 minutes before incubating in 50 % (v/v) 
methanol in PBS for 5 minutes. The 50 % methanol is removed and replaced with 100 
% methanol to dehydrate the samples. The samples are then kept in 1.5 ml microfuge 
tubes at -20 °C for at least 6 hours. 
 
2.3.17.3 In situ hybridization 
100 % methanol was removed from the samples and replaced with 75 % (v/v) 
methanol in PBS, followed by 50 % (v/v) methanol in PBS and 25 % (v/v) methanol in 
PBS, allowing a 5-minute incubation with each buffer change. The methanol was 
removed completely and the samples were washed with PBS with 0.1 % (v/v) Tween-
20 (PBT) three times, for 5 minutes each time. The samples were then post-fixed in 
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PFA for 20 minutes at room temperature. Following this, the samples were washed with 
PBT four times, for 5 minutes each time.  
Next, 12 !g/ml and 50 !g/ml of proteinase K (Roche #03115836001, IN, USA) 
was added to the embryos and adult organs respectively. For zebrafish embryos younger 
than 12 hpf, proteinase K digestion was not performed. For 12 hpf embryos, proteinase 
K digested proceeded at room temperature for 1 minute; and for 1 to 2 dpf embryos, 
digestion proceeded for 2 minutes. Proteinase K digestion for the adult organs was 
carried out at 37 °C for 15 minutes. After the digestion, the samples were washed with 
PBT three times before fixation with PFA for 20 minutes at room temperature. The 
samples were then washed with PBT four times, for 5 minutes each time.  
PBT was removed from the samples and replaced with 500 !l of 50 % (v/v) 
Hybe B in PBT, for 5 minutes, after which 250 !l of Hybe B was added to the samples 
for 5 minutes. Hybe B was removed completely and replaced with 250 !l of Hybe A. 
The samples were then incubated in a 68 °C water bath for 4 hours. After this 
prehybridization step, Hybe A was removed and replaced with 100 ng of DIG-labelled 
RNA probe in 50 !l of Hybe A. Hybridization was performed at 68 °C overnight.  
The probe was later removed completely from the samples and replaced with 
pre-warmed Hybe B. The samples were washed with Hybe B at 68 °C five times, for 15 
minutes each time. The samples were then washed with PBT at room temperature four 
times, for 10 minutes each time. The samples were subsequently blocked in blocking 
buffer for 3 hours at room temperature, following which anti-DIG AP (Roche 
#11093274910, IN, USA) was added to the samples (in a 1:2000 dilution in blocking 
buffer) and incubated in the dark for 4 hours. Thereafter, the samples were washed in 
PBT six times for 20 minutes each time.  
Prior to staining the samples, they were washed twice in pre-staining buffer for 
10 minutes, after which the samples were transferred to glass cavity dishes and 1 ml of 
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staining solution was added. The samples were protected from direct light and observed 
for colour development every 15 minutes under the Leica MZ16 stereomicroscope 
(Germany). When sufficient colour has developed, the staining reaction was stopped by 
washing three times in PBT for 5 minutes each time. The samples were post-fixed in 
PFA for 20 minutes and imaged with the Leica DC500 camera connected to the MZ16 
stereomicroscope (Germany).  
 
Hybe A 
• 100 !g/ ml tRNA (Sigma R8759, MO, USA) 
• 50 !g/ ml heparin (Sigma H3393, MO, USA) 
• 200 !g/ ml salmon sperm DNA (Invitrogen AM9680, CA, USA) 
*the salmon sperm DNA is denatured for 5 minute at 100 °C before adding to 
the buffer 
• Hybe B added to 10 ml  
 
Hybe B, pH 5.5 
• 6.5X saline-sodium citrate (SSC) buffer 
• 0.1 % (v/v) Triton X-100 
• 66 % (v/v) Ultra-pure Formamide (Invitrogen #15515-026, CA, USA) 
 
Blocking buffer 
• 0.5 % (w/v) blocking reagent (Roche #11096176001, IN, USA) 
Pre-staining buffer 
• 100 mM Tris-HCl, pH 9.5 
• 50 mM MgCl2 
• 100 mM NaCl 
• 0.1 % (v/v) Triton X-100 
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Staining solution 
• 1 SigmaFast BCIP/NBT tablet (Sigma B5655, MO, USA) dissolved in 10 ml 
dH2O 
 
2.3.18 Whole mount immunohistochemistry 
2.3.18.1 Fixing and dehydration of samples 
Zebrafish embryos were collected, dechorionated with a pair of forceps and 
fixed for 2 hours at room temperature in 4 % (w/v) paraformaldehyde with 120 mM 
CaCl2 (PFA). The fixation of adult organs was performed as described in Section 
2.3.15. After fixation, the samples were washed with PBS for 10 minutes thrice before 
incubating in 50 % (v/v) methanol in PBS for 5 minutes. The 50 % methanol is 
removed and replaced with 100 % methanol to dehydrate the samples. The samples are 
then kept in 1.5 ml microfuge tubes at -20 °C for at least 6 hours. 
 
2.3.18.2 Immunohistochemistry 
100 % methanol was removed from the samples and replaced with 75 % (v/v) 
methanol in PBS, followed by 50 % (v/v) methanol in PBS and 25 % (v/v) methanol in 
PBS, allowing a 5-minute incubation with each buffer change. The methanol was 
removed completely and the samples were washed with PBS three times, for 2 minutes 
each time. For the permeabilization of the zebrafish embryos, 1 ml of ice-cold acetone 
was added and they were incubated at -20 °C for 7 minutes. After this, they were 
washed with PBS four times for 2 minutes each time.  
For the excised organs, they were treated with 50 !g/ml of proteinase K (Roche 
#03115836001, IN, USA) and incubated at 37 °C for 15 minutes. After the digestion, 
the excised were washed with PBS with 0.1 % (v/v) Tween-20 (PBST) three times 
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before fixation with PFA for 20 minutes at room temperature. The excised organs were 
again washed with PBST four times, for 2 minutes each time.  
Next, the samples were blocked in blocking solution (PBDT) for 1 hour at room 
temperature. For samples that will be imaged with bright field microscopy, 1 % of 
hydrogen peroxide (H2O2; Merck, MA, USA) was added into the blocking solution to 
quench the endogenous peroxidases. At the same time, the primary antibodies were also 
diluted in blocking solution. Following this, the samples were incubated with the 
primary antibodies overnight at 4 °C. The next day, the samples were washed with the 
wash buffer four times, for 30 minutes each time, before incubation with the appropriate 
secondary antibodies for at least two hours at room temperature, in the dark. After this, 
the samples were washed five times, for 30 minutes each time. 
For immunofluorescence imaging, the samples were stained with 0.1 !g/ ml of 
DAPI for 3 minutes in the dark and washed for another five times before clearing in 
70% glycerol and either imaged in cavity dishes with the Leica M165FC fluorescence 
stereomicroscope fitted with the DFC310 camera (Germany), or mounted on bridged 
glass slides and imaged with the Zeiss LSM510 confocal microscope (Germany). For 
brightfield microscopy, the prepared DAB substrate (Dako K3468, MI, USA) was 
added to the samples in a cavity dish. When the colour of the staining has developed 
sufficiently, the samples were washed with PBS and imaged with the Leica DC500 
camera connected to the MZ16 stereomicroscope (Germany).  
 
Blocking solution (PBDT) 
• 1X PBS 
• 5 % (w/v) BSA (Sigma A9418, MO, USA) 
• 1 % (v/v) DMSO (Sigma D8418, MO, USA) 
• 0.5 % (v/v) Triton X-100 
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Wash buffer 
• 1X PBS 
• 0.8 % (v/v) Triton X-100 
 
2.3.19 Immunohistochemistry on paraffin-embedded tissue sections 
Adult zebrafish were euthanized as described in Section 2.3.14. The heads and 
tails were removed, leaving the trunk of the fish, which were immersed and fixed in 
Larison’s fixative for 24 to 48 hours at room temperature. They were then sent to the 
Histology Unit at the Institute of Molecular and Cell Biology (IMCB, A*STAR, 
Singapore) for paraffin-embedding and sectioning. The tissue samples were returned on 
labelled glass slides that were subsequently processed for immunohistochemistry. 
The tissue sections were first deparaffinised in xylene and rehydrated through 
descending percentages of ethanol and finally, water, as shown below: 
• Xylene (3 x 3 minutes) 
• 100 % ethanol (2 x 3 minutes) 
• 90 % ethanol (3 minutes) 
• 80 % ethanol (3 minutes) 
• 70 % ethanol (3 minutes) 
• dH2O (3 minutes) 
The tissue sections were then incubated in 1 % H2O2 (v/v) in methanol for 30 minutes at 
room temperature to quench the endogenous peroxidases. The sections were washed in 
dH2O for 5 minutes and rinsed in PBS briefly before performing antigen retrieval by 
heating in 0.01 M sodium citrate buffer (pH 6.0) in a pressure cooker till 120 °C.  
When the slides have cooled to room temperature, they were washed three times 
in PBS for 5 minutes each time and blocked in PBDT for 20 minutes at room 
temperature. Thereafter, the block was poured off the slides and the primary antibodies 
91  
diluted in PBDT were added on the slides and allowed to incubate for 3 hours at room 
temperature. For the negative control, only PBDT was added to the slides.  
After the primary antibody incubation, the slides were washed under a running 
tap for 10 minutes and rinsed in PBS for 5 minutes before addition of the secondary 
antibodies. The secondary antibody incubation proceeded for 1 hour at room 
temperature, in the dark. Next, the slides were washed under a running tap for 10 
minutes, rinsed in PBS for 5 minutes and had the DAB substrate added to them. The 
colour development of the tissues were monitored under the microscope Leica MZ16 
stereomicroscope (Germany) and promptly washed in running tap water thereafter.  
The slides were dehydrated in a series of ethanol and cleared in xylene before 
mounting coverslips onto them with DPX mounting media (Leica, Germany). 
• 70% ethanol (1 minute) 
• 80 % ethanol (1 minute) 
• 90 % ethanol (1 minute) 
• 100 % ethanol (2 x 1 minute) 
• Xylene (3 x 1 minute) 
Nuclei counterstaining was carried out for some slides. The order of staining is 
as follows: 
• Hematoxylin (1 minute) 
• Running tap water (30 seconds) 
• Acid: alcohol (0.25 % HCl in 95 % ethanol in water; 10 seconds) 
• Running tap water (30 seconds) 
• Scott’s Tap Water (20 g/L sodium bicarbonate, 2.5 g/L magnesium 
sulphate; 3 minutes) 
• Running tap water (30 seconds) 
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The slides were then dehydrated and cleared in xylene before mounting, as described 
above. Imaging of the slides were performed on the Zeiss AxioImager Z1 upright 
microscope (Germany) and analysed with the AxioVision 4.6 software.  
 
Larison’s Fixative 
• 30 % (v/v) ethanol 
• 10 % (v/v) formalin (Sigma, MO, USA) 
0.05 M sodium phosphate, pH 7.2 
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2.4 Primers 
Table 2.9: Primers for generating the DNA probe for Southern blotting 
Southern Probe Forward 
Primer 
5’ GGC CCT GCT CAA GGG GTC T 3’ 
Southern Probe Reverse 
Primer 
5’ GAG CAT TGA AAA CAT GAC ATT TTT CCC C 3’ 
 
Table 2.10: Primers for PCR screening of DT40 knockout clones 
gRNF4 Exon5 Forward 
Primer 
5’ CCA AAC CTT TTT GCT CTG CTA CCT CAC TGC 
3’  
gRNF4 Exon5 Reverse 
Primer 
5’ GCT CAT AAG GCA TAC ATA CTT GGA GCT TGC 
3’  
 
Table 2.11: Primer sequences for Gallus gallus actin and RNF4 for qPCR 
Actin qPCR Forward 
Primer 
5’ ATG AAG CCC AGA GCA AAA GA 3’  
Actin qPCR Reverse 
Primer 
5’ GGG GTG TTG AAG GTC TCA AA 3’  
gRNF4 qPCR Forward 
Primer 
5’ GGA CCA CTG GAG GAT GAA AC 3’ 
gRNF4 qPCR Reverse 
Primer 
5’ CAG GAG TTG GCG TTC CTA AG 3’  
 
Table 2.12: Primer sequences for site-directed mutagenesis of rRNF4 (mutated sites 
are underlined) 
RatRNF4_M140A_F 
5’ AGT TGT CCG ATC TGC GCG GAT GGA TAC TCT 
GAG 3’ 
RatRNF4_M140A_R 
5’ CTC AGA GTA TCC ATC CGC GCA GAT CGG ACA 
ACT G 3’ 
RatRNF4_R181A_F 
5’ CAC TTG CCC AAC TTG TGC GAA AAA GAT CAA 
CCA TAA ACG 3’ 
RatRNF4_R181A_R 
5’ CGT TTA TGG TTG ATC TTT TTC GCA CAA GTT 
GGG CAA GTG 3’ 
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Table 2.13: Primers for RACE-PCR 
Primer SP1 5’ GGC GTA GAC CTG GCT CGT GA 3’ 
Primer SP2 5’ CAA CTC TCC TTT GCA CAC CAT CTT C 3’ 
Primer SP3 5’ ATG TTA AGT CTA CCA CAT CTT CAC TGT TAG 3’ 
Primer SP5 5’ ATT CCG AGA TCA TGG ACA GTG GTA G 3’ 
3’ RACE Nested Primer 5’ CAC CTG TTC TGC AGT CAG TGC ATC CGC G 3’ 
T7 5’ TAA TAC GAC TCA CTA TAG GG 3’ 
SP6 5’ ATT TAG GTG ACA CTA TAG 3’ 
 
Table 2.14: Primers for cloning full-length zRNF4 into pLou3 vector (Restriction 
sites are underlined) 
Forward primer (with 
NcoI restriction site) 
5’ CA ATA CCA TGG GAA TGA GTA CTA CTG TTA 
CCC 3’ 
Reverse primer (with 
BamHI restriction site) 
5’ CTC GGA TCC TTA GAT ATA TAT AGG GTG ATA 
CTG 3’ 
 
Table 2.15: Primers for site-directed mutagenesis of zRNF4 (mutated sites are 
underlined) 
zRNF4_M131A_F 
5’ GCT GTC CTG TTT GTG CGG ATG TTT ATT CCG 
AG 3’  
zRNF4_M131A_R 
5’ CTC GGA ATA AAC ATC CGC ACA AAC AGG ACA 
GC 3’  
zRNF4_R172A_F 
5’ CTC ACA GCT GCC CTA CAT GTG CAA AGA AAC 
TCA CAC ATA AAC 3’  
zRNF4_R172A_R 
5’ GTT TAT GTG TGA GTT TCT TTG CAC ATG TAG 
GGC AGC TGT GAG 3’  
zRNF4_I183A_F 
5’ TAA ACA GTA TCA CCC TGC ATA TAT CTA AGG 
ATC CTC 3’ 
zRNF4_I183A_R 
5’ GAG GAT CCT TAG ATA TAT  GCA GGG TGA TAC 
TGT TTA 3’ 
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Table 2.16: Primer sequences for cloning zRNF4 into pcDNA3 vector (Restriction 
sites are underlined) 
zRNF4_BamF 5’ ATG GAT CCA TGA GTA CTA CTG TTA CCC 3’  
zRNF4 XhoR 
5’ TTC TCG AGT TAG ATA TAT ATA GGG TGA TAC 
TG 3’  
 
Table 2.17: List of primer pairs for qPCR in zebrafish 
zf actin qPCR Forward 
Primer 
5’ ACA GGG AAA AGA TGA CAC AGA TCA 3’  
zf actin qPCR Reverse 
Primer 
5’ CAG CCT GGA TGG CAA CGT A 3’  
zf EF1# qPCR Forward 
Primer 
5’ CTT CCT CTT TCT GTT ACC TG 3’ 
zf EF1# qPCR Reverse 
Primer 
5’ GGA GCC CTT GCC CAT CT 3’  
zf L13a qPCR Forward 
Primer 
5’ TCT GGA GGA CTG TAA GAG GTA TGC 3’ 
zf L13a qPCR Reverse 
Primer 
5’ AGA CGC ACA ATC TTG AGA GCA G 3’ 
zRNF4 qPCR Forward 
Primer 
5’ TGG TGT GCA AAG GAG AGT TG 3’ 
zRNF4 qPCR Reverse 
Primer 
5’ ATT TCG TGG AGA CCA TGA GC 3’ 
 
Table 2.18: PCR primers used for preparing the DNA templates for zRNF4 in situ 
hybridization probes (The 15 bp overhang are in blue letters and the restriction sites 
are underlined.) 
ISH_Probe1_F 5’ CTT TTT GCA GGA TCC TTC TGT GAT TTG TGT 
GGA ACG 3’ 
ISH_Probe1_R 5’ TTC TAG AGG CTC GAG TCT TCC TCT TCA TCA 
CTG CT 3’ 
ISH_Probe2_F 5’ CTT TTT GCA GGA TCC GTC CAG TCT TAG ACT 
CAG TC 3’ 
ISH_Probe2_R 5’ TTC TAG AGG CTC GAG TTT TTG TAT CAA GTG 
CCT TTT  3’ 
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Table 2.19: PCR primers to clone zRNF4 5’UTR into the EGFP-N1 vector (The 
restriction sites are underlined.) 
UTR-GFP reporter 
Forward Primer 1 
5’ TG CTC GAG CTG ATT ATC ATC AGT ATC G 3’  
UTR-GFP reporter 
Reverse Primer 1 
5’ AAG GAT CCT CAT GGT CTC CAT CAC T 3’ 
 
Table 2.20: PCR primers to clone 5’UTR- zRNF4-EGFP into pCS2+ (The 
restriction sites are underlined.) 
UTR-GFP reporter 
Forward Primer 2 
5’ CGG AAT TCC TGA TTA TCA TCA GTA TCG AG 3’ 
UTR-GFP reporter 
Reverse Primer 2 
5’ GTC TCG AGT TAC TTG TAC AGC TCG TC 3’  
 
Table 2.21: Primers for site-directed mutagenesis of 5’UTR-GFP in pCS2+ 
SDM-UTR-GFP 
Forward Primer  
5’ GTC GCC ACC ATT GGT GAG CAA GGG 3’ 
SDM-UTR-GFP Reverse 
Primer 2 
5’ CCC TTG CTC ACC AAT GGT GGC GAC 3’ 
 
Table 2.22: PCR primers for amplifying the intron-exon boundary of Exon 3 in 
zRNF4 
zRNF4 intron2-exon3 
Forward Primer 
5’ GGC TTG AGG GCC GGC AGT TTG AG 3’ 
zRNF4 intron2-exon3 
Reverse Primer 
5’ GAC TGC AGG TTC AGA CCC TTC ACA TG 3’ 
zf EF1# Forward Primer 5’ CTT CCT CTT TCT GTT ACC TG 3’ 
zf EF1# Reverse Primer 5’ GGA GCC CTT GCC CAT CT 3’  
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Table 2.23: Primer sequences for zebrafish genomic PCR and sequencing   
zRNF4 genomic 641-672 
Forward Primer 
5' CAA CAC TAG TCA TCA TGA GTA CTA CTG TTG 
TG 3' 
zRNF4 genomic 969-
1000 Reverse Primer 
5' CTA TCT ATA ATG CCG CCT TAC ATC AAG AAG 
CC 3' 
Sequencing primer 
zRNF4 genomic 803-825 
5’ ACC CAG AGA AAA AGA CGA ACA TC 3’ 
 
Table 2.24: Primer sequences for genotyping F2 zebrafish 
&4 Forward Primer 1 5’ CCC AGA TGT CTC AGA CAG T 3’  
&4 Reverse Primer 1 5’ GGG AAA TCG TAT AAG CAG C 3’  
58.5 °C 
&4 Forward Primer 2 5’ CCC AGA TGT CTC AGT GAT G 3’  
&4 Reverse Primer 2 5’ GGG AAA TCG TAT AAG CAG C 3’  
62 °C  
Ins5sub2 Forward 
Primer 1 
5’ GGC CCA GAT GTC TCA GAC 3’  
Ins5sub2 Reverse Primer 
1 
5’ GGG AAA TCG TAT AAG CAG C 3’  
58.5 °C 
Ins5sub2 Forward 
Primer 2 
5’ GGC CCA GAT GTC TGT GTG T 3’  
Ins5sub2 Reverse Primer 
2 
5’ GGG AAA TCG TAT AAG CAG C 3’ 
55.9 °C 
 
2.5 Antibodies 
2.5.1 For immunoblotting 
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Table 2.25: Primary and secondary antibodies used in immunoblotting of lysates 
from DT40 cells 
Primary Antibody Dilution Secondary Antibody  Dilution 
Anti-zRNF4  
(Sheep polyclonal; 
generated in-house) 
1:5000 
Anti-SUMO1 (Sheep 
polyclonal; generated in-
house) 
1:1500 
Anti-sheep, conjugated to 
horseradish peroxidase (HRP) 
(Raised in donkey; Sigma A3415, 
MO, USA) 
1:4000 
Anti-SUMO2 (Rabbit 
polyclonal; Invitrogen 
CA, USA #51-9100) 
1:1000 
Anti-Lamin B1 
(Rabbit polyclonal; 
Abcam ab16048, MA, 
USA) 
1:25 000 
Anti-rabbit, conjugated to 
horseradish peroxidase (HRP) 
(Raised in donkey; Sigma A3415, 
MO, USA) 
1:3000 
Anti-Flag M2 (Mouse 
monoclonal; Sigma 
F3165, MO, USA) 
1:2000 
Anti-ß actin 
(Mouse monoclonal; 
Sigma A5316, MO, 
USA) 
1:25 000 
Anti-# Tubulin (Mouse 
monoclonal Clone 
DM1A; Sigma T9026, 
MO, USA) 
1:1000 
Anti-mouse, conjugated to HRP 
(Raised in goat; Jackson 
ImmunoResearch, PA, USA) 
1:3000 
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Table 2.26: Primary and secondary antibodies used for immunoblotting of in vitro 
ubiquitylation assays  
Primary Antibody Dilution Secondary Antibody  Dilution 
FK2 anti-ubiquitin 
(Mouse monoclonal; 
BIOMOL PW8810, Enzo 
Life Sciences, NY, USA) 
1:2000 
Anti-mouse, conjugated to HRP 
(Raised in goat; Jackson 
ImmunoResearch, PA, USA) 
1:3000 
Anti-SUMO2 (Sheep 
polyclonal; generated in-
house) 
1:2000 
Anti-sheep, conjugated to 
horseradish peroxidase (HRP) 
(Raised in donkey; Sigma A3415, 
MO, USA) 
1:4000 
 
Table 2.27: Primary and secondary antibodies used for immunoblotting of H1299 
lysates 
Primary Antibody Dilution Secondary Antibody  Dilution 
Anti-zRNF4  
(Sheep polyclonal; 
generated in-house) 
1:8000 
Anti-goat, conjugated to 
horseradish peroxidase (HRP) 
(Raised in rabbit; Dako P0449, MI, 
USA ) 
1:2000 
Anti-zRNF4 (chicken 
polyclonal; generated in-
house) 
1:2000 
Anti-chicken, conjugated to 
horseradish peroxidase (HRP) 
( Sigma A9046, MO, USA) 
1:20 000 
Anti-tubulin (Sigma 
T9026, MO, USA) 
1:10 000 
Anti-mouse, conjugated to 
horseradish peroxidase (HRP) 
(Raised in rabbit; Dako P0161, MI, 
USA) 
1:1000 
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Table 2.28: Primary and secondary antibodies used in the Western blot analysis of 
lysates from morpholino-injected zebrafish 
Primary Antibody Dilution Secondary Antibody  Dilution 
Anti-zRNF4  
(Sheep polyclonal; 
generated in-house) 
1:5000 
Anti-goat, conjugated to 
horseradish peroxidase (HRP) 
(Raised in rabbit; Dako P0449, MI, 
USA ) 
1:2000 
Anti- ! actin (mouse 
monoclonal AC-15) 
1:10 000 
Anti-mouse, conjugated to 
horseradish peroxidase (HRP) 
(Raised in rabbit; Dako P0161, MI, 
USA) 
1:1000 
 
2.5.2 For immunohistochemistry 
Table 2.29: Primary and secondary antibodies used for immunofluorescence of 
H1299 cells 
Primary Antibody Dilution Secondary Antibody  Dilution 
Anti-zRNF4  
(Sheep polyclonal; 
generated in-house) 
1:500 
AlexaFluor488 Anti-sheep 
(Raised in donkey; Invitrogen A-
11015) 
1:500 
Anti-zRNF4 (chicken 
polyclonal; generated in-
house) 
1:200 
AlexaFluor488 Anti-chicken 
 (Raised in goat; Invitrogen A-
11039) 
1:500 
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Table 2.30: Primary and secondary antibodies used for immunohistochemistry of 
zebrafish samples 
Primary Antibody Dilution Secondary Antibody  Dilution 
AlexaFluor546 Anti-sheep 
(Raised in donkey; Invitrogen A-
21098, CA, USA) 
1:500 
Anti-zRNF4  
(Sheep polyclonal; 
generated in-house) 
1:500 Anti-goat, conjugated to 
horseradish peroxidase (HRP) 
(Raised in rabbit; Dako P0449, MI, 
USA ) 
1:100 
AlexaFluor594 Anti-chicken 
 (Raised in goat; Invitrogen A-
11042, CA, USA) 
1:500 
Anti-zRNF4 (chicken 
polyclonal; generated in-
house) 
1:200 
Anti-chicken, conjugated to 
horseradish peroxidase (HRP) 
( Sigma A9046, MO, USA) 
1:500 
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Chapter Three: Studying the role of RNF4 in DNA damage 
using DT40 lymphocytes  
3.1 Foreword: DT40 cells as a tool to study the DNA damage response  
The DT40 chicken B lymphocytes are derived from an avian leukosis virus-
induced lymphoma and is a popular choice for creating genetic knockouts because of its 
high ratio of targeted to random DNA integration through homologous recombination. 
The ability to create successive gene knockouts in a single DT40 clone also facilitates 
the study of complex signalling networks and determination of the epistatic relationship 
between genes in a specific cellular process.  
DT40 cells have been well utilised to study cell cycle checkpoints, with the 
exception of the G1/S checkpoint due to the p53-null status of these cells (Takao et al., 
1999). For example, the analysis of Chk1 and Chk2 -/- DT40 cells revealed their unique 
functions in cell cycle progression. Chk1, and not Chk2, is pivotal for the G2/M 
checkpoint and also initiates an S-M phase delay by maintaining replication fork 
stability until DNA replication is complete (Zachos et al., 2003, 2005). 
The roles of various DNA damage proteins have also been expounded using 
DT40 cells. Rad51, Rad52, Mre11 and BRCA1 are some of the many knockout cell 
lines that have been generated to dissect the roles of these genes in the DNA damage 
response (Sonoda et al., 1998; Yamaguchi-Iwai et al., 1998; Yamaguchi-Iwai et al., 
1999). The use of DT40 cells has also been shown to be particularly advantageous for 
understanding the extensive network of Fanconi anaemia genes and how each gene 
contributes to the pathway and to maintain genomic stability (Alpi et al., 2007; Alpi et 
al., 2008; Takata et al., 2009) 
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This chapter comprises of a study that involves generating a homozygous RNF4 
knockout in DT40 cells, as well as a characterization of these knockout cells to gain 
insight to the involvement of RNF4 in the vertebrate DNA damage response. 
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3.2 Results 
3.2.1 Generation of DT40 RNF4 knockout (RNF4 -/-) cells 
DT40 RNF4 -/- cells were obtained by homologous recombination events 
following the transfection of targeting constructs that have regions of homology to the 
Gallus gallus RNF4 genomic locus flanking an antibiotic resistance cassette (Figure 
3.1A). The DT40 cells carry two alleles of the RNF4 gene and these alleles were 
replaced sequentially with a puromycin-resistance cassette and a blasticidin-resistance 
cassette by homologous recombination.  The insertion of these cassettes generate 
additional HpaI restriction sites at the RNF4 genomic locus, enabling the detection of 
different sized DNA fragments via Southern blot analyses, confirming the genomic 
status of RNF4 in the DT40 cells (Figure 3.1A and B). Since the knockout of the second 
RNF4 allele yields DT40 clones which lack the RNF4 genomic loci completely, 
successful clones could be screened in a quick manner via polymerase chain reaction 
(PCR) cycling (Figure 3.1C). From these experiments, a total of four DT40 clones with 
different RNF4 genetic backgrounds were obtained: heterozygous Clone 2 (C2 +/-); and 
homozygous knockouts Clone 16 (C16 -/-), Clone 20 (C20 -/-) and Clone 22 (C22 -/-). 
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Figure 3.1: Generation of DT40 RNF4 knockout cells 
(A) A schematic representation of the Gallus gallus RNF4 locus and targeting 
constructs used for the deletion of the two RNF4 alleles in DT40 cells, with HpaI 
restriction sites shown. The exons are represented by black boxes and the white bar 
indicates the region where the Southern probe binds. Genomic fragments that are 
detected by the probe are shown as black bars. 
(B) Southern blot analysis of HpaI-digested genomic DNA from DT40 wild type (WT), 
RNF4 +/- (Clone 2) and RNF4 -/- (Clones 16, 20 and 22) cells. 
(C) PCR screening of RNF4 -/- clones. Primers amplifying a region in Exon 5 were 
used in the screen. 
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3.2.2 Validation of the DT40 RNF4 -/- cells 
In addition to Southern blot analyses, the loss of expression of RNF4 in the 
DT40 cells was further validated by quantitative real-time PCR and western blotting. 
The results show that neither RNF4 mRNA nor protein is detectable in any of the RNF4 
-/- DT40 clones (Figure 3.2A and B).  
 
A 
  
B 
 
 
Figure 3.2: Validation of DT40 RNF4 knockout cells 
 
(A) Quantitative real-time PCR of the various DT40 clones to show that the synthesis of 
RNF4 mRNA is abrogated in the knockout clones. Data represented is a mean of two 
independent experiments. 
(B) Western blot analysis of lysates from the DT40 clones with the polyclonal sheep 
antibody that was raised against zebrafish RNF4. 
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3.2.3 Characterization of DT40 RNF4 -/- cells 
3.2.3.1 RNF4 -/- cells have similar growth characteristics and cell cycle distributions to 
wild type cells 
The growth rates of the four DT40 clones with different RNF4 genetic 
backgrounds were compared to WT DT40 cells by counting the number of viable cells 
in culture every 24 hours for 4 days. The RNF4 +/- and RNF4 -/- cells did not show any 
distinct difference in growth characteristics (Figure 3.3A), suggesting that RNF4 is not 
essential for viability in DT40 cells. The DT40 clones were subsequently stained with 
propidium iodide and analysed by FACS. Their cell cycle profiles were then determined 
using the Watson Pragmatic mathematical model. The loss of a single or both RNF4 
alleles did not appear to affect the cell cycle distribution of the DT40 cells (Figure 
3.3B).  
 
3.2.3.2 RNF4 -/- cells have a functional G2/M checkpoint 
To further determine if the loss of RNF4 affects the G2/M checkpoint in 
response to a DNA damage signal, the DT40 clones were incubated with nocodazole for 
8 hours with or without a preceding exposure to IR. Nocodazole is a microtubule poison 
that interferes with microtubule polymerization, causing cells to arrest in prometaphase 
of mitosis. In unchallenged cells, the G2/M checkpoint is not activated and nocodazole 
treatment causes the cells to accumulate in mitosis, as reflected by positive staining for 
phospho-histone H3 (pH3). When exposed to IR, the G2/M checkpoint is triggered and 
blocks cell cycle progression into mitosis, causing the cells to arrest in G2. If RNF4 
plays a role in the DNA damage checkpoint, a similar phenotype as Chk1 -/- DT40 cells 
would be observed in this experiment – the cells will still enter mitosis despite being 
exposed to IR. However, since the RNF4 -/- clones, like the WT cells, failed to enter 
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mitosis after irradiation and nocodazole treatment (Figure 3.3C), it can be concluded 
that RNF4 does not play an obligatory role in the G2/M checkpoint.  
 
3.2.3.3 RNF4 -/- cells show increased levels of high molecular weight SUMO1 and 
SUMO2 conjugates 
It was previously shown in human U2OS and HeLa cells that the knockdown 
of RNF4 by siRNA results in the accumulation of both SUMO1 and SUMO2 
conjugates, with the levels of SUMO2 conjugates increasing to a much greater extent 
than SUMO1 (Tatham et al., 2008). To establish if RNF4 played a similar role in the 
regulation of SUMO conjugates in DT40 cells, cell lysates were obtained from the 
clones with different RNF4 genetic backgrounds and analysed by Western blot with 
SUMO1 and SUMO2 antibodies. Similar to siRNA knockdown in human cells, high 
molecular weight SUMO2 conjugates accumulated in the RNF4 -/- DT40 clones (Figure 
3.3D), suggesting that the role of RNF4 in regulating the turnover of sumoylated 
proteins in cells is likely to be conserved across species.  
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Figure 3.3: Characterization 
of DT40 RNF4 knockout 
cells 
 
(A) Growth rates of the 
different RNF4 DT40 clones 
in culture. The number of 
viable cells was determined 
by cell counting over 4 days. 
The represented values are a 
mean of three independent 
experiments and the error bars 
indicate one standard 
deviation. 
 
(B) Cell cycle profiles of the 
RNF4 DT40 clones. The cells 
were stained with propidium 
iodide and analysed by flow 
cytometry. The proportion of 
cells in each cell cycle phase 
was determined by fitting to 
the Watson Pragmatic 
mathematical model in 
FlowJo. The represented 
values are a mean of three 
independent experiments and 
the error bars indicate one 
standard deviation.  
 
(C) Functional analysis of 
G2/M checkpoint in RNF4 -/- 
DT40 cells. DT40 cells were 
exposed to nocodazole for 8 
hours, with or without prior 
exposure to IR. They were 
subsequently stained with 
pH3 and PI and subjected to 
FACS analysis. The mitotic 
indices are normalized to the 
nocodazole-treated cultures. 
Chk1-/- DT40 cells were used 
as a positive control in the 
assay. The represented values 
are a mean of three 
independent experiments and 
the error bars indicate one 
standard deviation. 
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Figure 3.3D: Characterization of DT40 RNF4 knockout cells 
Accumulation of SUMO conjugates in RNF4 -/- DT40 cells. Cell lysates from the 
RNF4 DT40 clones were analysed by western blotting with antibodies to SUMO1 and 
SUMO2. 
!
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3.2.4 RNF4 -/- cells display increased sensitivity to some DNA damaging agents but 
not others 
Colony formation assays were carried out on the DT40 clones to determine if 
RNF4 plays a role in cell survival in response to DNA damaging agents. The cells were 
exposed to each of the following treatments: gamma irradiation (IR), methyl 
methanesulfonate (MMS), ultraviolet radiation (UV), hydroxyurea (HU) and cisplatin. 
As shown in Figure 3.4A to C, the homozygous loss of RNF4 does not affect the colony 
formation potential of the DT40 cells in response to either IR, MMS or UV. In these 
treatments, UBE2T -/- cells were used as a positive control. The UBE2T -/- cells have a 
homozygous deletion of UBE2T, a ubiquitin E2 conjugating enzyme that plays a pivotal 
role in the Fanconi Anemia pathway (Alpi et al., 2007; Machida et al., 2006), and has 
been previously shown to display increased sensitivity to an array of DNA damaging 
agents.  
In contrast, RNF4 -/- cells displayed a hypersensitivity to a chronic HU 
treatment as compared to WT and RNF4 +/- cells (Figure 3.5A). This was also evident 
for the cisplatin-treated cells, albeit to a lesser extent (Figure 3.5B).  
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!Figure 3.4: Loss of RNF4 in DT40 cells does not affect cell survival in response to (A) IR, (B) MMS and (C) UV treatment!
 
UBE2T-/- DT40 cells are used as a positive control in these treatments. Survival rates determined from the number of colonies formed. The data 
presented are a mean of three independent experiments and the error bars indicate one standard deviation. 
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Figure 3.5: Colony formation assays show that the complete loss of RNF4 in DT40 cells reduces cell survival in response to (A) HU and (B) 
cisplatin treatment 
The data presented are a mean of three independent experiments and the error bars indicate one standard deviation. 
A B 
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3.2.5 Generation of RNF4 rescue clones 
To validate that the hypersensitivity to HU and cisplatin observed in the RNF4 -
/- cells is attributed to the loss of RNF4 expression, Flag-tagged wild type and double 
mutant RNF4 from Rattus norvegicus  (WT and DM rRNF4), and untagged wild type 
RNF4 from Danio rerio (zRNF4) were stably transfected in the RNF4 -/- DT40 cells 
(Figure 3.6A and B). The DM rRNF4 (M140A, R181A) was previously shown to have 
impaired binding to the ubiquitin E2 conjugating enzyme, and is therefore an inactive 
ubiquitin E3 ligase (Plechanovova et al., 2011). In order to determine if the levels of 
RNF4 protein in the cells affected its function in protection against DNA damage, two 
clones expressing different amounts of WT rRNF4 were chosen for the colony 
formations assays. WT rRNF4 Clone 9 (C9) expressed a low level of RNF4 while WT 
rRNF4 Clone 10 (C10) expressed a higher level of RNF4, and this was shown by a 
Western blot analysis with an anti-Flag antibody (Figure 3.6A).  
To enrich the population of SUMO2 conjugates, the nuclear fraction of the DT40 rescue 
clones were obtained. A western blot of the nuclear fractions with the SUMO2 antibody 
(Figure 3.6C) showed that WT rRNF4 Clone 10 (C10) and DM rRNF4 accumulated 
large amounts of high molecular weight SUMO2 conjugates. This suggests that the 
levels and activity of RNF4 has a direct effect on the amount of SUMO2/3 conjugates in 
the cells. 
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Figure 3.6: Generation of 
RNF4 rescue clones 
 
Western blot analysis of 
lysates from various rescue 
clones established by the 
stable transfection of   
(A) Flag-tagged wild type 
(WT) and double mutant 
(DM) rat RNF4; and  
(B) zebrafish RNF4 
(zRNF4) in the RNF4 -/- 
DT40 cells. 
(C) A western blot showing 
the SUMO2 conjugates in 
the nuclear lysates of the 
rescue clones. 
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3.2.6 RNF4 E3 ligase activity is vital for cell survival in response to DNA damage in 
DT40 cells 
Rescue colony formation assays were carried out with the newly generated 
RNF4 rescue clones. The results show that the stable transfection of WT rRNF4 at low 
levels (WT rRNF4 C9) in the RNF4 -/- DT40 cells could not only obviate the 
hypersensitivity to HU, it appeared to enhance the cells’ colony formation potential, 
surpassing that of the WT DT40 cells (Figure 3.7A). Higher levels of rRNF4 (WT 
rRNF4 C10) and zRNF4 could partially rescue the colony formation potential of the 
RNF4 -/- cells while DM rRNF4 not only failed to rescue this mutant phenotype, it 
made the cells even more sensitive to HU than the RNF4 -/- cells. This implies that it is 
the ubiquitin E3 ligase activity of RNF4 that is engaged in the DNA damage response 
pathway responsible for cell survival in response to HU treatment.  
The effects of the rescue colony formation assay are less prominent in the 
cisplatin treatments. In fact, all of the rescue clones appear to alleviate the sensitivity to 
cisplatin caused by the homozygous deletion of RNF4 in the DT40 cells (Figure 3.7B). 
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Figure 3.7: RNF4 ubiquitin E3 ligase 
activity is essential for reverting the 
DNA damage phenotype of RNF4 -/- 
DT40 cells  
 
Rescue colony formation assays with 
WT, DM rat RNF4 and zebrafish RNF4. 
Low levels of stably expressed WT rat 
RNF4 (C9) and zebrafish RNF4 is able to 
rescue cell survival in response to (A) 
HU and (B) cisplatin treatment. The data 
presented are a mean of three 
independent experiments and the error 
bars indicate one standard deviation. 
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3.3 Discussion  
3.3.1 RNF4 and its role in S-phase specific DNA repair 
Homozygous genomic knockouts of RNF4 in DT40 cells were successfully 
generated. The loss of RNF4 did not have a significant effect on the growth rates or the 
cell cycle profiles unlike those observed in cells lacking important DNA repair genes 
such as Mre11 and Ku70 (Yamaguchi-Iwai et al., 1999). The colony formation assays 
demonstrated that the RNF4 -/- cells have an increased sensitivity to HU and cisplatin, 
but not to MMS, UV or IR. HU is a ribonucleotide reductase inhibitor, which depletes 
deoxyribonucleotides and interferes with DNA replication while cisplatin is a DNA 
crosslinking drug that generates intra- and interstrand links in DNA. These two drugs 
are different from the other treatments in that they both have an increased cytotoxicity 
towards cells in S-phase (Donaldson et al., 1994; Kim et al., 1967). Both drugs cause 
replication fork stalling – fork progression is inhibited when it encounters interstrand 
crosslinks in the DNA template or when the pool of free dNTPs is depleted. Prolonged 
stalling of the replication machinery would subsequently lead to its collapse and 
generate DNA DSBs (Lopes et al., 2001). It would be intuitive to hypothesize that the 
reason why the RNF4 -/- cells exhibit hypersensitivity to HU and cisplatin is because it 
is implicated in DSB repair specifically in S-phase of the cell cycle. IR also generates 
double-strand breaks independent of the cell cycle and the RNF4 -/- cells did not show a 
hypersensitivity to it. This is consistent with the recently published work that RNF4 
plays a role in homogolous recombination ((Galanty et al., 2012; Yin et al., 2012); 
Appendix A), which is a DNA repair pathway specific to S-phase cells.   
If RNF4 is involved in an S-phase-specific function such as maintaining 
replication fork stability, the RNF4 -/- cells might accumulate DNA lesions during 
replication and we might expect to observe an accumulation of cells in the S and G2-
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phases due to the activation of the G2/M checkpoint. However, the cell cycle profiles of 
the RNF4 -/- cells did not vary significantly from the wild-type DT40 cells. Further 
analysis on the RNF4 -/- cells showed that they have a functional G2/M checkpoint. 
This suggests that in the absence of exogenous DNA insults, other proteins acting in 
complementary pathways are sufficient to repair DNA lesions generated endogenously, 
allowing RNF4 -/- cells to remain viable. 
 
3.3.2 RNF4 promotes the repair of DNA double strand breaks 
Together with the data from the RNF4 -/- DT40 cells, it was demonstrated that 
RNF4 is implicated in the DNA damage response, in particular, the repair of DNA 
DSBs. RNF4 was recruited to DNA DSBs in a manner dependent on its SIMs and an 
intact RING domain (Yin et al., 2012). As with most STUbLs, RNF4 recruitment is 
SUMO-dependent and results in ubiquitylation: it is preceded by the PIAS1 and PIAS4-
mediated accumulation of SUMO2/3 (Galanty et al., 2012; Yin et al., 2012), and it 
contributes to the formation of Lys63-linked polyubiquitin chains at the DNA DSBs 
(Yin et al., 2012).  
The depletion of RNF4 resulted in hypersensitivity to gamma-irradiation and 
chronic hydroxyurea treatment (Galanty et al., 2012; Yin et al., 2012), which generate 
DNA DSBs. RNF4 is not involved in the early damage sensing and signal transduction 
steps of DNA DSB repair as it was recruited downstream of NBS1, MDC1, RNF8, 
53BP1 and BRCA1. In the absence of RNF4, !H2AX and MDC1 persisted at the DNA 
DSBs, indicating a delay in effective repair, which could account for the stalling of the 
G2/M checkpoint recovery in RNF4-depleted cells that were gamma-irradiated (Galanty 
et al., 2012; Yin et al., 2012).  
Yin and colleagues discovered that RNF4 binds to sumoylated MDC1 at the 
DNA DSBs and is required for the recruitment of the CtIP DNA endonuclease which 
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mediates DNA end resection in homologous recombination. The depletion of RNF4 
blocks the generation of single stranded DNA, which then hinders the binding of the 
RPA complex and Rad51 at the DNA DSBs (Yin et al., 2012).  
Galanty and colleagues also detected a defective loading of Rad51 and BRCA2 
at the DNA DSBs in cells that lacked RNF4, and they hypothesized that RNF4 is 
required for the turnover of RPA and MDC1, so that it vacates the sites for Rad51 and 
BRCA2 to bind. Both RPA and MDC1 are SUMO-conjugated in response to DNA 
damage and are possible interactors with RNF4. RNF4 is also imperative for the 
recruitment of the proteasome subunit PSMD4, the main ubiquitin-binding component 
of the 19S proteasome regulator, to DNA DSBs. These findings suggest that RNF4 also 
regulates the molecular transition for the progression through each stage of DNA DSB 
repair by targeting sumoylated proteins to ubiquitin-mediated proteolysis (Galanty et 
al., 2012). 
 
3.3.3 RNF4 maintains homeostasis of SUMO conjugation in DT40 cells 
In line with the observations of the yeast STUbL mutants as well as the siRNA 
knockdown of RNF4 in human cells, the RNF4 -/- DT40 cells also displayed an 
increase in SUMO1 and SUMO2/3-conjugates (Kosoy et al., 2007; Tatham et al., 2008; 
Zhang et al., 2006). This supports the theory that STUbLs have a universal role in 
regulating the levels of sumoyated proteins in cells. Kosoy and colleagues hypothesized 
that the accumulation of sumoylated proteins is the cause of the DNA repair defect in 
yeast, but it is a contentious idea because the accumulation of sumoylated substrates 
could be a cellular response to exogenous stress. When cells were subjected to heat 
shock or irradiation, an increase in SUMO conjugates were observed (Golebiowski et 
al., 2009; Yin et al., 2012), of which a fraction are likely to be substrates for RNF4. A 
mass spectrometry analysis identifying the SUMO2/3 conjugates that appear in the 
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RNF4 -/- DT40 cells but not in WT DT40 cells may aid in the unearthing of novel 
substrates of RNF4.  
The rescue experiments showed that the protective function of RNF4 against the 
DNA damaging agents is attributed to its ubiquitin E3 ligase activity. The ligase-dead 
mutant, DM rRNF4, has two point mutations that disrupts its interaction with the E2 
conjugating enzyme. These point mutations do not affect its overall protein tertiary 
structure (Plechanovova et al., 2011), which may otherwise result in protein aggregation 
and hinder its binding to other interacting partners independent of its E3 ligase activity. 
The expression of DM rRNF4 exerts a dominant negative effect: it aggravates the 
hypersensitivity of the RNF4 -/- DT40 cells to HU, as well as the accumulation of 
SUMO2/3 conjugates. The levels of accumulated SUMO2/3 conjugates in the DM 
rRNF4 expressing cells surpassed that of the RNF4 -/- cells, suggesting that there might 
be other functional homologues of RNF4 in DT40 cells that fail to carry out their 
activities because the sumoylated substrates are sequestered by the ligase-dead DM 
rRNF4.  
 
3.3.4 Is RNF4 implicated in tumour chemoresistance? 
The rescue clone expressing low levels of WT rRNF4 showed an enhanced 
resistance to HU compared to WT DT40 cells. Interestingly, RNF4 was reported to be 
downregulated in human testicular germ cell tumours (Hirvonen-Santti et al., 2003; 
Pero et al., 2001). Testicular germ cell tumours are highly responsive to cisplatin 
treatments (Bosl and Motzer, 1997) but about 10% of patients develop drug resistance. 
The deregulation of many other ubiquitin E3 ligases have shown to correlate with 
chemoresistance and poor clinical prognosis in human cancers (Sun, 2006), leading to a  
tempting postulation that reduced levels of RNF4 in cancer cells might associate with 
the development of chemoresistance. It would be interesting to perform histological 
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analyses of RNF4 protein levels on different human cancer samples, particularly those 
that are responsive to hydroxyurea treatments, such as chronic or acute myeloid 
leukemia, head and neck cancers, and ovarian cancer (Source: Cancer Research UK 
website http://cancerhelp.cancerresearchuk.org/about-cancer/treatment/cancer-
drugs/hydroxycarbamide), to substantiate this hypothesis. 
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Chapter Four: Identification and Biochemical 
Characterization of Danio rerio RNF4 
4.1 Foreword: Danio rerio as a vertebrate model organism for cancer-
related studies 
 
Danio rerio (zebrafish), from the genus of teleosts, is a tropical freshwater fish 
that was originally identified in rivers and ponds in the Ganges region of India (Spence 
et al., 2008). There are many advantages for using zebrafish as a vertebrate model 
organism. They are small, easy to maintain, and cost much lesser than caring for mouse 
colonies. They have high fecundity - a female zebrafish can lay up to 200 embryos each 
week, a favourable trait for large scale forward genetic screens or drug toxicity screens. 
Zebrafish have a relatively short generation time - embryonic development occurs 
rapidly such that all major organs are formed within 24 hour post fertilization (hpf), and 
they reach sexual maturity within 3 to 4 months. Since zebrafish embryos are fertilised 
and develop ex utero, and are transparent, the early developmental stages are easily 
followed by visual observation under a stereomicroscope. Zebrafish are highly 
genetically amenable and are useful tools for identifying genes that contribute to the 
development of mono- or polygenic diseases, by means of forward or reverse genetics.  
Tumours have been shown to develop spontaneously in teleosts in the wild (Amatruda 
et al., 2002) and are histologically similar to mammalian tumours (Hawkins et al., 
1985). As in man, tumours occur more frequently in older animals. Forward genetics 
using chemical carcinogenesis and reverse genetics using transgenic fish models have 
been established successfully, allowing the isolation of cancer-inducing mutations that 
have similar pathology to the disease in humans. For instance, the heterozygous 
mutations in zebrafish resulting in the loss-of-function of the adenomatous polyposis 
coli gene (APC) increases the propensity for the development of intestinal neoplasias 
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and sensitivity to intestinal carcinogens, a phenotype similar to that observed in humans 
and mice (Haramis et al., 2006). In addition, the liver is a tissue that has a higher 
predisposition to develop spontaneous tumours in wild-type zebrafish (Kent ML, 2002) 
and a comparison of the gene expression profile of zebrafish liver tumours to human 
liver tumours showed significant similarities (Lam and Gong, 2006; Lam et al., 2006), 
demonstrating that the genetic pathways in tumorigenesis in humans are likely to be 
conserved in the zebrafish. 
Some examples of successful zebrafish cancer models include that for 
melanoma and leukemia. A transgenic zebrafish carrying the V600E oncogenic 
mutation of the BRAF tyrosine kinase gene driven by a melanocyte-specific promoter 
develop nevi in a wild-type genetic background, but in a p53-mutant background, a 
predisposition to melanoma is observed, illustrating the cooperative interaction between 
BRAF and p53 in the pathogenesis of melanoma (Patton et al., 2005). The transgenic 
fish model for lymphoid leukemia was established by the overexpression of the murine 
c-myc oncogene under the control of the zebrafish lymphocyte-specific Rag2 promoter. 
It displayed similar disease characteristics as in humans such as a long latency and 
incomplete penetrance, suggesting that other mutations are required to contribute to the 
pathogenesis of the disease (Langenau et al., 2005; Langenau et al., 2003).  
In addition to its potential as a cancer disease model, recent discoveries have suggested 
that the SUMO conjugation pathway and machinery are also conserved in zebrafish 
(Bakkers et al., 2005; Li et al., 2010; Nowak and Hammerschmidt, 2006; Wen et al., 
2011; Yuan et al., 2010). The zebrafish is thus an excellent model organism for 
understanding the physiological role of RNF4 in a whole animal. This chapter 
summarizes the results of the identification and sequencing of the zebrafish RNF4 gene, 
analysis of its in vitro E3 ligase activity, and generating polyclonal antibodies as a tool 
for in vivo analyses. 
                                                                          126 
4.2 Results 
4.2.1 Rapid Amplification of cDNA ends PCR (RACE-PCR) and cloning full length 
Danio rerio RNF4  
The search for RNF4 in Danio rerio (zRNF4) began at the National Center for 
Biotechnology Information Homologene database 
(http://www.ncbi.nlm.nih.gov/homologene), making use of a gene homology tool that 
identifies putative orthologs in different species. The nucleotide sequence for zRNF4 
found is located on Chromosome 14 (NC_007125.5) and the coding regions of zRNF4 
were predicted by an automated computational analysis, GNOMON, which derives 
putative mRNA and protein sequences from existing expressed sequence tags (EST) in 
the database. A further search in the database showed that two Danio rerio mRNA 
sequences, IMAGE: 5914563 and IMAGE: 5601552, displayed high similarities to the 
putative zRNF4 sequence. However, these IMAGE clones did not have ATG start 
codons, and their corresponding translated sequences yield a truncated four amino-acid 
peptide due to an early stop codon. 
 
• Predicted RNF4 protein sequence:        MSTTVTQRKRRT… 
• IMAGE 5914563 translated sequence: VSAF*TQRKRRT…  
• IMAGE 5601552 translated sequence: VSAF*TQRKRRT… 
 
Thus, the coding sequence of zRNF4 was determined experimentally from RNA 
extracted from 2 days old wild type AB strain zebrafish embryos. The extracted RNA 
was reverse transcribed to cDNA and subsequently carried through a series of PCR 
reactions known as rapid amplification of cDNA ends (RACE) PCR. The primers used 
in the RACE-PCR were designed based on the predicted cDNA sequence of zRNF4 
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provided by NCBI (Figure 4.1A and B). For 5’ RACE, the primer sequences was 
chosen from sites approximately 500, 400 and 300 base pairs downstream of the ATG 
start codon while for 3’ RACE, they were approximately 700 and 600 base pairs 
upstream of the stop codon. Nested PCR was carried out sequentially with these primers 
until a single band of PCR product is detected for each reaction (Figure 4.1C). These 
products were subsequently ligated into pGEM-T easy vector and their sequences were 
determined. These PCR product sequences revealed the untranslated regions (UTR) of 
the zRNF4 gene (Figure 4.4A).  
From the UTR sequences obtained, primers were further designed to clone and 
sequence the full-length coding region of zRNF4 (Figure 4.1D). The zRNF4 coding 
sequence obtained is 558 base pairs long and encodes a 185 amino acid protein (Figure 
4.2B and C). It is highly similar to the predicted RNF4 protein sequence except that it 
has an additional serine residue at amino acid position 12. A blastn search for the RNF4 
coding sequence in the Danio rerio genomic database showed that it was located on 
Chromosome 14, nucleotides 15 399 933 to 15 408 830 of Zv9 (the ninth and latest 
assembly of the zebrafish genome). A comparison of the zRNF4 coding sequence with 
the bases in this genomic region allowed the determination of the intron-exon 
boundaries in the zRNF4 RNA (Figure 4.2C). 
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Figure 4.1: Cloning RNF4 from Danio rerio cDNA by RACE-PCR  
(A) Overview of 5’ RACE 
(B) Overview of 3’ RACE 
(C) 5’ and 3’ RACE nested PCR was carried out on cDNA obtained from the reverse 
transcription of RNA extracted from 2 dpf zebrafish embryos. The PCR products 
obtained were subsequently sequenced to obtain the 5’ and 3’ UTR regions of the 
zRNF4 gene. 
(D) PCR amplification of full-length zRNF4 from 2 and 3 dpf zebrafish cDNA, using 
primers that anneal to the 5’ and 3’ UTR regions of the zRNF4 gene. 
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5’ UTR (120 bases) 
ttc tgt gat ttg tgt gga acg ttc gtt gtg tgg ctg aca gtt gga 
gag ttc tga tta tca tca gta tcg agg aat cat ctt ttg gct tga 
tat cat ttg gag tga tca aca cta gtc atc 
 
3’ UTR + polyadenylation signal (161 bases) 
cga caa gac cag cag ctc act tca gct gaa tgc ttc tcg aaa gtt 
ctg cgg tat gaa aca act tca tgt tct cgc tgg ctg ttt cat gtt 
tac aca caa acg cac ata caa aat gat ttg tta gaa ata aaa agg 
cac ttg ata caa aaa aaa aaa aaa aa 
 
B 
ATG AGT ACT ACT GTT ACC CAG AGA AAA AGA CGA ACA TCT TCC ACT  
 M   S   T   T   V   T   Q   R   K   R   R   T   S   S   T       
ACA TGT TCA CGC CGT GGC AAC AGC AAG AGG AAC CGG GCC CAG ATG 
 T   C   S   R   R   G   N   S   K   R   N   R   A   Q   M    
TCT CAG ACA GTG ATG GAG ACC ATT GAT GTG CTA GAA AAC GAC AGA 
 S   Q   T   V   M   E   T   I   D   V   L   E   N   D   R    
ACT AAC AGT GAA GAT GTG GTA GAC TTA ACA TGT GAA GGG TCT GAA 
 T   N   S   E   D   V   V   D   L   T   C   E   G   S   E 
CCT GCA GTC GTT GAC CTC ACC AAT AAT GAC TCT ATT GTG GTT GTA 
 P   A   V   V   D   L   T   N   N   D   S   I   V   V   V   
GAA GAT GGT GTG CAA AGG AGA GTT GGG CCG TGC ACA GAG AGT TAT  
 E   D   G   V   Q   R   R   V   G   P   C   T   E   S   Y   
GTA CTG AGC AGT GAT GAA GAG GAA GAG TCC AGT CTT AGA CTC AGT 
 V   L   S   S   D   E   E   E   E   S   S   L   R   L   S     
CCA GGC TTA CTG TCC TCT CTA CGT GAC AGC TCA CGA GCC AGG TCT 
 P   G   L   L   S   S   L   R   D   S   S   R   A   R   S 
ACG CCC GGC GCC ATT AGC TGT CCT GTT TGT ATG GAT GTT TAT TCC 
 T   P   G   A   I   S   C   P   V   C   M   D   V   Y   S       
GAG ATC ATG GAC AGT GGT AGG CTC ATG GTC TCC ACG AAA TGC GGT 
                                                                          131 
 E   I   M   D   S   G   R   L   M   V   S   T   K   C   G       
CAC CTG TTC TGC AGT CAG TGC ATC CGC GAC TCT CTC AGC AGA GCT 
 H   L   F   C   S   Q   C   I   R   D   S   L   S   R   A   
CAC AGC TGC CCT ACA TGT AGA AAG AAA CTC ACA CAT AAA CAG TAT 
 H   S   C   P   T   C   R   K   K   L   T   H   K   Q   Y     
CAC CCT ATA TAT ATC TAA 
 H   P   I   Y   I   * 
 
C 
 
 
  Figure 4.2: Sequence information of RNF4 in Danio rerio (zRNF4) 
(A) The longest and most complete zRNF4 5’ and 3’ UTR sequences obtained from 
sequencing of the RACE-PCR products that were cloned into pGEM-T Easy vectors. 
(B) Coding and translated sequence of zRNF4 
(C) Diagrammatic representation of the zRNF4 genomic locus 
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4.2.2 Functional domains and key residues of RNF4 are conserved in Danio rerio  
The known RNF4 sequences in higher eukaryotes were aligned with the zRNF4 
sequence. The phylogenetic tree in Figure 4.3B represents the evolutionary relationship 
of RNF4 in these higher order eukaryotes. It suggests that RNF4 in Gallus gallus 
(chicken) and Danio rerio (zebrafish) evolved in the more recent past, resulting in more 
divergent protein sequences.  
In spite of a less than 50% sequence identity between the zebrafish and the other 
mammals (human, mouse and rat) (Figure 4.3A), the multiple sequence alignment 
shows that the critical functional domains and amino acid residues essential for RNF4’s 
ubiquitin E3 ligase activity are still well conserved in all these species (Figure 4.3C). In 
all the compared species, there are four SUMO-interacting motifs at the N-terminus of 
the protein (highlighted in yellow). This is also the substrate-binding region of RNF4.  
The functionally important RING domain lies at the C-terminus, with 8 distinct residues 
required for coordinating zinc (highlighted in green). At the very C-terminal end of 
RNF4, are the three residues that have been shown to be vital for its dimerization 
(highlighted in pink). Interestingly, even the key residues that were shown to be critical 
for the ubiquitin E3 ligase activity of RNF4 (highlighted in cyan; (Plechanovova et al., 
2011), have the same positions within the RING domain in all RNF4 sequences. These 
results suggest that the functional role of RNF4 in the higher eukaryotes may be 
conserved.  
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Figure 4.3: The functional domains (SIMs, zinc coordinating residues and dimerization motif) and key residues critical for RNF4’s 
ubiquitin E3 ligase activity are conserved in Danio rerio 
 
(A) Pairwise alignment scores (in % sequence identity) of RNF4 protein sequences from Homo sapiens (human), Mus musculus (mouse), Rattus 
norvegicus (rat), Gallus gallus (chicken) and Danio rerio (zebrafish). 
(B) A representative phylogenetic tree of RNF4 from Homo sapiens, Mus musculus, Rattus norvegicus, Gallus gallus and Danio rerio, based on 
their protein sequence identities. 
(C) A multiple sequence alignment of RNF4 protein sequence from Homo sapiens, Mus musculus, Rattus norvegicus, Gallus gallus and Danio 
rerio, with the functional domains and key amino acid residues highlighted. 
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Species/ Protein sequence 
identity (%) 
Homo sapiens Mus musculus Rattus norvegicus Gallus gallus Danio rerio 
Homo sapiens 100 91 93 69 39 
Mus musculus  100 96.4 68.4 49.5 
Rattus norvegicus   100 67.9 48.4 
Gallus gallus    100 57.7 
Danio rerio     100 
B 
C 
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4.2.3 Expression and purification of recombinant zRNF4 
To perform biochemical analyses and to generate antibodies against zRNF4, a 
substantial amount of purified protein was required. zRNF4 was subcloned into the 
pLou3 vector, which, when transformed into E. coli Rosetta cells, results in the 
expression of recombinant zRNF4 that has an N-terminal 6x-His-MBP tag and a TEV 
cleavage site following the tag. The expression of zRNF4 as an MBP fusion protein 
enhances its solubility and this is enables the straightforward assessment of zRNF4’s E3 
ligase activity in vitro. As shown in Figure 4.4A, although some of the expressed 
protein remains in the insoluble fraction after the bacteria cells are lysed (Lane: Pellet 
after sonication), a substantial amount is in the soluble fraction (Lane: Supernatant after 
sonication).  
This soluble fraction from the bacterial lysate was subsequently passed through 
a column of amylose beads, which binds MBP on the tagged zRNF4 protein. Purified 
MBP-tagged zRNF4 was thereafter used for the in vitro assays. Single site E2-binding 
mutants M131A and R172A; double site E2-binding mutant (DM) M131A- R172A; and 
dimerization mutant I183A, were also expressed and purified in the same way (Figure 
4.4B). 
MBP is considerably larger (42 kDa) as compared to that of zRNF4 (20 kDa).  
For the generation of antibodies, it is preferable to remove the MBP tag from the fusion 
protein to ensure that most of the antibodies raised in the immunized animals are against 
epitopes on zRNF4 and not MBP. Thus, the purified MBP-zRNF4 protein was 
incubated overnight with TEV protease, which cleaves at the TEV site situated between 
MBP and zRNF4 (Figure 4.5A).  
To remove all the cleaved MBP protein, any uncut MBP fusion protein, as well 
as TEV, the sample was passed through a Ni-NTA column. The MBP tag and TEV 
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carry a 6x-His sequence and will hence bind to the Ni-NTA column, allowing the 
untagged zRNF4 to be collected in the flow-through. Figure 4.5B shows that most of 
the untagged zRNF4 can be removed from the column without a detectable cross-
contamination of free MBP using up to 30 mM imidazole in the column wash buffer. 
This concentration of imidazole appears to be sufficient to prevent the non-specific 
binding of zRNF4 to the Ni-NTA column whilst not eluting the bound MBP protein.  
An additional purification step was added to ensure the removal of most MBP-
fusions and free MBP protein. The flow-through from the Ni-NTA column was 
therefore passed through an amylose column (Figure 4.5C). Purified and concentrated 
zRNF4 protein (Figure 4.5D) was sent to Dr. Maggie Chambers at the Scottish National 
Blood Transfusion Service for the immunization of sheep and chickens to produce 
polyclonal antibodies.  
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B 
Figure 4.4: Expression and 
purification of recombinant 
zRNF4 and zRNF4 mutants 
 
Coomassie blue-stained reducing 
SDS-PAGE gels showing:   
(A) The induction of 6x-His-MBP-
tagged WT zRNF4 in E. coli 
Rosetta cell (DE3) and the 
subsequent amylose column 
purification of the bacterial lysates. 
(B) The expression of 6x-His-MBP-
tagged zRNF4 mutants: single site 
E2-binding mutants M131A and 
R172A; double site E2-binding 
mutant M131A-R172A (DM); and 
dimerization mutant I183A. (* 
refers to an unsuccessful induction 
of DM zRNF4) 
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Figure 4.5: Removal of 6x-His-MBP tag and purifying untagged zRNF4 
 
Coomassie blue-stained reducing SDS-PAGE gels showing:   
(A) TEV-cleavage on 6x-His-MBP-tagged zRNF4 fusion protein to obtain untagged 
zRNF4. 
(B) Ni-NTA column purification of TEV-cleaved MBP-zRNF4 with increasing 
concentrations of imidazole in the column wash buffers.  
B 
A 
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Figure 4.5: Removal of 6x-His-MBP tag and purifying untagged zRNF4 
 
Coomassie blue-stained reducing SDS-PAGE gels showing:   
(C) The purification of untagged zRNF4 on Ni-NTA followed by amylose columns, to 
remove the cleaved 6x-His-MBP tag. 
(D) Purified, untagged recombinant zRNF4 that was used to immunize sheep and 
chickens for polyclonal antibody production. 
 
 
 
 
 
 
 
 
D C 
 140 
4.2.4 zRNF4 is an active ubiquitin E3 ligase in vitro 
An in vitro ubiquitylation assay was set up to determine if zRNF4 possessed 
ubiquitin E3 ligase activity.  In essence, a ubiquitin E1 (Ube1), E2 (UbcH5a) and free 
ubiquitin was incubated with the zRNF4 in the presence of ATP for 3 hours at 37 °C. In 
this ubiquitylation assay, wild-type RNF4 from Rattus norvegicus (WT rRNF4) and its 
catalytically dead RING-mutant CS1, were used as positive and negative controls 
respectively (Tatham et al., 2008).  
As shown in Figure 4.6, some high molecular weight smears are detected at the 
top region of the Coomassie blue stained gel for the samples collected after 3 hours but 
not at t=0, before the reaction started. This high molecular weight smear corresponds to 
the polyubiquitin-conjugated E3 ligase. In this experiment, all the ubiquitin E3 ligases 
tested are MBP-fusion proteins. This not only enhances the solubility of the ligase, but 
the additional MBP protein sequence also serves as additional substrates for 
autoubiquitylation, thus amplifying the polyubiquitin smear that is detected on the gel. 
WTzRNF4 exhibits robust autoubiquitylation activity which is impaired slightly by a 
single amino acid mutation at its E2-binding site (M131A or R172A). The single amino 
acid mutation in its dimerization motif (I183A) shows a greater inhibition but it is the 
double site mutation in the E2-binding site (DM M131A-R172A) that appears to ablate 
zRNF4’s E3 ligase activity completely.  
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Figure 4.6: zRNF4 is an active ubiquitin E3 ligase  
 
A Coomassie blue-stained reducing SDS-PAGE gel showing an in vitro 
autoubiquitylation assay. Ube1 (35 nM), UbcH5a (0.8 !M), and ubiquitin (35 !M) were 
incubated for 3 hours at 37 °C with the respective ubiquitin E3 ligase (2 !M). The 
reactions were stopped by the addition of 2X SDS sample buffer.  
WT – wild type zRNF4; M131A – single mutation in the E2 binding site of zRNF4,  
R172A – single mutation in the E2 binding site of zRNF4; DM – double mutation in the 
E2 binding site of zRNF4; I183A – single mutation in the dimerization motif of zRNF4; 
WT rRNF4 – wild type rat RNF4, a positive control for the assay; CS1 rRNF4 – a 
RING mutant rat RNF4, a E3 ligase dead mutant and negative control for the assay. 
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4.2.5 zRNF4 targets polySUMO2 for ubiquitylation in vitro 
Since it was previously shown that RNF4 targets SUMOylated proteins for 
ubiquitylation in human cells (Lallemand-Breitenbach et al., 2008; Tatham et al., 2008; 
Weisshaar et al., 2008) it was of interest to show that zRNF4 also targets polySUMO 
chains for ubiquitylation. As described in Dr. A. Plechanovova’s thesis and recent 
publication (Plechanovova et al., 2011), the rates of ubiquitylation of E3 ligases can be 
determined by conducting a single turnover substrate ubiquitylation assay. In a 
ubiquitylation reaction, it could be that the charging of an E2-conjugating enzyme to 
form an E2~Ub thioester becomes rate-limiting step. Thus, to isolate the enzymatic 
reaction catalyzed by the E3 ligase, the E2 in the reaction should be pre-charged with 
ubiquitin. In a single turnover assay, once ubiquitin has been transferred from the 
E2~Ub to the substrate, the E2 cannot be charged again with ubiquitin. An outline of 
this assay is shown in Figure 4.7A.  
The E3 ligase activities of zRNF4 and its mutants were determined in this single 
turnover assay. The E2 (UbcH5a) was first charged with ubiquitin in the presence of E1 
(Ube1) and ATP. ATP was then depleted with the addition of apyrase to stop the 
reaction. Finally, the E3 ligase and the substrate (a linear chain of 4 SUMO2 molecules 
– 4XSUMO2) were added to the reaction.  
Within 60 seconds of adding either WTzRNF4 or WTrRNF4 (positive control), 
the ubiquitylation of 4XSUMO2 is detected (Figure 4.7B, second panel). This is shown 
by the appearance of a second, higher molecular weight 4XSUMO2 band in the anti-
SUMO2 western blot. A corresponding immunoblot with an anti-ubiquitin antibody was 
performed to show that the appearance of the higher molecular 4XSUMO2 band was a 
result of ubiquitin conjugation. 
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 After 600 seconds of incubation, some modification of 4XSUMO2 is detected 
for the single site E2-binding mutants (M131A and R172A) but not for DM zRNF4, 
I183A dimerization mutant, nor for the CS1 rRNF4 (negative control) (Figure 4.7B, 
third panel). The effects of the mutations in zRNF4 are more pronounced in this single 
turnover assay as compared to that shown in the autoubiquitylation assay, suggesting a 
higher stringency in substrate ubiquitylation than in autoubiquitylation. 
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Figure 4.7: zRNF4 is able to target polySUMO2 
for ubiquitylation in vitro 
 
(A) A schematic diagram of the single turnover 
ubiquitylation assay of RNF4, with 4XSUMO2 as a 
substrate. In this assay, the E2 conjugating enzyme 
is first charged with ubiquitin via the activity of E1, 
resulting in the formation of the E2-ubiquitin 
thioester. The reaction is stopped with the depletion 
of ATP by adding apyrase to the reaction. The E3 
ligase and polySUMO2 substrate is then added, 
allowing substrate modification to take place 
efficiently. 
 
 (B) Following reducing 
SDS-PAGE, a western 
blot using anti-SUMO2 
and anti-ubiquitin 
antibodies was 
performed to show 
ubiquitylation of 
polySUMO2 by zRNF4 
and the various mutants. 
Ube1 (0.2 !M), UbcH5a 
(100 !M) and ubiquitin 
(60 !M) were incubated 
for 12 minutes at 37 °C 
in the presence of ATP 
before the addition of 
apyrase. RNF4 (0.275 
!M) and 4XSUMO2 
(5.5 !M) was then 
added and the reactions 
were stopped after 60 
and 600 seconds by the 
addition of 2X SDS 
sample buffer.  
B 
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4.2.6 Testing and purification of polyclonal anti-zRNF4 antibodies 
4.2.6.1 Testing crude antibody preparations from sheep and chicken  
The crude antibody sheep serum and chicken egg yolk extracts were first tested 
on dot blots of zRNF4 recombinant protein (Figure 4.8A). Egg yolk extracts from two 
immunized chickens (#14 and #15) were tested. At the same dilution factor, the sheep 
serum was the most sensitive  - it could detect up to 3.125 ng of protein, while the egg 
yolk extracts could detect up to 50 and 12.5 ng of protein (for #14 and 15). These crude 
antibody preparations were further tested on a Western blot of the recombinant zRNF4 
and the results show that the sheep serum is more than four times more sensitive than 
the egg yolk extracts in the detection of recombinant zRNF4 (Figure 4.8B).  
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Figure 4.8: Testing crude anti-zRNF4 antibody extracts raised in sheep and 
chickens against recombinant protein 
 
(A) A dot blot of recombinant zRNF4 protein with crude antibody extracts obtained 
from immunized sheep and chickens. Similar dot blots were incubated with the 
corresponding pre-immune extracts as well to rule out non-specific antibody 
recognition.  
(B) A western blot analysis of recombinant zRNF4 with the crude antibody extracts. 
A 
B 
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4.2.6.2 Analysis of the purified polyclonal antibodies on immunoblots  
The sheep serum and egg yolk extract from #15 were affinity-purified with 
recombinant zRNF4 protein bound to N-Hydroxysuccinimidyl-activated agarose (NHS) 
beads and the purified polyclonal antibodies were first tested on lysates from H1299 
cells overexpressing zRNF4. The sheep polyclonal antibody is more sensitive and gave 
stronger bands at a higher dilution of the antibody (Figure 4.9, left panel). However, a 
lower molecular weight band was also detected to a similar intensity which could be a 
truncated zRNF4 protein. The chicken polyclonal antibody, albeit less sensitive and 
requiring a lower dilution, is cleaner and detects the overexpressed zRNF4 (Figure 4.9, 
right panel).  
  
Figure 4.9: Testing purified sheep and chicken anti-zRNF4 polyclonal antibodies 
on immunoblots  
 
A western blot analysis of H1299 lysates overexpressing WT and DM zRNF4, using 
purified sheep and chicken anti-zRNF4 antibodies.  
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4.2.6.3 Analysis of the purified polyclonal antibodies for immunofluoescence 
To determine if the polyclonal antibodies will work in immunohistochemistry, 
H1299 cells were grown on coverslips and transfected with zRNF4 in pcDNA3, as for 
the immunoblots. Consistent with the results from the immunoblots, both the sheep and 
chicken polyclonal antibodies were able to detect zRNF4 in H1299 cells (Figure 4.10A 
and B) although the sheep antibody has a higher non-specific background – there was 
some staining detected in the untransfected cells (Figure 4.10A, top panel). It can also 
be noted that the overexpressed zRNF4 is largely nuclear, but is also detected in the 
cytoplasm.  
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Figure 4.10: Immunofluorescence staining of H1299 cells overexpressing WT 
zRNF4, using purified (A) sheep and (B) chicken anti-zRNF4 antibodies. The scale 
bar represents 20 !m.  
A 
B 
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4.3 Discussion 
 This chapter collates the in vitro data on zebrafish RNF4 (zRNF4). The full-
length mRNA sequence of zRNF4 was cloned and was found to be highly similar to the 
NCBI predicted sequence. The positions of the SIMs, zinc-coordinating residues of the 
RING domain and dimerization motif were uniform with those in other vertebrate 
RNF4 sequences, suggesting that RNF4 also targets sumoylated proteins for 
ubiquitylation in zebrafish. This was tested with in vitro biochemical assays using 
bacterially-expressed recombinant zRNF4.  
zRNF4 exhibited in vitro autoubiquitylation and was also able to ubiquitylate a 
polySUMO peptide substrate. Based on results obtained from analogous amino acid 
mutations in rat RNF4 (rRNF4), mutating the two E2-binding residues or one residue in 
the dimerization motif is sufficient to render zRNF4 an inactive ubiquitin E3 ligase, at 
least in vitro. These mutants would be useful as negative controls for zRNF4’s E3 ligase 
functions for subsequent in vivo studies.  
In spite of the many advantages of using zebrafish as a model organism, there is 
an indisputable drawback in the limited availability of antibody reagents that recognize 
zebrafish proteins (Lieschke and Currie, 2007). Thus, to facilitate the in vivo 
characterization of zRNF4, polyclonal antibodies were raised in sheep and chicken and 
subsequently purified. Both antibodies were able to detect overexpressed zRNF4 in 
immunoblots as well as on fixed cells and were thereafter used on zebrafish samples, as 
described in Chapter 5.  
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Chapter Five: Characterization of the physiological role of 
RNF4 in Danio rerio  
 
5.1 Foreword: Zinc finger nuclease knockout technology  
 
The involvement of RNF4 in the context of the DNA damage response in 
vertebrates is a relatively recent discovery. Its impact on a whole organism has yet to be 
expounded. Here, the in vivo functions of the RNF4 are explored in the zebrafish model. 
Molecular techniques such as quantitative real time PCR, in situ hybridization and 
immunohistochemistry using the in-house generated polyclonal antibodies were 
employed to determine the expression profile of RNF4 in zebrafish. Loss-of-function 
studies were also performed concomitantly using antisense morpholino knockdowns.  
To further enhance the in vivo analysis, the zinc-finger nuclease knockout technology 
was exploited to create homozygous loss-of-function knockout embryos.  
Zinc finger nucleases (ZFN) are fusion proteins composed of the FokI 
endonuclease and sequence-specific DNA binding C2H2 zinc finger modules. The 
dimerization of a pair of ZFNs when they bind to a target DNA sequence activates the 
FokI endonuclease which cleaves the DNA, generating a DNA DSB. The mutagenic 
outcome of the ZFN is dependent on the DNA DSB being repaired via non-homologous 
end joining (NHEJ). NHEJ is an error-prone repair mechanism that ligates the DNA 
ends whilst introducing insertions and/or deletions. It has been demonstrated in several 
groups, that the mutagenic effect of ZFNs is efficient enough to be transmitted through 
the germline at a high frequency (Doyon et al., 2008). In addition, known genes that 
were disrupted by ZFNs were able to manifest the well-characterized mutant 
phenotypes that were previously described, demonstrating the reliability of ZFNs as a 
method for creating gene-specific knockouts in zebrafish (Meng et al., 2008).  
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5.2 Results 
5.2.1 The spatial and temporal expression of RNF4 in Danio rerio  
5.2.1.1 zRNF4 is a maternally provided transcript and its RNA is highly abundant in 
adult zebrafish gonads 
 
Since RNF4 is a newly cloned gene in the zebrafish, it was befitting to perform a 
fundamental characterization of it. The temporal expression pattern of zRNF4 was first 
determined using quantitative real-time PCR (qPCR). RNA from embryos of different 
developmental stages, as well as from different adult tissues, were extracted and 
reversed transcribed to cDNA, which was the template for the qPCR experiment. The 
results showed that the RNA levels of zRNF4 are the highest in embryos younger than 4 
hpf, after which they decrease to low levels. The zRNF4 transcript levels becomes more 
abundant again in the adult zebrafish (Figure 5.1A).  
Mid-blastula transition (MBT) is the developmental time point at which the first 
zygotic transcription takes place, and it occurs at approximately 3.5 hpf (Kimmel et al., 
1995). At this point, the levels of maternal transcripts decrease as they are degraded. 
The observed decrease in the levels of zRNF4 transcript beyond 2 hpf suggests that 
zRNF4 plays a role in early embryonic development and is thus present in the embryo 
as maternal RNA, but is thereafter dispensable, and is thus not compensated by zygotic 
transcription.   
To determine if the higher levels of zRNF4 transcript in adult zebrafish is 
ubiquitous or tissue-specific, various adult tissues were excised for RNA extraction. The 
qPCR results show that zRNF4 mRNA localization in the adult zebrafish is highly 
tissue-specific – it is present in significantly elevated levels in the sexual reproductive 
organs (Figure 5.1B), indicating that RNF4 is likely to be involved in the zebrafish 
sexual reproductive pathway. Since the organ to animal ratio of the female ovaries far 
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exceeds that of the male testes, it accounts for the drastic difference in the RNF4 
transcript levels observed between the female and male adult fish in Figure 5.1A. 
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Figure 5.1: zRNF4 is a maternally provided gene that is highly expressed in the 
gonads of adult fish 
 
Quantitative real-time PCR was performed on cDNA from (A) zebrafish embryos at 
different developmental stages and (B) various zebrafish adult tissues. The data shown 
is a mean of two independent experiments and the error bars indicate the standard 
deviation.  
A 
B 
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5.2.1.6 Spatial distribution of zRNF4 mRNA in the early embryos and in adult gonads 
To gain further insight on the physiological role of RNF4 in zebrafish, in situ 
hybridization and immunohistochemistry was performed. Two RNA probes specific to 
non-overlapping regions on the zRNF4 transcript were prepared (Figure 5.2A) and were 
each tested on excised zebrafish ovaries. Both RNA probes showed the same staining 
pattern in the ovaries (Figure 5.2B, top panel). The corresponding negative control 
sense probes showed undetectable staining (Figure 5.2B, bottom panel), validating the 
specificity and consistency of the RNA probes. A 1:1 mixture of the two probes were 
subsequently used for all in situ hybridization experiments.  
 
5.2.1.6.1 Early zebrafish embryos  
As shown previously in Figure 5.1A, the transcript levels of zRNF4 decrease 
significantly after MBT. As such, for the zebrafish embryos, the in situ hybridization 
stainings for the 7.7, 20 and 24 hpf embryos had to proceed sufficiently longer than for 
the 1.75 hpf embryos in order for the distinct staining to be observed. From the late 
segmentation stage to the pharyngula stages (20 to 24 hpf), the distribution of zRNF4 
mRNA is not uniform throughout the embryo but is dominant in the head region (Figure 
5.3, top panel).  
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Figure 5.2: The two antisense probes for zRNF4 are specific and display a similar 
spatial distribution of zRNF4  
 
(A) A diagram showing the regions on the zRNF4 mRNA where each of the RNA 
probes to zRNF4 binds. 
(B) Whole mount in situ hybridization of excised adult zebrafish ovaries to test the 
specificity of the two RNA probes for zRNF4. The sense probes are negative controls. 
The scale bars represent 0.5 mm.  
 
 
A 
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Figure 5.3: In situ hybridization of zRNF4 in the early developmental stages 
 
Whole mount in situ hybridization of zRNF4 was performed to show the spatial distribution of zRNF4 mRNA in the early 
embryos. 
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5.2.1.6.2 Zebrafish gonads 
RNF4 has a distinctive localization in the zebrafish gonads. A description of the 
zebrafish ovary and testes anatomy is shown in Appendix B. 
 In the ovaries, the presence of the zRNF4 transcript appears to correlate with 
the stages of oocyte development (Appendix B, Figure B4). The immature, Stage I 
oocytes (Figure 5.4A) show the strongest staining for zRNF4 mRNA, followed by the 
Stage II oocytes (Figure 5.4A) and is almost non-detectable in the more developed 
Stage III and above oocytes (Figure 5.4A). This distribution of zRNF4 in the ovary is 
further substantiated by zRNF4 protein detection by whole mount 
immunohistochemistry with the sheep polyclonal antibody (Figure 5.5A), and 
immunohistochemistry on paraffin-embedded sections (Figure 5.5B).  
In the testes, zRNF4 mRNA appears to localize to microstructures within the organ 
which are not clearly visible in the whole mount stained tissue (Figure 5.4B). 
Subsequent analysis by immunohistochemistry staining revealed a weak staining of 
zRNF4 in all the cells within the seminiferous tubules (spermatocytes, spermatids and 
spermatozoa) and a much stronger, distinct staining of a fine, thread-like structure that 
surrounds the tubules (Figure 5.6A). The precise nature of this structure is unclear, but 
based on its location, it might correspond to the basement membrane and/ or the 
interstitial connective tissue (Appendix B, Figure B5). The immunohistochemical 
stainings on the paraffin-embedded sections (Figure 5.6B) reveal a nucleo-cytoplasmic 
distribution of RNF4 in all the developmental stages of the sperm cells. Contrary to the 
pattern observed in the ovaries, the spermatids and mature spermatozoa (arrow and star, 
lower panel of Figure 5.6B) stains darker for RNF4 than the immature spermatocytes 
(arrowhead, lower panel of Figure 5.6B). 
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Figure 5.4: zRNF4 mRNA is localized to specific regions in the adult gonads 
 
Whole mount in situ hybridization of zRNF4 in (A) adult ovaries and (B) adult testes.  
zRNF4 mRNA is highly abundant in the early stage oocytes (Stage I) and its levels 
decrease as the oocyte matures (Stage II and above). In the testes, zRNF4 appears to be 
localized to fine regions throughout the tissue. The scale bars represent 0.5 mm. 
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Figure 5.5A: The protein localization of RNF4 in zebrafish ovaries is consistent with its mRNA 
 
Whole mount immunohistochemistry of zRNF4 in zebrafish ovaries, using both the sheep and chicken polyclonal antibodies for 
immunofluorescence and DAB staining. The developmental stages of the oocytes are indicated. The scale bars represent 0.5 mm. 
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Figure 5.5B: The protein localization of RNF4 in zebrafish ovaries is consistent with its mRNA 
Immunohistochemistry on paraffin-embedded sections using the sheep polyclonal antibody. I, II, III  and IV indicate the respective 
developmental stages of the oocyte.  
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Figure 5.6A: RNF4 protein is ubiquitously expressed in zebrafish testes  
 
Whole mount immunohistochemistry of zRNF4 in zebrafish testes, using both the sheep and chicken polyclonal antibodies for 
immunofluorescence and DAB staining.  
The scale bars represent 0.5 mm. 
A 
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Figure 5.6B: RNF4 protein is ubiquitously expressed in zebrafish testes  
 
Immunohistochemistry on paraffin-embedded sections using the sheep polyclonal 
antibody. Arrowhead: immature spermatocytes; arrow: spermatids; star: mature 
spermatozoa 
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5.2.2 Loss-of-function study of RNF4 in zebrafish using morpholinos 
5.2.2.1 Testing the efficiency of translation-blocking morpholinos 
Knowing that zRNF4 is a maternally supplied transcript in the early embryos, it 
was obligatory to determine if the maternal RNA has already been spliced or if it exists 
in the embryos as pre-mRNA. RNA extracted from embryos at stages before and after 
MBT (1 and 4 cells embryos are before MBT, while the 6-somite embryo is after MBT) 
were reverse transcribed to cDNA and PCR was carried out with a pair of primers that 
amplified the intron-exon boundary of zRNF4 (Figure 5.7A). Figure 5.7B indicates that 
the maternally provided RNF4 RNA in early zebrafish embryos has already been 
spliced and therefore lacks the intron-exon boundary template for a successful PCR 
reaction.  
5’ UTR translation-blocking morpholinos are thus preferred for performing a 
knockdown of RNF4 in zebrafish embryos as the splice-blocking morpholinos are 
ineffective against the maternal transcripts. Two non-overlapping translation-blocking 
morpholinos (UTR2 and UTR3) that bind to sequences on the 5’ UTR of the zRNF4 
mRNA, were thus designed and ordered from Gene Tools.  
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Figure 5.7: Maternally supplied zRNF4 RNA is present in the spliced form  
 
(A) A diagram showing where the primers for the reverse-transcription PCR bind (red 
arrows).  
(B) DNA gel photo of the PCR products formed from cDNA obtained from embryos 
before MBT (1 and 4 cell stage), and after MBT (6-somite). No RT (from the 6-somite 
stage cDNA) is the negative control for the reverse transcription reaction, indicating that 
the results are obtained solely from RNA material and not from genomic DNA material. 
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To test the in vivo efficiency of these two translation-blocking morpholinos, a 
GFP reporter RNA was prepared. The 5’ UTR sequence of zRNF4 was cloned just 
upstream of the eGFP gene, such that the binding of either the UTR2 or UTR3 
morpholino would block the translation of eGFP and the embryos would not fluoresce 
green (Figure 5.8A). Embryos at the 1-cell stage were first injected with the GFP 
reporter mRNA and subsets of these injected embryos were subsequently injected with 
a control morpholino, UTR2 or UTR3. The control morpholino is specific for a human 
beta-globin intron mutation that causes beta-thalessemia but does not result in any 
phenotype except in human beta-thalessemic hematopoetic cells. As shown in Figure 
5.8B, UTR2 is less effective than UTR3 in inhibiting the expression of GFP. Likewise, 
a western blot analysis of lysates harvested from 24 hpf zebrafish after they were 
injected with the morpholinos showed that UTR3 is able to knockdown zRNF4 protein 
to undetectable levels while the effect of UTR2 is less pronounced (Figure 5.8C).  
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Figure 5.8: Testing UTR 
morpholinos against zRNF4 
 
(A) A diagram depicting the transcribed 
reporter mRNA and where the UTR 
morpholinos (UTR2 and UTR3) would 
bind to inhibit translation of the eGFP 
protein. 
(B) 6 hpf embryos that have been 
injected with 200 pg of GFP reporter 
mRNA alone, or with a morpholino 
(0.2mM). The scale bar represents 0.25 
mm.  
(C) A western blot of 24 hpf lysates 
from zebrafish that were injected with 
the 0.2 mM of UTR morpholinos. 
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5.2.2.2 Morpholino knockdown of RNF4 does not affect viability and primordial germ 
cell migration in zebrafish 
Most maternally provided genes are actively involved in the early 
developmental processes such as axis formation and determination of cell fates. If 
zRNF4 is involved in such a process, the loss of zRNF4 protein in the early stages may 
result in gross abnormalities and lethality. A titration of UTR2 and UTR3 was 
performed and at concentrations sufficient to knockdown zRNF4 protein (Figure 5.8), 
the embryos are able to survive beyond 7 days without any detectable phenotype. At 
higher morpholino concentrations, the survival of the embryos decrease substantially 
(Figure 5.9A) and a significant proportion of them develop pericardial edema and fail to 
inflate their swim bladder (results not shown). This is most likely due to the toxicity and 
non-specific effects of the morpholinos because the same phenotypes were observed in 
the control morpholino-injected embryos.  
Since RNF4 is highly expressed in the gonads of the adult zebrafish, it was of 
interest to find out if it plays a role in germ cell development, in particular, the 
migration of primordial germ cells (PGCs) at the early embryonic stages. vasa RNA is a 
marker for zebrafish PGCs. vas::eGFP transgenic embryos were injected with the 
morpholinos and the localization of PGCs were observed at 24 hpf. The knockdown of 
zRNF4 does not appear to affect the migration of PGCs (arrowhead, Figure 5.9B).  
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Figure 5.9: Morpholino knockdown of zRNF4 does not have significant effects on 
viability and primordial germ cell migration 
  
(A) A survival curve of embryos injected with varying concentrations of UTR2 and 
UTR3 morpholinos. 
(B) 24 hpf vas::eGFP transgenic embryos that were injected with 0.2 mM of 
morpholino. The arrowhead denotes the primordial germ cells. The scale bar represents 
0.25 mm.  
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5.2.3 Zinc finger nuclease knockout of RNF4 in Danio rerio 
To better understand and unravel the physiological functions of RNF4 in 
zebrafish, a knockout zebrafish was created. This was done using a recently established 
method, the zinc-finger nuclease technology. 
 
5.2.3.1 Designing and testing of the zinc finger nuclease (ZFN) for RNF4 
The zinc finger nucleases for RNF4 were designed by scientists at Sigma-
Aldrich Corporation (CompoZr, Sigma, MO, USA) based on the cloned and sequenced 
zRNF4 gene that was described in Section 4.2.1. The candidate ZFN pairs were tested 
with a yeast-based proxy system that correlates to the ZFN activity in some cell types. 
In this assay, each ZFN pair was transfected into the yeast cells and their activity is 
measured using the MEL-1 reporter assay (Doyon et al., 2008).  The ability of the ZFNs 
to generate double-strand breaks at the target site positively correlates with MEL1 
levels, which are measured before and after the induction of the ZFN expression. The 
most active ZFN pair (ZFN1) was then delivered in a ready-to-inject mRNA prep while 
DNA expression vectors were provided for the next two highest efficiency ZFN pairs 
(ZFN2 and ZFN3).  
 
5.2.3.2 Unsuccessful expression of ZFN pairs in the pZFN plasmid vector 
Zebrafish embryos were collected before the 2-cell stage and injected with 25, 
50 or 100 pg of ZFN1 mRNA. These F0 embryos were scored for the number of normal, 
‘monster’ or dead embryos at 24 hpf. The term ‘monster’ depicts embryos that are 
malformed and have gross physical abnormalities (Meng et al., 2008). Scoring the 
number of normal embryos allows the selection of a suitable injection dosage. Protein 
lysates were also extracted from 50 normal, injected embryos for a Western blot 
analysis, to validate the expression of the Flag-tagged zinc finger nuclease proteins.  
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At 48 hpf, the efficiency of somatic mutation for ZFN1 in the injected F0 
embryos was determined. In brief, 10 normal embryos injected with the same amount of 
ZFN1 were pooled and their genomic DNA was extracted. The genomic region 
containing the ZFN1 binding and cutting sites was then amplified by PCR, and the PCR 
products were further cloned into the TOPO vector. 200 clones for each injected amount 
of ZFN1 were sequenced but all the clones possessed the wild-type genomic sequence 
of RNF4 and not a single mutation was identified. The western blot analysis also failed 
to detect any Flag-tagged protein in the lysates of the F0 embryos (results not shown), 
suggesting that ZFN1 was unable to induce somatic mutations because it was not 
properly expressed in the zebrafish embryos.  
To rule out the degradation or inactivation of the ZFN1 mRNA provided, in 
vitro transcription was performed from the DNA expression vectors for ZFN1 and 
ZFN2. The ZFN1 and ZFN2 RNA was successfully transcribed from the linearized 
expression constructs and was each injected into zebrafish embryos and the efficiency 
of somatic mutation as well as the expression of the ZFN proteins were determined 
again. Similar to the previous attempt, no somatic mutations or Flag-tagged proteins in 
the Western blot analysis were detected (results not shown).  
In order to circumvent any incompatibilities between the mRNA transcribed 
from the pZFN vector (Sigma, MO, USA) and protein expression in zebrafish, the ZFN 
expression cassettes were subcloned into the pCS2+ vector.  The pCS2+ vector was 
described to be one of the preferred expression vectors for the overexpression of genes 
in zebrafish (Hyatt and Ekker, 1999) because of the presence of the 5’ UTR of the ß-
globin gene, which stabilizes the transcribed mRNA in vivo and enhances the 
expression of the encoded gene.  
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5.2.3.3 ZFN2 and ZFN3 successfully induced somatic mutations in the injected 
zebrafish embryos 
mRNA transcribed from the ZFN2 and ZFN3 expression vectors (Figure 5.10A) 
was injected into zebrafish embryos. A titration of the amount of ZFN mRNA was 
performed to determine the ideal concentration of mRNA to inject into the embryos 
(Figure 5.10C). As described in Section 5.2.3.2, the efficiencies of ZFN2 and ZFN3 
were determined by the levels of somatic mutation detected in the genomic DNA from 
the 10 pooled F0 embryos. Figure 5.10D shows that ZFN3 appears to have a higher rate 
of somatic mutation than ZFN2; and is more efficient when administered at a lower 
dose (50 pg) because the highest dose (100 pg) results in increased embryo abnormality 
and mortality (Figure 5.10C). Thus, a large number of WT fish were injected with 50 pg 
of ZFN3 mRNA.  
The western blot analysis of the lysates from the injected F0 embryos, using an 
anti-Flag antibody, also showed the detection of a pair of doublets for each of the ZFN 
pairs injected (Figure 5.10B). This doublet corresponds to the Flag-tagged monomers 
that constitute the ZFN heterodimer. These results suggest that the pZFN construct 
provided by Sigma was not a suitable vector to prepare mRNA for expression of target 
genes in zebrafish.  
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Figure 5.10: Injecting zinc finger nuclease pairs 2 and 3   
  
(A) A RNA gel photo of transcribed mRNA for ZFN2 and ZFN3.  
(B) A western blot of lysates from zebrafish injected with different amounts of ZFN2 
and ZFN3. 
(C) Titration of injected ZFN mRNA and the numbers of normal, ‘monster’ and dead 
embryos. 
(D) The frequency of somatic mutations observed in the ZFN-injected embryos. 
ZFN Pair 
 
 
Amount of mRNA 
injected (pg) 
Number of 
mutated 
sequences 
Number of 
clones 
sequenced  
% somatic 
mutation 
100 8 59 13.6 2 
50 14 49 28.6 
100 11 29 37.9 3 
50 15 33 45.5 
D 
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5.2.3.4 Outcrossing the F0 fish  
The process of acquiring homozygous RNF4 knockout zebrafish is summarized 
in Figure 5.11A. F0 fish that accumulate mutations are chimeras because the distribution 
and activity of the ZFN are variable, resulting in mosaic cells in the fish. When these 
chimeric F0  fish reached sexual maturity at 12 week post-fertilization (wpf), they were 
outcrossed with WT AB fish, and their progeny (F1) comprised of WT and 
heterozygotes for RNF4 mutations. By extracting the genomic DNA from the scales of 
individual F1 fish for genotyping through direct DNA sequencing, transmitted germline 
RNF4 mutations were determined and the heterozygotes that carried ‘loss-of-function’ 
RNF4 mutations were identified. Here, ‘loss-of-function’ RNF4 is defined as a RNF4 
protein that is truncated and is functionally inactive due to its inability to bind to its 
substrate or an E2 conjugating enzyme. 
The rates of germline transmission of mutations caused by the ZFNs are 
represented in Figure 5.11B with statistics from two F0 fish. Each of these F0 fish are 
mosaic and are hence able to generate progeny with different RNF4 mutations.  
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F0 fish Number of F1 
progeny 
RNF4 mutation & 
number of mutants 
% germline 
transmission  
Wild type; 26 26/82 = 31.7 % 
4 bp deletion; 38 38/82 = 46.3 % 
12 bp deletion; 8  8/82 = 9.8 % 
5 bp insertion + 2 bp 
substitution; 7 
7/82 = 8.54 % 
6 bp deletion; 2 2/82 = 2.4 % 
3-17 ! 82 
4 bp insertion; 1 1/82 = 1.2 % 
Wild type; 6 6/12 = 50 % 
11 bp deletion; 3 3/12 = 25 % 
3-5 ! 12 
13 bp deletion; 3  3/12 = 25 % 
Figure 5.11: Generating RNF4 mutant heterozygotes 
  
(A) A schematic diagram illustrating the process of generating a homozygous RNF4 
knockout. 
(B) A table showing the frequency of germline transmissions of RNF4 mutations in two 
representative founder fish.  
A 
B 
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5.2.3.5 Generating F2 RNF4 knockout homozygotes  
Several ‘loss-of-function’ RNF4 mutations were identified in the F1 fish, but 
three of these mutations recurred the most: a four base pair deletion (!4), an eleven base 
pair deletion (!11) and a 5 base pair insertion with a 2 base pair substitution (ins5sub2). 
These mutations result in an early stop codon in the RNF4 coding sequence, which 
generates a truncated protein that lacks both the substrate-binding SIMs and the RING 
domain (Figure 5.12). F1 heterozygotes carrying the same ‘loss-of-function’ RNF4 
mutations were crossed, and their progeny (F2) were genotyped by both direct DNA 
sequencing as well as PCR amplification. Two pairs of PCR primers were designed 
specifically for each of the two ‘loss-of-function’ mutations (!4 and ins5sub2) such that 
one pair anneals only to the WT RNF4 genomic sequence while the other pair anneals 
only to the mutant RNF4 sequence. This way, it would be possible to screen a large 
number of F2 fish quickly and effectively discriminate the three genotypes: WT, RNF4 
mutant heterozygotes and RNF4 knockout homozygotes, as illustrated in Figure 5.12B.  
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A 
4 base pair deletion (!4)  
 
DNA sequence: 
 
CCCAGATGTCTCAGACAGTGATGGAGACCATTG 
CCCAGATGTCT----CAGTGATGGAGACCATTG 
 
Protein sequence: MSTTVTQRKRRTSSTTCSRRGNSKRNRAQMSQ 
 
11 base pair deletion (!11) 
 
DNA sequence: 
 
CCGGGCCCAGATGTCTCAGACAGTGATGGAGACCATTG 
CCGGGCCCAGATGTCT-----------GGAGACCATTG 
 
Protein sequence: MSTTVTQRKRRTSSTTCSRRGNSKRNRAQMSGDH 
 
5 bp insertion + 2 base pair substitution (ins5sub2) 
 
DNA sequence: 
 
CCCAGATGTCT     CAGACAGTGATGGAGACCATTG 
CCCAGATGTCTGTGTGTGGACAGTGATGGAGACCATTG 
 
Protein sequence: MSTTVTQRKRRTSSTTCSRRGNSKRNRAQMSVCGQ 
 
B 
 
 
 
Figure 5.12: Screening zebrafish for 
‘loss-of-function’ RNF4 mutations 
 
(A) DNA and protein sequences of three 
RNF4 genomic mutations identified in the 
F1 fish. The top DNA sequence is the wild 
type sequence and the bottom sequence is 
the mutated sequence. The ZFN cutting site 
is highlighted yellow. Deletions are 
indicated by red dashes, insertions by blue 
highlighted blue letters and substitutions 
are underlined red letters.  
 
(B) An example of PCR screening of !4 
and ins5sub2 mutants using two different 
sets of primers. 
 178 
5.2.3.6 The loss of RNF4 function does not result in embryonic lethality 
Figure 5.13 shows the DNA sequence chromatograms from the F2 fish and Table 5.1 
presents the distribution of the different genotypes. By means of a Chi-square test, the 
difference in proportions of WT, heterozygotes and RNF4 knockout homozygotes for 
each ‘loss of function’ mutation as compared to Mendelian ratios is not statistically 
significant. This indicates that the RNF4 -/- homozygotes are fully viable and are not 
critically required for the early embryonic development in zebrafish. This is also 
supported by the results from the morpholino knockdown of RNF4 which was described 
in Section 5.2.2.2.
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Figure 5.13: 
Chromatograms 
showing the wild 
type, heterozygous 
and mutant 
homozygous 
sequences of RNF4 
from the F2 fish 
 1
8
0
 
Table 5.1: Distribution of observed genotypes from an incross of heterozygous RNF4 mutant fish 
 
 
 
 
 
 
 
 
Genotype WT RNF4 +/- (!4) RNF4 -/- (!4) "
2 
Observed % 23/74 = 31 % 33/74 = 45 % 18/74 = 24 % 1.54, P=0.05 
Genotype WT RNF4 +/- (!11) RNF4 -/- (!11)  
Observed % 5/21 = 23.8 % 13/21 = 61.9 % 3/21 = 14.3 % 1.57, P=0.05 
Genotype WT 
RNF4 +/- 
(ins5sub2) 
RNF4 -/- 
(ins5sub2) 
 
Observed % 23/96 = 24 % 43/96 = 44.8 % 30/96 = 31.3 % 2.06, P=0.05 
Expected % 25 % 50 % 25 %  
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5.3 Discussion 
In an endeavour to understand the physiological role of RNF4 in the vertebrate 
DNA damage response, the zebrafish was chosen as a model organism. As this is the 
first time RNF4 has been identified in zebrafish, it was imperative to know if RNF4 was 
involved in any major biological function such as early embryonic development or 
whether it was essential for viability. This was addressed in a two-pronged approach: 
first, a general characterization of RNF4 expression in zebrafish was made; and second, 
a loss-of-function analysis was undertaken.   
 
5.3.1 RNF4 is a non-essential gene in zebrafish  
The results herein demonstrate that zRNF4 is a maternally provided gene and is 
minimally expressed when the first zygotic transcription commences. Maternally 
provided genes are often involved in early development and are described to affect 
specific developmental stages: oogenesis, egg activation, cleavage, patterning and 
morphogenesis (Abrams and Mullins, 2009). While most of such maternal-effect genes 
are identified by forward genetics screening of mutants that display aberrant early 
development phenotypes (Dosch et al., 2004; Wagner et al., 2004), the use of 
translation-blocking morpholinos to knockdown maternal genes have also successfully 
recapitulated abnormal developmental phenotypes (Nasevicius and Ekker, 2000).  
When the morpholino knockdown of zRNF4 failed to show any effects on 
embryo cleavage, patterning and morphogenesis, two possibilities emerged: either 
zRNF4 is dispensable for early development in zebrafish altogether, or, it is implicated 
in the processes prior to fertilization and thus, injecting the translation-blocking 
morpholinos at the 1-cell stage is too late to block the function of zRNF4. This dilemma 
may be resolved by the analysis of the RNF4 ZFN-knockout zebrafish. However, since 
the F2 homozygotes were generated from an incross of heterozygote parents, they are 
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still carrying wild type copies of maternally provided zRNF4 RNA, which will nullify 
their RNF4 -/- genotype. Thus, only the F3 embryos obtained from an incross of the F2 
homozygotes would give a definite answer. 
When RNF4 knockout mice were generated, they were embryonic lethal and 
failed to survive beyond day 15 due to cardiac insufficiency (Hu et al., 2010). The ZFN 
knockout zebrafish, on the other hand, are able to survive beyond the early 
developmental stages and have now just reached the juvenile stage (3 months post 
fertilization). The protective feature of the maternally provided mRNA may have 
sustained the F2 homozygotes through the early developmental processes but beyond the 
MBT, it appears that the loss of RNF4 does not affect the embryo survival. This is 
unlike the roles of SUMO and Ubc9 in zebrafish development.  
The three SUMO paralogs (1, 2 and 3) and Ubc9 are maternally provided and 
zygotically expressed in zebrafish (Nowak and Hammerschmidt, 2006; Yuan et al., 
2010). Similar to RNF4, the transcripts of these genes were ubiquitously expressed at 
the early embryonic stages but later showed to be more predominant in the head regions 
of the pharyngula. This similar spatial expression pattern shared between all three genes 
might correspond to a common biological function. On the contrary, the use of 
morpholinos to deplete zygotically expressed SUMO or Ubc9 resulted in severe 
developmental defects and embryonic lethality which was not observed in RNF4-
depleted embryos (Nowak and Hammerschmidt, 2006; Yuan et al., 2010). Interestingly, 
in the SUMO rescue experiments, the expression of a SUMO2 K11E mutant, which is 
unable to form polymeric SUMO chains, was able to revert the SUMO mutant 
phenotype, indicating that the formation of polySUMO chains may not be imperative 
for the physiological functions in early development (Yuan et al., 2010). Since the 
polysumoylation of proteins is not critical in the early developmental processes in 
zebrafish, RNF4, which regulates the levels of polysumoylated proteins, is likely to be 
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likely to be dispensable, thus explaining for the minimal zygotic expression and non-
lethal phenotype in the ZFN-knockout fish. 
 
5.3.2 RNF4 and gonadal development 
The elevated levels of RNF4 mRNA in the adult zebrafish gonads suggests that 
it might be implicated in gonadal development and/ or the developmental processes 
leading up to fertilization. These results concur with work that have already been 
performed in mice and rats, which was done in the context of steroid-dependent 
transcriptional regulation (Hirvonen-Santti et al., 2004).  
Other than spermatogenesis taking place within cysts (a single germ cell clone is 
surrounded by the cytoplasmic projections of a Sertoli cell), spermatogenesis in teleost 
fish is highly akin to that in mammals (Nobrega et al., 2009). The spatial expression 
pattern of RNF4 is similar to that in the rat testes: RNF4 accumulates in postmeiotic 
spermatids and was postulated to be involved in spermiogenesis or spermatid 
maturation (Yan et al., 2002). One of the major processes in spermiogenesis is the 
compaction of DNA. It was previously described that RNF4 is able to bind to 
nucleosomes in a non-sequence specific manner (Hakli et al., 2001) and it may be 
speculated that RNF4 aids spermatid maturation by enhancing chromatin condensation. 
  The proper initiation and progress of meiosis is a key event in gametogenesis. 
Homologous recombination between non-sister chromatids has a well-documented role 
in genetic diversity and increasing the fitness of a species. In this context, DNA repair 
proteins involved in homologous recombination repair are especially crucial in ensuring 
successful chromosomal crossover and meiotic progression because DNA DSBs are a 
fundamental for the initiation of meiotic recombination (Richardson et al., 2004). The 
recent work on RNF4 culminates on its role in homologous recombination repair 
(Galanty et al., 2012; Yin et al., 2012) and indicates a possible involvement in meiosis. 
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This is further supported by the discovery that SUMO colocalizes with !H2AX in 
meiotic germ cells (Shrivastava et al., 2010).  
In zebrafish, the DNA repair genes FANCL and FANCD-1 (also known as 
BRCA2) were separately reported to be associated with sex determination via regulating 
apoptosis of germ cells (Rodriguez-Mari and Postlethwait, 2011). In FANCL mutants, 
the activation of p53-mediated apoptosis impairs the survival of oocytes and directs a 
female-to-male sex reversal (Rodriguez-Mari et al., 2010). On the other hand, the 
FANCD-1 mutants appeared phenotypically male but were infertile. Functional 
FANCD-1 was essential for the development of ovaries and the depletion of FANCD-1 
led to impaired meiosis and p53-mediated apoptosis of germ cells, which was also 
observed in the testes of the mutant fish. In addition, these FANCD-1 mutants had a 
predisposition to testicular neoplasia, demonstrating how deregulation of gonad 
development may also lead to tumorigenesis (Shive et al., 2010). These results depict a 
manner in which DNA repair proteins may regulate basic cellular functions like 
apoptosis that translate into a complex physiological phenomenon in an organism. 
The results herein shows that RNF4 protein and mRNA is abundant in specific 
stages of oocytes in the zebrafish ovaries – it is highly expressed in the early Stage I 
oocytes and decreases as the oocytes mature. Stage I or primary oocytes include cells in 
meiosis I leptotene, zygotene, pachytene and diplotene stages. At these meiotic stages, 
the chromosomes have duplicated, undergone synapsis and homologous crossover. The 
stage I oocytes arrest at the diplotene stage where desynapsis occurs and the 
chromosomes decondense for RNA synthesis of oocyte storage material (Selman et al., 
1993). In mice, RNF4 levels was also shown to peak in oocytes of preantral follicles, a 
stage where they arrest at the diplotene stage in meiosis I (Hirvonen-Santti et al., 2004), 
indicating that even with the anatomical differences between the teleost and mammalian 
ovaries, the role of RNF4 in oocyte development may be conserved.  
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A similar expression pattern in zebrafish oocytes has previously been recorded 
for the genes vasa, ziwi and nanos1. These genes were expressed in high levels in the 
early stage oocytes and are essential for germ cell development and survival (Houwing 
et al., 2007), and maintenance of oocyte production (Draper et al., 2007). These 
observations suggest that RNF4 might play a similar role in germ cell maintenance in 
zebrafish. However, the exact role of RNF4 in gonads and whether it is linked to its 
function as a DNA repair protein has yet to be elucidated.  
 
5.3.3 Future work 
The results in this chapter convey a preliminary characterization of RNF4 in 
zebrafish. The zinc-finger nuclease technology has successfully generated homozygotes 
that lack functional RNF4, which is a constructive tool for the subsequent analysis on 
the specific roles of RNF4 as a STUbL protein in DNA damage, as well as in gonad 
development.  
The F2 homozygotes of the RNF4 ZFN-knockout zebrafish have been obtained, 
but to prevent maternally provided wild type material from interfering with the 
manifestation of the loss-of-function phenotype, these F2 homozygotes would have to 
be incrossed to obtain F3 embryos for analysis. The involvement of RNF4 in early 
development and survival can then be ascertained. A histological examination of gonads 
from juvenile homozygotes will shed light on the role of RNF4 in gonadal development 
and meiosis.  
It was earlier discovered that zebrafish embryos express different sensitivity to 
different types of DNA damage before and after MBT (McAleer et al., 2004). This was 
attributed to the change in cell cycle profiles consisting of synchronous, short cycles of 
S & M phases, to complete cycles with the G1 and G2 phases. If RNF4 does indeed 
play a significant role in DSB repair, we would expect to see a significant increase in 
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sensitivity to DNA damage before the MBT in the RNF4 ZFN-knockout embryos. This 
hypersensitivity may drastically affect the gross morphology of the embryos due to the 
rapidly proliferating cells during development. Once it is known if RNF4 is engaged in 
protecting embryos from DNA damaging agents, rescue experiments can be performed 
by introducing exogenous WT or DM RNF4 RNA in the embryos, to affirm that RNF4 
E3 ligase activity is necessary for its protective function in zebrafish. Ultimately, it is 
hoped that the mechanism by which RNF4 regulates DSB repair in zebrafish can be 
deciphered. This includes identifying the substrates of RNF4, the E2 it interacts with, 
and the type and consequence of the ubiquitin modification on the substrates.      
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Chapter Six: Directions for further analysis on the biological 
role of RNF4  
6.1 Using the DT40 RNF4 -/- cells as a tool to further expound the 
DNA damage role of vertebrate RNF4   
6.1.1 A strategy to identify the substrates of RNF4 
The data in Chapter Three showed that the homozygous loss of RNF4 in DT40 
cells resulted in an accumulation of high molecular weight SUMO2/3 conjugates. It is 
likely that these sumoylated proteins are substrates for RNF4 under normal conditions 
when the cells are not exposed to external stresses. The SILAC (stable isotope labelling 
by amino acids in culture) proteomics approach is a possible method to identify these 
proteins (Golebiowski et al., 2009). In essence, while wild-type DT40 cells are grown in 
complete cell culture media, the RNF4 -/- cells are grown in cell culture media lacking 
the amino acids L-lysine and L-arginine, which will then be supplemented with stable 
isotope forms such as Lys4 and Arg6. The lysates from both cell populations are then 
harvested and purified using the N-terminal fragment of RNF4 containing the four 
SIMs, before separation by SDS-PAGE, in-gel tryptic digestion and mass spectrometry 
analysis as described previously (Bruderer et al., 2011; Golebiowski et al., 2009). In this 
experiment, the identified proteins that appear in the RNF4 -/- cells and not the wild-
type cells are potential substrates of RNF4.  
A second experiment may be performed, but this time with the cells exposed to 
various stress conditions such as drug treatment with hydroxyurea, before harvesting 
their lysates. Similarly, the SIM-peptide affinity purified proteins present in the RNF4  
-/- cell lysates but not in the wild-type lysates are likely to be the substrates of RNF4 in 
the context of its role in the DNA damage response.  
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6.1.2 Understanding the mechanism of RNF4 as a DNA damage response protein 
Identifying the relevant ubiquitin E2 conjugating enzymes that RNF4 
cooperates with is one way to dissect the mechanism of RNF4’s ubiquitin E3 ligase 
activity. Screening kits for E2 ubiquitin conjugating enzymes are available from 
companies such as Ubiquigent (E2
scan
™ Kit) and they facilitate the isolation of E2s that 
promote the ubiquitylation of a substrate by a specific ubiquitin E3 ligase of interest. 
Preliminary experiments performed by my colleague, Ellis Jaffray (Hay Lab, University 
of Dundee), has identified Ube2W as an E2 that mediates the monoubiquitylation of 
polySUMO2 by RNF4 in vitro. Further analysis showed that monoubiquitylated 
polySUMO2 is a substrate for polyubiquitylation by RNF4, with Ubc13-Uev1 as the E2 
conjugating enzyme. These observations suggest that RNF4 may direct the assembly of 
a variety of ubiquitin conjugates on its substrates depending on the E2 it engages.  
The homozygous deletion of Ube2W in DT40 cells resulted in a similar 
hypersensitivity to hydroxyurea as observed in the RNF4 -/- cells (unpublished data), 
suggesting the likely role of Ube2W in the S-phase specific DNA damage response. To 
further determine if Ube2W and RNF4 cooperate to target DNA-damage specific 
substrates in the same pathway, a double knockout of both genes can be obtained in the 
DT40 cells and subjected to the same clonogenic survival assays. If the double 
knockout cells exhibit a sensitivity to hydroxyurea similar to the RNF4 -/- or Ube2W -/- 
cells, it may be hypothesized that they have a positive epistatic relationship and function 
in the same pathway. If the subsequent loss of Ube2W aggravates the hypersensitivity 
of the cells to hydroxyurea, it suggests that both proteins function in compensatory 
pathways. On the other hand, if the loss of Ube2W rescues the mutant phenotype of the 
RNF4 -/- cells, it is likely that they function in opposing pathways (Collins et al., 2007). 
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6.1.3 Measuring repair of DNA double strand breaks in DT40 cells 
Since it has been established that RNF4 in involved in mediating DNA end 
resection in homologous recombination repair of DNA double strand breaks, a delayed 
or impaired effective DNA DSB is expected in the DT40 knockout cells. A quantitative 
assay of measuring DNA DSB repair would allow the comparison of DNA repair 
activities between wild type and various mutants of RNF4, for instance, a ligase-dead 
mutant or a mutant with disrupted SIMs. GFP reporter assays have been established for 
DT40 cells, to measure the repair of a restriction-enzyme (I-Sce-I)-induced DNA DSBs 
by homologous recombination, single strand annealing, non-homologous end-joining or 
microhomology-mediated end-joining (Yun and Hiom, 2009). Briefly, the gene of 
interest (RNF4, Ube2W and/ or any identified substrate of RNF4) is knocked out in 
each of the individual stable lines of the various GFP reporter constructs. The 
subsequent transient expression of the restriction enzyme, I-Sce-I, would induce a DNA 
DSB in the GFP expression cassette. Effective repair can be detected by the restoration 
of a GFP signal, which is measured by FACS analysis for the number of GFP-positive 
cells. These assays would narrow down the DSB repair mechanisms in which RNF4 are 
involved in. 
 
6.2 Prospective studies on RNF4 in Danio rerio 
6.2.1 Detailed characterization of the loss of RNF4 in the zinc-finger nuclease 
knockout zebrafish 
Thus far, the loss of RNF4 in the ZFN knockout fish has been only validated 
by genomic DNA sequencing. The loss-of-function mutants have a premature stop 
codon and are likely to express a truncated protein. However, eukaryotic cells have 
evolved a mechanism to prevent the accumulation of potentially harmful truncated 
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proteins by the nonsense-mediated mRNA decay (NMD) pathway (Conti and 
Izaurralde, 2005; Wittkopp et al., 2009). Performing a reverse transcription PCR 
followed by RNF4-specific quantitative real-time PCR on RNA samples obtained from 
the ZFN knockout fish can validate this. In addition, if NMD regulates the degradation 
of the mutant RNF4 mRNA, the sheep polyclonal antibody generated (Section 4.2.6) 
could be used in a western blot or whole mount immunohistochemistry analysis to show 
the ablation RNF4 protein expression in the knockout fish.  
 
6.2.2 Analysis on the zinc-finger nuclease knockout F3 generation fish 
As described in Section 5.3.3, the F3 homozygotes of the RNF4 knockout line 
may give a clearer loss-of-function phenotype because they will not carry any wild-type 
maternal mRNA at the early developmental stages which may prevent the manifestation 
of a developmental or DNA-damage phenotype. The survival and normal development 
of the F3 knockout homozygotes would substantiate the hypothesis that RNF4 is not an 
essential gene in zebrafish. The embryonic lethality of the knockout of RNF4 in mice 
was associated with its role in regulating DNA demethylation (Hu et al., 2010). The 
reason why the loss of RNF4 is not lethal in zebrafish could be that it is not imperative 
in mediating DNA demethylation. To substantiate this hypothesis, the levels of DNA 
methylation in the RNF4 knockout fish may be analysed by bisulphate sequencing 
analysis of maternally imprinted genes, or by using methylation sensitive restrictions 
enzymes on several genes (Zilberman and Henikoff, 2007).  
The ratio of females to males, as well as a histological analysis of the adult 
gonads, would indicate if the loss of RNF4 conferred a defect in the development of the 
sexual reproductive organs. If meiosis was impaired in the knockout fish, we would 
expect to see an abnormal distribution of oocytes and spermatocysts of the different 
developmental stages in the gonads. It might also lead to infertility or sex-reversal in the 
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adult fish, as observed in the FANCL and FANCD-1 mutant zebrafish (Rodriguez-Mari 
et al., 2010; Rodriguez-Mari and Postlethwait, 2011; Shive et al., 2010).  
The vas::eGFP transgenic line generated by Krovel and colleagues is a useful 
tool to visualize and track the migration and location of primordial germ cells in 
juvenile zebrafish (Krovel and Olsen, 2002). To determine if RNF4 has any influence 
on the migration and survival of the primordial germ cells, the knockout fish can be 
crossed with the transgenic line. 
 
6.2.2.1 Elucidating the DNA-damage phenotype of the ZFN RNF4 knockout fish 
The morpholino knockdown of RNF4 failed to render zebrafish embryos more 
sensitive to DNA damaging agents (results not shown). It is possible that a complete 
ablation of RNF4 protein expression is required to generate a detectable DNA-damage 
phenotype in zebrafish. McAleer and colleagues found that zebrafish embryos were 
more sensitive to ionizing radiation before the mid-blastula transition (MBT) because 
most cells were in the S and M phases of the cell cycle (McAleer et al., 2004). Since 
RNF4 expression was also high before MBT, it may be assumed that RNF4 has an 
important function in maintaining genomic stability during this highly proliferative 
stage. Thus, wild-type and the RNF4 knockout embryos could be exposed to a range of 
DNA damaging agents that induce a variety of DNA lesions, to determine the damage 
protective function of RNF4.  
Other than monitoring the gross morphology of the embryos after the various 
DNA damaging treatments, several assays may be performed to assess efficient DNA 
repair and cell survival. A straightforward assay that does not require sacrificing the 
embryos is acridine orange staining, which is able to label apoptotic cells in live 
embryos. The extent of cell death can be further determined by TUNEL (terminal 
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deoxynucleotidyl transferase dUTP nick end labeling) staining, which detects 
fragmented DNA in apoptotic cells.  
Since the work in human cells hypothesized that of RNF4 is involved in DNA 
end-resection of DNA DSB repair (Yin et al., 2012), it might be worthwhile to perform 
BrdU (Bromodeoxyuridine) incorporation and detection by a BrdU-specific antibody on 
the challenged zebrafish embryos. A failure to effectively perform DNA end-resection 
after the generation of DNA DSBs would lead to a decrease in the formation of single-
stranded DNA, which is indicated by BrdU staining (without the DNA denaturation 
step). Effective DNA repair can be further assessed by immunohistochemistry staining 
with the antibody against the DNA damage marker, !H2AX. In addition, reporter 
systems for analyzing DNA DSB repairs in zebrafish have recently been established 
(Liu et al., 2012). These assays are similar to the ones used in DT40 cells but they also 
enable DNA repair to be measured quantitatively by real-time PCR.  
The yeast STUbL mutants displayed genomic instability hallmarks such as 
gross chromosomal rearrangements (Zhang et al., 2006). It would be interesting to 
perform a cytogenetics study such as chromosomal karyotyping on the cells from the 
RNF4 knockout fish (Peterson and Freeman, 2009; Sola and Gornung, 2001), to see if 
the role of STUbLs in maintaining chromosomal integrity in yeast is conserved in 
vertebrates. 
  
6.2.2.2 Considering the possibility of functional redundancy 
In the event that a DNA damage or genomic instability phenotype cannot be 
observed in the RNF4 knockout fish, there is a possibility that there are other proteins 
that may function in compensatory pathways to RNF4, leading to functional 
redundancy. Screening embryos from RNF4 knockout fish exposed to ENU (N-ethyl-N-
nitrosourea) will enable the identification of such genes. ENU mutagenesis generates 
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random mutations in the fish genome and should a desired phenotype be obtained, 
positional cloning will be performed to identify the mutated gene responsible for the 
phenotype. ENU mutagenesis can be used to screen for synthetic lethal genes, genes 
that result in a hypersensitivity to DNA damage or genes that cause infertility in the 
only in the RNF4 knockout fish but not in wild-type fish.  
Another approach would be to cross the RNF4 knockout fish with other 
tumour-prone fish such as the p53-M214K mutant fish that have a predisposition to 
malignant peripheral neural sheath tumours (Berghmans et al., 2005); the BRAF V600E 
mutant fish that have a high incidence of melanoma in the absence of wild-type p53 
function (Patton et al., 2005; Patton and Zon, 2005); the FANCD-1 mutant fish that 
develop testicular neoplasia (Shive et al., 2010); as well as several mutants that develop 
germ cell tumours (Neumann et al., 2011a; Neumann et al., 2009; Neumann et al., 
2011b). The progeny of the crosses should then be monitored for the spontaneous 
occurrence of tumours by morphological observations as well as histological analysis.  
 
6.3 Taking the study of RNF4 from bench to bedside 
The data from Chapter 3 suggests that the levels of RNF4 in cells might be 
critical in its role in DNA-damage sensitivity. In the DT40 knockout rescue, 
reintroducing a low level of wild-type RNF4 resulted in a resistance to HU that 
surpassed that of the wild-type cells. On the contrary, a high level of wild-type RNF4 
could only partially rescue the DNA-damage sensitive phenotype associated with the 
homozygous loss of RNF4. It is highly intriguing to find out if these in vitro 
observations have any relevance or consequences in medical treatments of human 
cancers. Moreover, human testicular germ cell tumours have shown reduced levels of 
RNF4 expression (Hirvonen-Santti et al., 2003; Pero et al., 2001).  
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It would be interesting to perform a histological analysis of RNF4 protein 
levels on tumour samples from patients suffering from various forms of cancers that are 
routinely treated with hydroxyurea. Some examples are chronic and acute myeloid 
leukemia, head and neck cancers, and ovarian cancers. It might be necessary to generate 
and purify a monoclonal antibody against human RNF4 in order to make a good semi-
quantitative comparison of RNF4 protein levels across the different samples. In 
addition, the treatment history of each patient including the types, dosage and length of 
treatment received, the occurence of any resistance, remission or recurrence, should be 
taken into account with each sample that is analyzed. This way, the association between 
RNF4 and human cancers can be better understood. 
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Conclusion 
The aim of this study was to establish the role of RNF4 in the vertebrate DNA 
damage response. The homozygous knockout of RNF4 in the DT40 cell line 
demonstrated that RNF4 protects cells from genotoxic insults, particularly during S-
phase, and that its ubiquitin E3 ligase activity is essential for its protective function. 
These results were subsequently validated and expanded in work performed in human 
cell lines, establishing the role of RNF4 in homologous recombination repair, 
specifically by promoting DNA end resection (Appendix A).   
To understand the implications of this novel DNA repair protein in a whole 
organism, RNF4 was analysed in zebrafish. Zebrafish RNF4 (zRNF4) is a newly cloned 
gene and was shown to share the same functional domains and key amino acid residues 
as the other vertebrate RNF4 proteins. zRNF4 displayed robust ubiquitin E3 ligase 
activity in vitro and could target polySUMO2 for ubiquitylation. In zebrafish, zRNF4 is 
a maternally provided and minimally expressed in zygotes. It is highly expressed in the 
gonads of adult zebrafish in a developmental stage-specific manner, suggesting a role in 
the oocyte and sperm development. Loss-of-function studies using morpholino 
knockdown as well as zinc-nuclease knockout technologies demonstrate that RNF4 is 
not an essential gene in zebrafish. However, its in vivo role as a DNA repair protein has 
yet to be elucidated by further analysis on the loss-of-function ZFN RNF4 knockout 
model.  
The findings in this thesis illustrate how the function of a ubiquitin E3 ligase 
may influence a diverse range of biological processes. It would be of interest to 
expound on how the activity of RNF4 is regulated in the different pathways, to ensure 
that RNF4 targets the appropriate substrates at the right time, in specific cells. The 
ultimate objective is to establish the clinical implications of this study. 
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Appendix B: Anatomy of the zebrafish ovary and testes  
 
The zebrafish ovary is a paired organ located in the abdomen and surrounded 
by the other internal organs such as the liver and intestines (Figure B1). The zebrafish 
undergoes asynchronic ovulation – its ovaries contain ovary follicles (or oocytes) at 
different stages of development (Garg, 1998). Figure B3 is a schematic diagram of a 
view of part of the zebrafish ovary containing oocytes at different developmental stages. 
From this view, the stages are determined by their sizes. A histological section of the 
ovary shows further details of the different stages of oocytes, as represented by the 
schematic in Figure B4 (Selman, 1993; Yön, 2008).  
The zebrafish testis is also a paired organ that lies laterally along the mid-trunk 
of the male adult fish, in between the swim bladder and intestines (Figure B2). The 
testis is composed of a series of seminiferous tubules, of which the lumen is filled with 
mature spermatozoa. The organization of the testes is shown in a nuclear-stained 
paraffin section in Figure B5 (Leal et al., 2009; Menke et al., 2011).  
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Figure B: The zebrafish 
gonads 
 
(1) The trunk section of a 1 
year-old adult female 
zebrafish with part of the 
skin removed to show the 
position of the ovaries.  
 
 
 
 
 
(2) The trunk section of a 1 
year-old adult male 
zebrafish with part of the 
skin removed to show the 
position of the testes. 
 
 
 
 
 
 
(3) A schematic diagram of 
a part of the zebrafish 
ovary that is dissected 
from the animal. The ovary 
contains oocytes at 
different developmental 
stages, represented by 
different colours. Orange: 
Stage I oocytes, Green: 
Stage II oocytes, Purple: 
Stage III & IV oocytes 
   
 4 
Figure B4: Oocyte development in zebrafish 
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Figure B5: Paraffin section of an adult 
zebrafish testis stained with a nuclear 
stain. 
 
The seminiferous tubule is composed of 
cysts of spermatocysts (spermatocytes and 
spermatids) of different developmental 
stages. The green boundary outlines a 
tubule with a lumen (outlined in orange) 
containing mature spermatozoa. Each 
tubule is surrounded by a basement 
membrane and connective tissue (shown 
with an arrow). Androgen-producing 
Leydig cells are also located between the 
seminiferous tubules. Diploid 
spermatogonia are located at the luminal 
side of the basement membrane (shown 
with an arrow). They undergo the first 
meiotic division to form spermatocytes 
(diploid). After the second meiotic 
division, spermatids (haploid) are formed. 
Mature spermatozoa are eventually formed 
after spermiogenesis and are released into 
the tubule lumen. (Leal et al., 2009) 
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Appendix C: Plasmid Vector Maps 
                               
                           
 
Figure C1: DT40 rescue construct (Rat RNF4) 
              
Figure C2: DT40 rescue construct (Zebrafish RNF4) 
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Figure C3: Vector construct of zRNF4 in pLou3 
 
                      
Figure C4: pCS2+ 
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Figure C5: 5’UTR-zRNF4-GFP reporter 
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Appendix D: Graphs for qPCR primers  
 
 
 
 
Figure D1: Template dilution curves for actin and RNF4 primers used in qPCR in 
DT40 cells 
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Figure D2: Template dilution curves for primers used in qPCR in zebrafish 
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Figure D3: Relative efficiencies of amplification of the qPCR primer pairs 
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